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Hypervalent iodine oxidants have been used extensively in oxidative metal catalysis, 
especially in gold catalysis, where the redox potential of gold(I) to gold(III) is large. The 
reoxidation of gold(I) within an intramolecular gold-catalysed direct arylation reaction 
developed previously in the group occurs after the turnover-limiting step, and so cannot be 
studied by analysing the reaction rates. Competition reactions between ArIIII(OR)2 oxidants 
with different electronic parameters have been carried out to gain further understanding into 
the reoxidation of gold(I) under the following reaction conditions.  
 
Scheme 1: Summary of oxidant competition carried out under a gold(III)-catalysed direct 
arylation reaction of an intramolecular substrate. 
It was found that the more electron-rich oxidant has a higher relative rate compared to 
electron-poor oxidants and log krel gave the best correlation with σ+ of the para-substituent. 
This suggests that the oxidant undergoes an initial ligand dissociation step to give an iodonium 
species before the gold is oxidised, as opposed to forming a π-complex with the gold(I) 
intermediate. 
Contrary to this result, the relative redox potential of these oxidants, calculated by looking at 
the equilibrium position between an iodine(III) oxidant and an aryl iodide showed that the 
more electron-deficient oxidant has a higher redox potential, and is therefore the more 
oxidising oxidant when compared to electron-rich oxidants. This trend has also been illustrated 




In an attempt to obtain a system where the absolute rates of oxidation of gold(I) can be 
obtained, a new experimental setup was utilised. Injection of an oxidant into the reaction 
mixture within the NMR spectrometer allowed for the monitoring of the oxidation product 
with very small dead time, and the oxidation of gold(I) generated in the reaction can be 
monitored.  
In addition to this, the oxidation of (Ph3P)Au(Cl) as a gold(I) example was studied. At low 
amounts of free CSA, an induction period was observed, and was significantly lengthened by 
the presence of stoichiometric amount of Cl−. A tentative mechanism has been proposed, 





A major goal in chemical synthesis is the ability to transform a molecule completely into a 
different compound with no by-products or waste. Without the formation of by-products, 
issues such as separation of the desired products and disposal of the waste products are non-
existent. One way of describing the efficiency of a reaction in converting all the atoms in the 
starting material into product is to use atom economy. Atom economy is expressed as a 
percentage of the molecular weight of the desired product over the molecular weight of all the 
reactants used. 
One method of improving atom economy is to use catalytic amounts instead of equal 
(stoichiometric) amount of reagents to aid a reaction. This means that only a small quantity of 
reagents, relative to the starting material, is required. Furthermore, a catalyst is not consumed 
in a reaction, and so, the recovery of the catalyst is plausible. 
Cross-coupling reactions are typically reactions where two preactivated starting materials are 
reacted to give a product in a presence of a catalyst. These types of reactions, catalysed by 
palladium, were awarded the Nobel Prize in Chemistry in 2010.  In forming the product, the 
activating groups on the starting material are not incorporated in the product and are lost as 
by-products. Furthermore, preactivated starting materials are not typically commercially 
available, and have to be made. This introduces more steps into the synthesis, generating more 
waste from the reaction and purification steps. 
Strategies to obtain these coupling products where one or both starting materials do not require 
preactivation have been developed. However, issues such as selectively forming a 
cross-coupled product (as opposed to a homocoupled product, where two of the same starting 
material have reacted) or forming a bond in a specific site between the two coupling partners 
have proven challenging.  
This thesis looks at a gold-catalysed reaction where one starting material has been 
preactivated. Previous work looking into the mechanism of this reaction have led to: 
• The development of an improved precatalyst, with shorter reaction times. 
• A good understanding of the basis of selectivity for a cross-coupled product. 
• The identification of an inhibitor species present in the reaction. 
• The prediction of the site of reactivity on the unactivated starting material. 
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However, a major disadvantage of this reaction was that a stoichiometric amount of reagent, 
known as the oxidant, was required to regenerate the catalyst during the reaction. This 
produced a lot of waste and has been a problem during the separation process from the desired 
product. Other oxidants which have been shown to work in similar reactions result in no 
product forming, or a much lower yield of product formation.  
Thus, the focus of this thesis has been to understand the role of this reagent and how it reacts 
to regenerate the catalyst and subsequently, explore the possibility of replacing these oxidants 
to give a reaction with better atom economy. The research has shown that when two variants 
of this oxidant was used and competed against one another, the stronger oxidant was consumed 
at a slower rate. This has led to an insight into the requirements of the reagent, where the 
oxidant was proposed to change its form prior to reacting with the gold.  
A more robust experimental setup was explored to gain absolute rates of reactions. This meant 
that the oxidants competed cannot interact with each other to affect their rate of consumption. 
In order to carry this out, the equipment used to study these reactions had to be modified so 
that the time between the start of the reaction and the point where observation of the reaction 
can begin was shortened, since the reaction studied was expected to be very quick (< 10 
seconds). The results from these studies suggest that the gold complex, prior to reactivation, 
forms an inactive complex outside the catalytic cycle of reaction.  
Another study was carried out between the reaction of the oxidant and a different gold 
complex. This gold complex was previously found to be active in catalysing the above 
coupling reaction, but had a significant induction period, where the catalyst was being 
activated. Reacting the gold complex and the oxidant have shown that one of the ligands 
bonded to the catalyst had to be released before the active catalyst was produced. In this thesis, 
it was found that a large variety of processes were occurring in order to activate the catalyst, 
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1.1.1. A brief history 
Gold, from the Anglo-Saxon word, geolo (yellow) is a naturally-occurring element that lies in 
the transition-metal block of the periodic table. It has the symbol Au, which comes from the 
Latin name aurum, meaning “glowing dawn”. It is commonly found in its native state, and 
typically found alloyed with silver to give electrum.1  
It is estimated that approximately 190 000 tonnes of gold has been mined,2 and in 2018, China 
was the largest producer of gold, mining approximately 400 tonnes of gold and accounting for 
12% of the total global gold production.3 
The chemical inertness of gold, where it is resistant to oxidation and corrosion, as well as its 
malleability and ductility have made it extremely useful in the electronics and aerospace 
industry. In addition to this, it’s metallic lustre and unique colour have meant that historically, 
gold has been held at high value as ornaments and jewellery. Even now, gold jewellery is still 
highly sought after, with over half of the gold produced in 2017 used in the jewellery industry.4 
1.1.2. Physical properties of gold 
Gold has the electron configuration [Xe] 4f145d106s1 and is located in the same group as copper 
and silver. As it has the largest atomic number of the three, it is expected to have a larger 
atomic radius as well as lower electronegativity due to increased distance between the valence 
orbitals and a resulting lower attraction to the positively charged nucleus. However, the 
opposite is observed, where gold was found to be the most electronegative transition metal,5 
and its radius was found to be comparable to the radius of silver atoms.6 Table 1 compares the 
metallic radius6 and the Pauling electronegativity7 values of the elements in the same group as 
gold. 
Table 1: Physical properties of elements in the same group as gold.  
  
Metallic radius / nm Pauling electronegativity 
   
Cu 0.128 1.90 
Ag 0.144 1.93 





These observations were a result of the lanthanide contraction, where poor shielding from 
electrons in the 4f orbitals coupled with an increase of nuclear charge led to an increase in 
effective nuclear charge experienced by the electrons in the valence orbitals of gold. The 
electronegativity of gold has meant that it does not react with other electronegative elements 
(such as oxygen), has a high redox  potential (AuI/Au0 = 1.83 V, compared to PtII/Pt0 = 1.19 V, 
under standard conditions),8 and the auride anion, Au−, is known and stable.9  
This has meant that only relatively recently, gold complexes have been utilised in 
homogeneous catalysis, dominated mostly by gold(I) and gold(III) complexes. As pointed out 
by Bochmann et al., “the formation of purple gold nanoparticles during the course of 
unsuccessful reactions is only too familiar”,8 indicating that gold in these oxidation states can 
be unstable, and reduce down (or disproportionate) to gold(0) and gold(III). 
Figure 1 shows the number of publications per year since 1965 that matched the search term 
“homogeneous”, “gold”, and catalys*. The wildcard (*) was used to obtain results relating to 
catalysis as well as catalyst reported.  It is only from 2004 onwards that the interest in this field 
has taken off, with multiple reviews published,10–19 and it has also been recognised as an 
important tool in synthesis, with two reviews written on the use of gold in total synthesis.20,21 




























Figure 1: Number of publications per year when the search term “homogeneous”, “gold”, 
and catalys* was used in the Web of Science, carried out on the 18th of June 2019.  
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1.2. Gold complexes 
1.2.1. Gold(I) 
Gold in the +1 oxidation state has the electron configuration [Xe] 4f145d106s0, and is not 
considered a transition metal, as its d-orbitals are full. This means that bonding with ligands 
occurs through the s-orbital, which gives rise to two-coordinate, linear complexes with one 
neutral ligand (typically phosphines or organosulfur) and one anionic ligand (LAuIX). Since 
it has a full shell in the d-orbitals, these compounds are found as white solids.Some of the 
more common, commercially available gold(I) complexes are illustrated in Figure 2. 
 
Figure 2: Commercially available gold(I) complexes found on Sigma-Aldrich’s website. 
Search was carried out on the 18th of June 2019. 
1.2.2. Gold(III) 
In contrast to gold(I) complexes, organogold complexes in the +3 oxidation state are not as 
common. This is due to a high oxidation potential (AuIII/Au0 = 1.36 V under standard 
conditions) and a strong oxidant is typically required to oxidise gold(I) complexes to gold(III) 
complexes. Gold(III) is a transition metal, and has the electron configuration [Xe] 4f145d8. 
Gold(III) complexes typically have a coordination number of 4 and a square-planar geometry. 
Figure 3 shows some common gold(III) complexes used as catalyst in reactions. Since these 
compounds tend to be not very soluble in organic solvents, gold(III) catalysis is typically 
carried out with the addition of a gold(I) complex and a stoichiometric amount of oxidant.22  
 




1.3. Homogeneous gold catalysis 
The first reported homogenous gold catalysed reaction was the asymmetric aldol reaction 
between aldehydes and isocyanoacetates in 1986.23 The reaction used a gold(I) catalyst and a 
chiral ferrocenylphosphine ligand with an amine group The transition state proposed in the 
reaction involved σ-activation of both the electrophilic and nucleophilic species by the gold(I) 
catalyst. Using both copper and silver catalysts gave poorer enantioselectivity, and this 
rationalised to be because gold(I) has a higher affinity to the phosphorus atom on the ligand 
compared to copper and silver. 
The next milestone in the development of homogenous gold catalysis was achieved by Hashmi 
et al. in 2000, where they employed a gold(III) catalyst for the formation of C-C and C-O 
bonds.24 
Allenyl ketones, A1, in the presence of a gold(III) catalyst was found to cyclise to give a furan, 
A4, alongside A3 as a side product from the reaction of A4 with the starting material, A1 
(Scheme 2). In contrast, the use of a palladium(II) catalyst gave A2, the regioisomer of  
compound A3, and comparison of the different catalysts highlighted the high activity of the 
gold catalyst. 1 mol% of AuCl3 required only one minute at 20 °C for full conversion of the 
starting material, whereas 1 mol% of Pd(Cl)2(MeCN)2 had a reaction time of about an hour. 
Reducing the loading of the gold catalyst to 0.1 mol% still gave complete consumption of A1. 
When A3 and A4 were left together in the presence of AuCl3, further reactivity was observed 
to give compound A5, which is a trimer of compound A1. This suggested that the reaction of 
A4 with other Michael acceptors to form a new C-C bond were possible, something that did 
not work when using a Pd catalyst. Thus the possibility of developing new C-C bond forming 




Scheme 2: Difference in regioselectivity between a palladium(II) and gold(III) catalysed 
reaction. Additional C-C bond formed in the presence of the gold(III) catalyst. 
In attempting to extend the scope for the synthesis of the furan shown above, Hashmi et al. 
discovered that by subjecting a mixture of A6 and A7 with AuCl3 (2 mol%) in acetonitrile, the 
expected furan (A8), as well as a phenol product (A9) was obtained (Scheme 3).25 Further 
experiments carried out with A8 in AuCl3 showed transformation to the phenol product A9 at 
room temperature and without exclusion of air or water. 
 
Scheme 3: Gold-catalysed synthesis of phenols. 
Less than 1% of 18O incorporation was observed when the reaction was carried out with H218O. 
This was consistent with the proposal that the reaction proceeded via an intramolecular oxygen 
transfer with an epoxide intermediate A10, as illustrated in Scheme 4. A screening of a few 
late transition metal complexes found that the reaction proceeded with other d8 metal 
complexes including palladium(II) and rhodium(I) and not by metal complexes in other 
oxidation states such as palladium(0) and rhodium(III), supporting a gold(III) catalysed 
reaction. Furthermore, AuCl3 was the most active catalyst in the screen, which showed promise 




Scheme 4: Intermediate proposed in the gold-catalysed synthesis of phenol. 
1.4. Activation of C-H bonds 
1.4.1. Gold(III) complexes 
The first reported activation of C-H bonds by gold(III) complexes was in 1931. Karasch and 
Isbell26 found that reaction of anhydrous auric chloride and benzene gave off hydrogen 
chloride along with 1,2,4,5-tetrachlorobenzene and gold(I) chloride (Scheme 5). Quenching 
the reaction after a few minutes with Et2O allowed for the isolation of an intermediate in the 
reaction, and this was identified as phenyl auric dichloride A12. It was proposed that the 
activation of C-H bond is by an electrophilic aromatic substitution step to give the 
phenylgold(III) complex. 
 
Scheme 5: First reported activation of C-H bonds using gold(III) complexes. 
1.4.2.  Gold(I) complexes 
In contrast to gold(III), it was only recently, in 2010, that gold(I) complexes were shown to 
activate C-H bonds in electron deficient arenes (Scheme 6).27 Exploiting the π-acidity of 
gold(I) complexes, it was proposed that π-complexation followed by σ-bond metathesis routes 




Scheme 6: Activation of C-H bond with gold(I) complexes. 
The substitution pattern seen in a range of arenes tested were consistent with activation of the 
most electron-deficient C-H bond. C-H activation starts to become a challenge when more 
electron-rich arenes are utilised and no reaction was seen with p-fluoroanisole. 
The reaction proceeded best with strong donor ligands on the gold, which corresponds to the 
more stable π-complex formed between the gold and the arene at the start of the activation 
process. 
1.5. Oxidative gold catalysis 
One of the reasons gold has only recently become popular as a catalyst is due to its high redox 
potential. Typical cross-coupling reactions in late transition-metal catalysis involve oxidative 
addition of the metal complex by the substrate/reagent. Since the oxidation of gold(I) 
complexes are difficult, gold-catalysed cross-coupling reactions have been less reported. 
One of the first few reported use of gold as an oxidative catalyst is by Periana et al.28 in 2004, 
where methane was oxidised to methanol, using a selenium(VI) compound as the 
stoichiometric oxidant. This is summarised in Scheme 7. The gold catalyst activates the C-H 
bond in methane under acidic conditions, although it is unclear which oxidation state, gold(I) 
or gold(III), the catalyst is in. DFT calculations carried out on the system showed that both 
oxidation states are capable of activating the C-H bond and although the pathway via the 
gold(I) species is more favourable, the concentration of gold(I) complex compared to gold(III) 
complex is quite low in the presence of excess selenium(VI) oxidants. 
 




Evidence was obtained, showing the reductive elimination of gold(III) to gold(I) whilst 
forming a C-C bond was possible as an elementary step in oxidative gold catalysis.29 It was 
reported that substituted allenyl carbinols A19, in the presence of a gold catalyst can cyclise 
to form dihydrofurans A21 (Scheme 8). One of the side products obtained includes a 
dimerisation of the dihydrofuran compounds, A23. It was proposed that the cyclised gold 
intermediate A20 can react with itself in a ligand exchange reaction to give compound A22, 
which can then reductively eliminate to form the homocoupled dimer A23. In the absence of 
an external oxidant, the yield of the dimer was found to be less than twice the percentage of 
the catalyst loading. Increasing the catalyst loading increased this yield. 
 
Scheme 8: Gold(III) to gold(I) reduction pathway with the formation of a new C-C bond. 
The next advancement from this is to use gold catalytically to form new C-C bonds in biaryls. 
Using a similar strategy to the oxidation of methane to methanol, a stoichiometric oxidant can 
be used to reoxidise gold(I) into gold(III). Focusing on forming C-C bonds, Tse et al. 
developed a gold-catalysed homodimerisation reaction of simple arenes.30 It was found that 
p-xylene, A24, could dimerise to form the biphenyl A25 in the presence of 2 mol% of a gold 




Scheme 9: Gold(III) catalysed oxidative homocoupling of p-xylene. 
The method was then extended to heterocoupling of halogenated anisoles with benzene 
(Scheme 10).31 However, using a 1:1 ratio of halo-anisole to benzene gave a significant amount 
of biphenyl product A29, obtained from the homocoupling of benzene. Tuning the ratio of 
arene, so that there was an excess of anisole to benzene (15:6), the yield of the heterocoupled 
product could be increased to 46%. Unfortunately, about 22% of A29, the homocoupled 
product, was still observed. 
 
Scheme 10: Gold(III) catalysed cross-coupling of bromoanisole and benzene, with a 
significant amount of homocoupled side product formed 
Since the main issue with the reaction is the homocoupling of benzene, rather than the 
homocoupling of the halo-anisole, it was proposed that the mechanism proceeded via the 
activation of benzene first. The intermediate formed can then choose to either react with 
benzene or the halo-anisole to give biphenyl or the desired cross-coupled product.  
Using an excess of one of the arenes is not ideal, especially if the material is precious. One 
method in generating a cross-coupled product is demonstrated by Larrosa et al. in 2013.32 The 
difference in selectivities of gold(I) and gold(III) in activating C-H bonds was exploited. 
Gold(I) complexes can activate the most acidic C-H bonds in arenes with electron withdrawing 
groups. Conversely, gold(III) complexes tend to activate electron-rich arenes via an SEAr 
mechanism. 
It was hypothesised that by utilising the change in selectivity between the two oxidation states 
of gold, a double oxidative C-H coupling can proceed to give cross-coupled products of two 
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electronically different arenes. A general scheme of the reaction proposed is shown in Scheme 
11. 
 
Scheme 11: Proposed strategy in the selective formation of unsymmetrical biaryls. 
Firstly, the EWG arene is activated by the gold(I) complex. Following an oxidation of the 
corresponding aryl-gold(I) to aryl-gold(III) complex, the C-H bond in the EDG arene can be 
activated. Reductive elimination from the resulting gold(III) complex leads to the desired 
cross-coupled product and regenerates the gold(I) complex. 
The reaction between the aryl-gold(I) complex, an arene and the oxidant was optimised 
(Scheme 12), and the scope of reaction was tested. It was found that the reaction proceeded to 
give the cross-coupling product almost exclusively with a range of electron rich arenes. It 
should be noted that no product was observed when no EWG or when p-NO2 was attached 
onto the electron-deficient arene. This highlights the limitation of the reaction, where 
presumably when the aryl group on the gold(I) species is too electron-rich, the corresponding 
gold(III) species cannot activate C-H bonds from electron-rich arenes. On the other hand, 
when the aryl-gold(I) species is too electron-poor, oxidation of the gold(I) to gold(III) starts 
to become challenging. 
 
Scheme 12: Optimised reaction conditions for generation of the cross-coupled product. 
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In trying to determine nature of the aryl-gold(III) complex formed from the oxidation of the 
corresponding aryl-gold(I) complex, (C6F5)AuIII(Cl)2(PPh3) was used as a catalyst and shown 
to be unreactive in the presence of 1,3-dimethoxybenzene at 50 °C. Addition of AgOPiv to 
displace the Cl ligands on the gold with an OPiv group gave the cross-coupled product in 
similar yields to when the PhI(OPiv)2 oxidant was used, suggesting the formation of a more 
electrophilic gold(III)-pivalate complex is required. This supports the proposal that the second 
C-H activation step of electron-rich arenes is activated by an aryl-gold(III) complex.  
Although the procedure for this coupling is not a one-pot process, the gold(I) complex from 
the first activation can be obtained via simple filtration, and the reaction continued with the 
addition of oxidant. However, the need for five equivalents of the electron-rich arene is not 
ideal.  
In 2015, the same group reported an extension of the method.33 By using a sub-stoichiometric 
amount of AgOPiv as an additive, the cross-coupling reaction of an electron-rich and 
electron-deficient aryl group can be achieved, and this is summarised in Scheme 13. Although 
optimum yields were obtained with an excess of five equivalents of the electron rich arene, 
using 1.5 equivalents still gave the cross-coupled product selectively, although with a slight 
decrease in yield (from 85%). 
Scheme 13: One-pot cross-coupling of an electron-rich and electron-deficient aryl groups in 
high yields with an added AgOPiv additive 
However, the reaction conditions are quite harsh, requiring high temperatures for the coupling 




1.5.1. Activated coupling partners 
Another method of generating unsymmetrical biaryls is to use a preactivated coupling partner. 
Using inspiration from Pd cross-coupling reactions, arylboronic acids34–39 (Suzuki-Miyaura 
reaction) and arylsilanes40–43 (Hiyama coupling reaction) can be utilised for direct arylation 
reactions. 
A gold-catalysed direct arylation of arenes and arylsilane was reported in 2012.42 The reaction 
proceeded under mild conditions at room temperature. A range of moderately electron-rich 
arenes and electron-rich and electron-deficient arylsilanes could be coupled, where functional 
groups including halogens, primary alcohols, amides and amines were tolerated. This allows 
for further functionalisation of the substrate, for example, the C-Hal groups can be used as a 
handle for palladium cross-coupling methodologies, highlighting the complementary 
reactivity of gold(III) with palladium(0) complexes.  
A stoichiometric amount of iodine(III) oxidant was required, and this was generated in situ 
from PhI(OAc)2 and camphorsulfonic acid (CSA). A general scheme of reaction is shown in 
Scheme 14. 
 
Scheme 14: Gold(III)-catalysed direct arylation of arylsilanes and arenes in the presence of a 
stoichiometric external oxidant. 
A detailed mechanistic study was carried out on the reaction43 and a catalytic cycle was 
proposed. Using (tht)Au(Br)3 as the precatalyst instead of (PPh3)Au(OTs) gave a shorter 
induction period (and will be further explored in Chapter 5). Furthermore, (tht)Au(Br)3 is 
soluble in organic solvents and stable under air, moisture and light conditions, and is highly 
selective for the heterocoupled product. 
A simplified version of the catalytic cycle is shown in Scheme 15.  
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Scheme 15: Simplified catalytic cycle of the direct arylation of arylsilanes and arenes. 
The reaction first proceeds via the activation of the precatalyst, where the tetrahydrothiophene 
(tht) ligand is lost irreversibly. The nature of the active catalyst is unknown and is proposed to 
change throughout the cycle depending on the electronic and steric requirements of the 
catalyst. 
The next step involves a C-Si auration via an SEAr mechanism, where the formation of a 
wheland intermediate A40 is proposed (Scheme 16). The position of substitution is consistent 
with this as arylsilanes are known to undergo substitution at the ipso position due to the ability 
of silicon to stabilise β carbocations. This also means that the arylsilane will preferentially 





Scheme 16: Proposed intermediate formed from the reaction between a gold(III) catalyst and 
an arylsilane. 
Substituting one of the ligands on complex A37 with a camphorsulfonate species gives a more 
electrophilic gold centre, which can then selectively form a π-complex with the electron-rich 
arene A34. This complexation is found to be the turnover-limiting step and is irreversible, thus 
complex A37 is the catalyst resting state in the cycle. From this, the gold(III) complex can 
then activate the C-H bond via an SEAr mechanism through another wheland intermediate to 
give complex A39, where both the aryl groups attached onto the gold. 
Reductive elimination from A39 will give the desired cross-coupled product and a gold(I) 
species which can then be oxidised to regenerate the active gold(III) catalyst, A36. 
An extension of the substrate scope was reported in 2016 by the same group (Scheme 17).44 
Using a bulky hypervalent iodine(III) oxidant (A41) and a silyl group tethered to an alcohol 
(A42) on the silane coupling partner, the formation of diaryliodonium salts, a by-product from 
the reaction of the oxidant with electron-rich arenes was reduced. Furthermore, the yield of 
product obtained was increased, and a shorter reaction time was required.  
 
Scheme 17: Modifications to the gold(III)-catalysed direct arylation reaction. 
The steric bulk around the oxidant was proposed to slow down its reaction with the arene, and 
the use of silane A42 meant that methanol was no longer required as a co-solvent. Since 
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methanol was found previously to inhibit the catalysis,43 the exclusion of methanol resulted in 
increased rates of reactivity. 
In 2017, Hofer, Genoux, Kumar, and Nevado reported an oxidative direct arylation reaction 
between arenes (A34) and electron-deficient aryl boronates (A43) as the preactivated coupling 
partner.45 The reaction utilised an “internal base”, where an acetate ligand was attached to the 
gold(I) catalyst to prevent protodeboronation of the electron-deficient boronates.46–49 A 
summary of the reaction is shown in Scheme 18. 
 
Scheme 18: Summary of a gold-catalysed coupling reaction between electron-deficient aryl 
boronates and arenes. X = 2,4-pentanediol ester or pinacol ester. 
Studies on the mechanism were carried out using stoichiometric amounts of gold. Firstly, the 
transmetallation step between the gold(I) catalyst and the boronic ester was probed, and this is 
summarised in Scheme 19. Both (Ph3P)Au(Cl) and (Ph3P)Au(OAc) were reacted separately 
with A46, and transmetallation product was only detected when (Ph3P)Au(OAc) was used, 
indicating the importance of the acetate ligand. Only electron-deficient aryl groups on the 
boronic esters were transferred onto the gold(I) complex, and the reaction of A47 was 
unsuccessful. The reaction between A44 and A46 was repeated in the presence of p-xylene 
(two equiv.) and no change was observed in the product distribution, highlighting the 
selectivity of this step, where the boronic ester coupling partners are reacting.  
 
Scheme 19: Stoichiometric reactions carried out between a gold(I) complex and the aryl 
boronic ester. 
The oxidation step was examined next. Reaction of (Ph3P)Au(C6F5) with 3 equiv. of 
PhI(OAc)2 was carried out in C6F6/C6H6 (1:1) at 80 °C. The resulting gold(III) product 
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obtained is shown in Figure 4. The two additional acetate ligands are trans to each other, and 
A48 was characterised by X-Ray crystallography. 
 
Figure 4: Gold(III) product obtained from the oxidation of (Ph3P)Au(C6F5) with PhI(OAc)2. 
Finally, complex A48 reacted with p-xylene (1 equiv.) to give the expected coupled product 
in 59% yield.  
The reaction shown in Scheme 20 was monitored under both stoichiometric and catalytic 
gold(I) conditions by 19F NMR spectroscopy. Both intermediates identified in the 
stoichiometric studies described previously (Ph3P)Au(C6F5) and A48 were observe.  
 
Scheme 20: Reaction monitored by 19F NMR spectroscopy. 
A few months later, Lloyd-Jones et al. reported an extension on the mechanistic study of the 
gold-catalysed direct arylation reaction of arenes and arylsilanes.50 In this study, 
intramolecular substrates where the arene and silane were tethered together by a linker was 
examined. The general reaction is shown in Scheme 21. 
 
Scheme 21: Intramolecular gold-catalysed direct-arylation reaction of aryl silanes and arenes 
that are tethered together. 
It was found that using these substrates, where n = 1, and R’ is not strongly 
electron-withdrawing gave pseudo-zero-order kinetic profiles in the consumption of starting 
material. A Hammett plot was constructed on the substrates where n = 1 to give fluorene 
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products. It was found that the rate of reaction was faster when electron-donating groups (R 
or R’) were used and was independent of whether the same substituent was on the silane ring 
(R) or the arene ring (R’). This indicates that both substrates go through the same intermediate 
before, or during the turnover-limiting step.  
Along with an Eyring analysis and labelling studies, it was concluded that the reductive 
elimination step from a diaryl-gold(III) complex was the turnover-limiting step, and 
coordination of the arene to the resting state (A39) occurred irreversibly. The shift in the TLS 
was proposed to be a result of increased local concentration of the arene resulting in faster 






Hypervalent aryliodine(III) oxidants 
 




2.1. Hypervalent Iodine(III) Oxidants 
2.1.1. Overview 
Hypervalent iodine(III) species (λ3-iodanes) have been found to be a mild oxidant for reactions 
involving oxidative metal catalysis.51–54 These species typically have the general structure 
shown below in Figure 5, with some main classes illustrated.  
 
Figure 5: General structure of hypervalent aryliodine(III) oxidants. 
The iodine centre has 10 valance e⁻ and a trigonal bipyramidal geometry, where the ligands 
form a T-shaped structure. The equatorial position is occupied by the least electronegative 
ligand (Ar) and two lone pairs of electrons, with the other two ligands (X) occupying the axial 
positions. 
The X–I–X bond is proposed to be a three-centre, four-electron (3c-4e) bond utilising the filled 
5p orbital on iodine and the half-filled orbitals of ligands that are trans to each other. Compared 
to a regular covalent bond, this hypervalent bond is found to be longer and therefore weaker.55 
A molecular orbital bonding diagram illustrating the bonding, non-bonding and antibonding 
interactions are shown below in Figure 6. 
 
Figure 6: Molecular orbital diagram showing the 3c-4e bond between iodine and the two 




The highest occupied molecular orbital (HOMO) features a node at the iodine centre, and thus 
the hypervalent bond is highly polarised, where the electrons are more localised on the ligands. 
The HOMO can also be thought of as a pair of bonding electrons delocalised on the ligands. 
Thus, the axial ligands are typically the more electronegative ligands, compared to the ligand 
in the equatorial position, resulting in a highly electrophilic iodine centre.  
The role of trans influence in hypervalent aryliodine(III) compounds has been studied by 
examining the I–X bond lengths in their crystal structures, since both the X ligands share the 
5p orbital on iodine.56 Trans influence is a thermodynamic property which describes how 
much a ligand can weaken the bond trans to itself. It was found that ligands that had higher 
trans influence had smaller Hammett inductive parameters and were more electron donating. 
Iodine(III) compounds with two strongly trans influencing X ligands (PhI(OMe)2 and 
PhI(OOtBu)2) were correctly predicted to be unstable, whereas oxidants with two moderately 
trans influencing ligands (PhI(OAc)2) or ligands with a mixture of strong and weak trans 
influence (PhI(OH)(OTs)) resulted in stable iodine(III) compounds.  
2.1.2. Ligand exchange 
The X ligands on the iodine centre are susceptible to ligand exchange upon reaction with a 
nucleophile. Two mechanistic pathways have been proposed; the associative and the 
dissociative mechanisms.57 These are summarised in Scheme 22 shown below, starting from 
a general aryliodine(III) compound with two X ligands, B1.  
 




The associative pathway gives rise to the formation of a 12 e⁻, tetracoordinated iodate resulting 
from attack of the nucleophile into the C–I σ* orbital to give a square planar intermediate, B2. 
Following isomerisation and loss of ligand X, the new aryliodine(III) species B3 is generated. 
The dissociation pathway starts with an initial loss of ligand X to give an 8 e⁻ iodonium species 
B4, which then reacts with the nucleophile, Nu⁻ to give compound B3. 
It has been suggested that ligand exchange occurs through an associative mechanism, as 
tetracoordinate58–60 and pentacoordinate61 iodine centres have been observed previously. For 
example, the tetrachloroiodate anion has been characterised and crystallised,59 and there have 
been observed secondary bonding in the crystal structures of iodobenzene diacetate, B561 and 
(dichloroiodo)benzene, B6.60 These are illustrated in Figure 7. It should be noted that the 
bonding in the latter two compounds has been described as more of an electrostatic interaction, 
rather than a covalent bonding interaction. 
 
Figure 7: Secondary bonding in PhI(OAc)2 and PhI(Cl)2, as observed in the crystal structures 
of these compounds. 
2.1.3. Electrochemistry studies 
In 1988, Varvoglis, Kokkinidis, and Papadopoulou analysed the reduction of 
[bis(acyloxy)iodo]arenes electrochemically in order to understand their oxidising properties.62 
Electrochemistry involves studying the interrelation of chemical and electrical effects. For 
example, the measurement of electrical parameters due to chemical changes, as well as the use 
of electrical properties to bring about a chemical reaction.  
The electrochemical experiments conducted in this chapter concerns methods where the 





Figure 8: Illustration of a reduction process by increasing the potential of the electrode.63 
When the electrode is driven to a more negative potential, the energy of the electrons is raised 
to the point where electron transfer is thermodynamically favoured from the electrode to the 
analyte near the surface of the electrode. This results in a net movement of electrons out of the 
electrode, which produces a current response. As current is the rate of movement of charge, in 
this case, the current is as a result of the movement of electrons. 
Cyclic voltammetry 
One of the most popular techniques in electrochemistry and a technique used in this chapter is 
cyclic voltammetry (CV). This technique is typically the first electrochemical study carried 
out in an experiment and can provide a lot of useful qualitative information by monitoring the 
























Figure 9: Top: sweep of potential versus time for a cyclic voltammetry experiment. Bottom: 
current response as a result of a potential sweep, to give a cyclic voltammogram. Epc is the 
cathodic peak potential, and Epa is the anodic peak potential. The mid-point of the two peak 
potential is known as E1/2, the half-wave potential. 
As the potential is swept to a more negative voltage, a small initial increase in the magnitude 
of current is observed. This is due to the build-up of an electrical double layer, resulting in a 
background current or charging current. Increasing the potential further leads to a point where 





If the reduction is reversible and the reduced species is sufficiently stable and long-lived in 
solution, sweeping the voltage back to a more positive potential will result in a similar curve, 
but with a positive current response, as the reduced species is reoxidised. In a fully reversible 
system, the halfway point between the two peak currents is known as E1/2, or the half-wave 
potential. 
Although it is a qualitative method, cyclic voltammetry is able to provide a large amount of 
useful information in short periods of time. For example, redox active species within a 
potential window can be identified, including whether coupled homogenous chemical 
reactions occur before or after a redox process.63 Furthermore, the method serves as a simple 
means to identify the potentials required to drive a redox reaction, both for kinetic studies64,65 
and bulk electroredox processes.66–68 
In the study carried out by Varvoglis et al.,62 the authors utilise cyclic voltammetry in order to 
verify that a secondary reduction peak, observed in the reduction of 
[bis(acyloxy)iodo]benzene, is due to the reduction of iodobenzene generated from the first 
reduction wave (Figure 10). 
 
Figure 10: Cyclic voltammograms of PhI(OAc)2 (curve 1) and PhI (curve 2) carried out on 
an Au electrode, in 0.1 M Et4NClO4 in acetonitrile, with a scan rate of 200 mV s-1. Peak I 





Another technique utilised in this chapter is square-wave voltammetry (SWV), devised by 
Ramaley and Krause.69 This pulse voltammetry method is carried out on a stationary electrode, 
and the potential waveform applied is illustrated below in Figure 11. Each cycle consists of 
two pulses, forward and reverse, and the current is sampled twice in each cycle at the end of 
the pulses (at the points labelled as • in Figure 11). This allows for the charging current from 
an electrical double layer to decay, resulting in a more sensitive technique compared to CV.  
 
Figure 11: Applied potential versus time for a square-wave voltammetry experiment. 
The theoretical current response for a reversible system is shown in Figure 12, where the 
responses for the forward pulse (A) is separated from the response for the backwards pulse (B). 
The curve labelled as C is known as the difference current and is calculated by subtracting the 
resulting reverse current from the forward current, as a function of potential. Curve C is the 













Figure 12: Current response (ψ) versus potential, separated into current response as a result 
of the forward pulse (A) and the backwards pulse (B). Expected observed current (C) is 
obtained by subtracting curve B from curve A.70. n = number of electrons transferred. 
Following the study on the electrochemical reduction of iodoarene diacetates, Varvoglis et al. 
published another paper looking at the electrochemical reduction of the hypervalent iodine 
compounds shown in Figure 13.71 Using slightly different conditions, it was found that the 
reduction of B7, B8, and B9 were reduced at potentials that were outside the solvent window. 
It was estimated that the reduction potentials for these compounds were higher than 1.35 V 
versus a saturated calomel electrode (SCE). In comparison, the reduction of iodobenzene 
diacetate occurred at − 0.24 V (versus SCE)62 and the reduction of compounds B10 and B11 
at approximately − 0.12 V (versus SCE). This shows that in the terms of thermodynamics, 
these [(hydroxysulfonyloxy)iodo]benzene compounds are more oxidising compared to the 
iodoarene diacetates and their cyclic analogues. 
 
Figure 13: Range of oxidants studied by Varvoglis et al. by electrochemistry.71 
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2.2. Aims of the chapter 
This chapter focuses on probing the relative oxidising power of aryliodine(III) oxidants. 
Previous studies carried out using electrochemistry have shown that the electron-poor oxidants 
have higher redox potentials and therefore are stronger oxidants. Using the chemical 
equilibrium between the oxidised (iodine(III)) and reduced (iodine(I)) form of the oxidant, 
relative oxidising powers can be quantified and compared to the electrochemically measured 
values.  
2.3. Oxidant equilibration 
2.3.1. Control reactions 
Control experiments were carried out prior to the competition studies discussed in Chapter 3. 
From this, it was discovered that aryliodine(III) oxidants are able to oxidise aryl iodides to 




Scheme 23: Equilibrium of aryliodine(III) and iodine(I) species, under oxidative gold 
conditions. 
When one equivalent of both p-MeArI(OAc)2 (B12) and PhI (B13) were mixed in CDCl3 and 
CDCl3/CD3OD, no oxidant exchange was observed after 17.5 hours. Adding 1.3 equivalents 
of camphorsulfonic acid (CSA), which generates the ArI(OH)(OR) oxidant, gave a small 
amount of the corresponding PhI(OH)(OR) oxidant (B1) when left for 48 hours. 
 
Scheme 24: Equilibration of p-MeArIX2 (B12) with PhI (B13) in the presence of catalytic 




Addition of 2 mol% of gold catalyst, (tht)Au(Br)3 resulted in the formation of a significant 
amount of oxidised PhI product, B1 within 500 seconds, and a stable equilibrium by 1000 
seconds (Scheme 26). The equilibrium was monitored by 1H NMR spectroscopy, and the 
concentration profile versus time is shown below in Figure 14. 








 B1   - H(Ox)
 B12 - p-Me(Ox)
 B13 - PhI







Figure 14: Concentration versus time profile for the reaction in Scheme 24, 0.03 M 
p-Me(Ox) (B12), 0.03 M PhI (B13) and 0.04 M CSA in CDCl3/CD3OD (50:1), with 1 mol% 
(tht)Au(Br)3. 
More of the oxidant (p-Me(Ox), B12) was consumed relative to the aryl iodide (PhI, B13). 
This is possibly due to the activation of the precatalyst, (tht)Au(Br)3, where it was previously 
reported that five equivalents of oxidant reacts with one equivalent of gold precatalyst.43 
Consequently, the amount of p-MeArI (B14) product formed was slightly greater than the 
amount of oxidant B1 formed. This difference in product formation (Δ) is found to be largest 
with higher catalyst loadings (Table 1). However, the relative amounts of each component at 




Table 2: Equilibrium constant 𝐾eq =
product
reactant
 and difference in the amount of the two 
products (B14 and B1) formed (Δ). 
Catalyst / mol% Keq Δ / M × 1000 
  
 
1.0 0.41 0.679 
0.5 0.41 0.490 
0.3 0.40 0.214 
0.2 0.41 0.089 
Catalysts 
A variety of gold complexes and halide salts were tested as catalysts, in order to identify the 
requirements of the reaction. The results are illustrated in Table 3. 
Table 3: Results from testing gold complexes and halide salts as potential catalysts for the 
equilibrium shown in Scheme 24. 
No. Catalyst Equilibrate? 
   
 
1 (tht)Au(Br)3 ✓ 
2 (PPh3)Au(Br) ✓ 
3 (IPr)Au(Br) ✓ 
4 (IPr)Au(Cl)  
5 (tht)Au(Cl)  
6 KBr ✓ 
7 NBS ✓ 
8 Bu4NBr ✓ 




From entries 1-5 in Table 3, it was found that not all gold complexes were able to catalyse the 
equilibration shown in Scheme 24, and only complexes with bromide ligands present were 
active. Further testing of bromide containing compounds (entries 6-8) showed that the 
equilibration reaction could be catalysed in the absence of gold. This suggests that bromonium 
(generated from the reaction of bromide and aryliodine(III) oxidants) was the active species 
responsible for catalysing the equilibration reaction shown in Scheme 24. Finally, NaI was not 
an active catalyst for the reaction, as shown in entry 9, highlighting the importance of the 
presence of bromide.  
When the equilibration was carried out in chloroform stabilised with amylenes instead of 
ethanol-stabilised, or unstabilised chloroform, no reaction occurred. This was possibly due to 
a reaction between amylenes and a generated bromonium species. To test this further, the 
following reaction shown in Scheme 25 was carried out.  
 
Scheme 25: Possible product distribution from the reaction of B1-OAc and B15 in the 
presence of a stoichiometric amount of bromide. 
The crude mixture was analysed, and only PhI (B13) and compound B16 were observed by 
1H NMR spectroscopy.72 No oxidation of the m-OMeArI to give B18 was observed, indicating 
that bromonium required in catalysing the equilibration is no longer available and has been 
consumed by B15 in a bromination reaction.   
Proposed mechanism 
A tentative mechanism was proposed in Scheme 26, given that bromonium is thought to be 
responsible for catalysing the equilibration. Upon oxidation of bromide by the ArI(III) oxidant, 
the generated bromonium could react with aryl iodide in solution to give an iodonium(III) 
compound with a bromide attached.73 This could undergo ligand exchange via an 
associative-type intermediate with the added ArI(III) oxidant to form the new oxidant, and 
regenerate an iodonium(III) compound, which can then undergo ligand exchange again to give 




Scheme 26: Proposed mechanism for a bromonium-catalysed equilibration of ArI(III) 
oxidants. 
2.3.2. Oxidant potentials 
Using the equilibration reaction, the relative oxidising power of substituted ArI(III) oxidants 
can be examined. This is summarised in Scheme 27. The position of equilibrium between a 
range of substituted aryl iodides (B) with the unsubstituted oxidant (AO) was determined using 
1H NMR spectroscopy. The equilibrium constant (K) for these reactions were calculated, using 
Eq. 1, and the results are summarised in Table 4. 
 
Scheme 27: Equilibration of substituted aryl iodides with PhI(X)2 oxidants, catalysed by 
1 mol% of (tht)Au(Br)3 in CDCl3/CD3OD (50:1 mixture). 
𝐾 =  
[𝑨𝑶][𝑩]
[𝑨][𝑩𝑶]
 Equation 1 
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Table 4: Equilibrium constants (K) and calculated redox potentials (E) for various substituted 
aryliodine(III) oxidants. All concentrations were calculated by 1H NMR spectroscopy at 
300 K with CH2Br2 as an internal standard. The concentrations of each species obtained 
approximately after 30 minutes, 1 hour, and overnight remained constant. 
No. R σ K E  / v 
     
1 p-CF3      0.54 11.12 0.031 
2 p-NO2      0.78 40.35 0.048 
3 p-tBu − 0.20 0.30 − 0.015 
4 p-Me − 0.17 0.41 − 0.011 
5 p-Cl 0.23 2.75 0.013 
6 p-Br 0.23 2.92 0.014 
7 p-OMe − 0.27 0.24 − 0.019 
8 p-F 0.06 1.54 0.006 
9 m-NO2 0.71 29.29 0.044 
 
K values greater than one were obtained when aryl iodides with electron-withdrawing groups 
were used, and values of less than one with electron-donating groups. This is consistent with 
the proposal that electron-withdrawing groups result in a more electrophilic iodine(III) centre. 
These oxidants therefore have a higher affinity for electrons, and thus are the stronger oxidants, 
and will more readily reduce to the aryl iodides compared to iodine(III) oxidants with 







Once the equilibrium constants have been obtained, the Nernst equation (Eq. 2) can be used 
to calculate the relative redox potential (E) of the substituted oxidant (BO). 




Where: n (number of electrons transferred) = 2  
F (Faraday constant) = 96485 C mol-1 
R (gas constant) = 8.312 J K-1 mol-1 
T (Temperature) = 298 K 
Hammett Plot 
The relative potentials were plotted against the Hammett substituent constant (σ)74 for the 
corresponding R groups and a good linear correlation was obtained, shown in Figure 15. These 
results were compared against those obtained by Varvoglis et al.,62 where the electrochemical 
reduction of various substituted aryliodine diacetates were studied. The electrochemical 
measurements were made in acetonitrile, with a three-electrode cell: a rotating Au disc 
electrode, a calomel reference electrode and a Pt counter electrode with Et4NClO4 as the 
electrolyte. 


















y = 0.178x - 0.011
R2 = 0.978 
y = 0.063x - 0.001
R2 = 0.996
 
Figure 15: Hammett plot of redox potential (Erel) versus Hammett constant (σ) for the 
calculated potentials from the equilibration studies (Table 4) and the electrochemical 
reduction62. All values have been adjusted so that the unsubstituted oxidant, PhI(X)2 has a 




Although both sets of data agree that the more electron deficient oxidant has a higher redox 
potential, the electrochemical data suggests that the substituents have a larger effect on the 
redox potentials than the calculated potentials from equilibration studies show. To investigate 
this difference, the conditions in which the equilibration reactions were carried out in were 
modified, so that they were more similar to the electrochemical conditions.  
Firstly, the reactions in chloroform/methanol (50:1) and CSA were repeated, to ensure 
reproducibility. Removing CSA from the reaction media resulted in equilibration of the 
aryliodine diacetate species rather than the hydroxycamphorsulfonate oxidants, which is the 
class of oxidants examined electrochemically. 
Figure 16 (run 4) shows the resulting Hammett plot from equilibrating aryliodine diacetates. 
The obtained gradient is similar to that found previously when CSA was added (runs 1 and 2). 
This is because the different axial ligands on the iodine centre should only affect the absolute 
redox potential, rather than the relative redox potentials. Similarly, the reaction was repeated 
in acetonitrile (run 3), the solvent that was utilised in the electrochemical study,62 but gave 
negligible effects as the plot still matches the other runs.  
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Figure 16: Hammett plot obtained from calculated redox potentials based on the position of 
equilibrium in the reaction illustrated in Scheme 27. Conditions: 0.06 M PhI(OAc)2 and 0.06 
M RArI. Runs 1 & 2 were in CDCl3/CD3OD (50:1) solvent mixture, with added CSA and 
(tht)Au(Br)3 (1 mol%) as the catalyst. Run 3 was carried out in MeCN-d3/CD3OD (50:1) 
solvent mixture, with added CSA and Bu4NBr (2 mol%) as the catalyst. Run 4 was carried 
out in CDCl3 and (tht)Au(Br)3 (2 mol%) as the catalyst. All concentrations were calculated 
by 1H NMR at 300 K with CH2Br2 as an internal standard. 
Repeating the analysis of the equilibrium position under various conditions shows that the 
values calculated for the relative redox potentials of these oxidants are reproducible and are 
minimally affected by the solvent or the X ligands on the iodine(III) centre. 
2.4. Electrochemical Studies 
2.4.1. Method 
The electrochemical analysis of the aryliodine diacetate oxidants was then repeated. A 
three-electrode setup was used, with a glassy-carbon disc as the working electrode, a platinum 
gauze as the counter electrode, and Ag/AgCl as the quasi-reference electrode. [nBu4N][PF6] 




A cyclic voltammogram of PhI(OAc)2 in dichloromethane was obtained, in order to determine 
the window where reduction of the compound occurred. It was found that PhI(OAc)2 
undergoes an irreversible reduction process at Epc = − 1.6 V versus Ag/AgCl quasi-reference 
electrode. Previous analysis had determined that the reduction  corresponds to a two-electron 
reduction process.62 



















E / V vs Ag/AgCl
 
Figure 17 : Cyclic voltammogram for PhI(OAc)2 as a 5 mM solution in DCM with 0.1 M 
[nBu4N][PF6], using a glassy-carbon working electrode, a Pt gauze counter electrode and a 
Ag/AgCl quasi-reference electrode. A scan rate of 100 mV s-1 was used. 
Square-wave voltammetry was used to obtain a more accurate reading of the reduction 
potential of PhI(OAc)2. Ferrocene was added as the internal standard, and the resulting output 
is illustrated in Figure 18. The reduction potential, Epc was obtained at − 1.47 V versus Fc+/Fc.  
I(III)/I(I) reduction 
Epc = -1.6 V 
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Figure 18: SWV of PhI(OAc)2 as a 1 mM solution in DCM, with 0.1 M [nBu4N][PF6], using 
a glassy-carbon working electrode, a Pt gauze counter electrode and a Ag/AgCl quasi-
reference electrode. A scan rate of 100 mVs-1 was used. 
Performing square wave voltammetry on different electron rich and electron poor 
aryliodine(III) oxidants allowed for the Hammett plot analysis shown in Figure 19. Both sets 
of data were normalised so that the unsubstituted oxidant is referenced at zero volts. 











y = 0.196x - 0.008
R2 = 0.951
y = 0.178x - 0.011
R2 = 0.978
 
Figure 19: Hammett plot of relative redox potentials (Erel) obtained electrochemically versus 
Hammett substituent constants (σ). Plot of data obtained compared with literature data.62 
Fc+/Fc 
Epc = 0.11 V 
I(III)/I(I)  
Epc = − 1.36 V 
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Although the conditions used by Varvoglis et al.62 to obtain the electrochemical reduction 
potential of ArI(OAc)2 oxidants were very different to the conditions described above, the 
resulting Hammett plots of the relative potentials have similar gradients. These results show 
that there appears to be an inherent difference between measuring the redox potentials 
electrochemically and by analysing the equilibrium positions. This could be attributed to the 
fact that more than one oxidant species is present under the equilibrating conditions, and 
formation of dimers or aggregates may impact the position of equilibrium.  Even though the 
cause for the different gradients obtained is unclear, the general trend that electron poor 
oxidants are the stronger oxidants remains the same for both sets of data. 
2.5.  Conclusion 
The presence of catalytic amount of bromide in a solution containing aryliodine(III) oxidants 
and iodobenzene causes an equilibration reaction to occur, where a mixture of the starting 
materials, reduced iodoarene compounds, and oxidised phenyliodine(III) oxidants are 
observed, as illustrated in Scheme 24. The position of equilibrium was utilised in the Nernst 
equation to calculate the relative redox potentials of these aryliodine(III) oxidants. The 
potentials were plotted against the Hammett constants of the corresponding substituent on the 
ring, and it was found that the more electron-deficient oxidants have a higher redox potential 
and are therefore more potent oxidants. The relative redox potentials obtained were 
independent of the X ligands of the aryliodine(III) oxidants, as well as the solvent the reaction 
was carried out in.  
Comparison of the Hammett plot of calculated potentials with potentials obtained from 
electrochemical reduction of these oxidants showed a substantially different gradient. 
Although the direction of the gradient was the same, the electrochemistry data implied that the 
substituents on the aryl ring of these oxidants have a larger impact on the relative potential of 
these aryliodine(III) oxidants. However, the equilibrium studies were carried out under similar 
conditions to the gold-catalysed coupling reaction. In this case, both reactions occur in the 
solution state. In comparison, the electrochemical studies rely on an electron-transfer process 
between the solution at the surface of the electrode and the solid electrode, which may result 
in a less accurate description for the oxidants in the context of our studies, the oxidation of the 
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3.1 Gold(I) oxidation 
Hypervalent iodine oxidants are commonly used in oxidative metal catalysis, where a 
stoichiometric amount of external oxidant is required to complete the catalytic cycle. Typical 
oxidants used in oxidative gold catalysis include fluoronium oxidants36–39,75–77 and hypervalent 
iodine oxidants.31–33,42,78–81 
Interestingly, it was found that both oxidants give different products when reacted with 
(C6F5)AuI(PPh3), C1.82 A summary of the results are shown in Scheme 28. 
 
Scheme 28: Difference in observed reactivity oxidation of an electron-deficient Au(I) species 
with iodine(III) oxidants and fluoronium oxidants. 
With PhI(Cl)2 as the oxidant, the only product that was formed was C2, a gold(III) complex 
with the Cl ligands cis to each other. The complex was characterised by single-crystal X-ray 
crystallography as well as NMR spectroscopy. Using Selectfluor® however, gave an 
unanticipated gold(I)-gold(III) complex, C3, which was characterised by single-crystal X-ray 
crystallography. C3 was proposed to have formed via the oxidation of the starting material, 
followed by ligand exchange with the starting material C1, due to the instability of electron-
deficient fluorinated gold(III) complex.83 
3.1.1. Oxidation of (Ph3P)Au(Me) 
In 2009, Muñiz and Iglesias studied the stoichiometric oxidation of a gold(I) complex with 
PhI(OAc)2 in the context of a gold-catalysed diamination reaction of alkenes.78 The authors 
selected the methyl gold complex C4 as a probe for an alkyl gold complex, which was 
proposed as an intermediate within their catalytic cycle. The resulting products were identified 
as gold(III) complex cis-C5 and trans-C5 shown in Scheme 29, and characterised by 31P NMR 
spectroscopy and HRMS. A 90:10 mixture of the isomers (cis/trans) was obtained when a 
stoichiometric amount of oxidant was added, and a 58:42 mixture obtained when an excess of 
oxidant was utilised. Further reaction of the gold(III) mixture with an anionic urea to mimic 
the final step of the proposed catalytic cycle led to the expected N-methylated product, 





Scheme 29: Stoichiometric reaction of PhI(OAc)2 with alkyl phosphinegold(I) complex (C4) 
to give gold(III) complexes with acetate ligands either cis or trans to each other. 
3.1.2. Oxidation of bis(NHC)-Au(I) complexes 
A study on the oxidation of various gold(I) complexes with two N-heterocyclic carbene (NHC) 
ligands coordinated, with hypervalent iodine(III) compounds was carried out in 2016.84 It was 
found that these complexes reacted with PhI(Cl)2 to give a gold(III) complex with two NHC 
ligands and two Cl ligands, where both NHC ligands are trans to each other.  
 
Scheme 30: Reaction of bis(NHC) gold(I) complexes with PhI(Cl)2 as the oxidant, carried 
out at room temperature to give a gold(III) complex with Cl ligands trans to each other. 
Initial studies investigated the oxidation of gold(I) complexes with two NHC ligands attached 
and PhI(Cl)2 as the oxidant (Scheme 30). By varying one of the NHC ligands on the gold, the 
time taken for full conversion was analysed by NMR spectroscopy and compared with the 
steric descriptors of the varied NHC ligand. This parameter is known as the percent buried 
volume (%Vburr) and describes the percentage of the total volume of a defined sphere that is 
occupied by ligands, with the centre of the sphere on the metal.85 It was found that smaller and 




In particular, the complex with two IPr (N,N’-bis(2,6-diisopropylphenyl)imidazol-2-ylidine) 
NHC ligands, which had the largest %Vburr (38.2%), required a larger excess of oxidant (2.2 
equivalents) and 7 days at room temperature to reach full conversion. This is in contrast to the 
results obtained when one of the IPr NHC ligands was replaced with an ICy 
(N,N’-dicyclohexylimidazol-2-ylidene) NHC ligand, which had a %Vburr of 27.2% and 
required 1.3 equivalents of oxidant and 3.5 hours to reach full conversion. This was attributed 
to steric hindrance from the ligands on the gold centre slowing down the oxidation reaction. 
The reactions between gold(I)-bis(NHC) complexes and PhI(OAc)2 as well as PhI(OCH2CF3)2 
as oxidants were also studied. The complexes containing an IPr NHC ligand as shown in 
Scheme 30 gave no reaction with these oxidants. Instead, complex C6 featuring two smaller 
NHC ligands (%Vburr = 27.8% and 27.4%) was synthesised and oxidised with PhI(OAc)2 and 
PhI(OCH2CF3)2. The resulting gold(III) complexes obtained (C7 and C8) had two NHC 
ligands bound trans to each other, and both the X ligands from the hypervalent iodine species 
attached, as illustrated in Scheme 31.  
 
Scheme 31: Oxidation of complex C6 with PhI(OAc)2 and PhI(OCH2CF3).  
The examples above have shown that in general, the oxidation of gold(I) complexes to 
gold(III) is accompanied by the transfer of the X ligands from the hypervalent aryliodine(III) 
oxidants to the gold centre. However, the precise mechanism of this oxidation is currently 
unknown.  
3.2 Aims of the chapter 
This chapter probes the mechanism of the oxidation of gold(I) complexes within the context 
of an oxidative direct arylation reaction, covered in Chapter 1.42,43,50 It was found previously42 
that hypervalent iodine oxidants with sulfonyloxy and hydroxy X ligands gave the highest 
yield of product, whereas the iodine(III) oxidants with two acetate ligands were less effective. 
Furthermore, fluoronium based oxidants (SelectfluorTM and [PyrF][BF4]) gave no reaction. 
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Other reports where hypervalent iodine oxidants were superior as oxidants over other oxidants 
such as fluoronium based oxidants, peroxides, and Oxone® have also been reported.31,32,86,87 
It was therefore of interest to understand the mechanism of reaction of these hypervalent 
iodine(III) oxidants with gold(I). 
3.3 Competition of aryl oxidants 
Direct observation of the rate of reaction in Scheme 32 gives no information on the oxidation 
of gold(I) under the reaction conditions, as the turnover-limiting step occurs prior to 
oxidation.50 Instead, competition reactions can be designed to probe the oxidation, where the 
oxidant with favourable properties will be consumed preferentially. Scheme 32 shows a 
summary of the reaction studied, where substrate C9 was chosen, since it had a suitable 
reaction time in giving the product C10. 
 
Scheme 32: Intramolecular cyclisation of aryl silane C9. Two oxidants are competed against 
one another to obtain relative rates of reaction. 
Modelling 
The competition reaction was modelled in Dynochem® to obtain examples of the concentration 
versus time profiles for these reactions. A simplified catalytic cycle shown in Scheme 33 was 
constructed, where the active catalyst first reacts with the starting material to form an 
intermediate (INT). The next step from the intermediate (INT) to the gold(I) species 
([AuI])was set with a small k value (k2) compared to the rest of the processes and is therefore 




Scheme 33: Simplified catalytic cycle that was modelled in Dynochem® to represent the 
reaction studied in Scheme 32. 
Following the simplified catalytic cycle and setting one of the oxidants to react at twice the 
rate of the other, the concentrations of all components during the reaction can be simulated. 
The resulting plot is shown in Figure 20. 
















 P      OX 2      ArI 2     
 OX 1      ArI 1      SM      Total OX
 
Figure 20: Reaction profile generated from modelling the catalytic cycle in Scheme 33. 
0.1 M of starting material (SM) and 0.05 M of both oxidants (OX 1 and OX 2) were used as 
the starting point of the model. P is product of the cyclisation, ArI 1 and ArI 2 are formed 
from reducing the oxidant. Total Ox shows the concentration versus time profile of both 
oxidants together, where the decay of total oxidant is pseudo zero-order. 
Input values: 
k1 = 100 mol-1 dm3 s-1 
k2 = 0.01 s-1 
k3 = 1000 mol-1 dm3 s-1 
k4 = 2000 mol-1 dm3 s-1 
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As the reaction proceeds, the oxidant which is set to react at a faster rate constant (OX 2) is 
consumed faster (red line). A difference in the relative rates of consumption is seen, where the 
concentration of OX 2 decreases quicker than the concentration of OX 1. However, as the 
oxidant is consumed, the relative probability of reacting with OX 2 is reduced compared to 
OX 1, increasing the rate of consumption of OX 1.  
It should be noted that the overall rate of consumption of the oxidants remain tied to the 
turnover-limiting step, and so by looking at the total concentration of oxidant, the overall 
consumption of oxidant follows the same rate as the consumption of starting material. 
3.3.1. Method  
Monitoring reactions using 1H NMR Spectroscopy 
The consumption of oxidant was monitored via 1H NMR spectroscopy under the reaction 
conditions described in Scheme 32. Figure 21 shows the stacked temporal 1H NMR spectra 
for the competition between p-BrArI(OAc)2 and p-OMeArI(OAc)2, and it was observed that 
the peaks for the ortho protons on these oxidants are distinct and separated from the rest of the 
other proton peaks. This is because the iodine centre itself is in the +3 oxidation state, resulting 
in a more electron-poor aromatic ring, thus the protons around the aromatic ring are more 
deshielded and are shifted downfield. Therefore, utilising 1H NMR spectroscopy, accurate 
concentration values were obtainable, even towards the end of the reaction, where the 




Figure 21: Stacked temporal 1H NMR spectra of the reaction shown in Scheme 32, with 
0.05 M p-BrArI(OAc)2 and 0.05 M p-OMeArI(OAc)2  as oxidant 1 and oxidant 2. 0.1 M of 
C9 was used, with 2 mol% of (tht)Au(Br)3 catalyst in CDCl3/CD3OD (50:1) with CH2Br2 as 
the internal standard. Each spectrum was obtained after a 60 second delay, with the first 
delay at 125 seconds. 
3.3.2. Reaction profile 
Equimolar amounts of the oxidants p-OMeArI(OAc)2, OMe(Ox)  and p-BrArI(OAc)2, Br(Ox) 
were competed together to study the effect of electronics on the oxidation of gold(I) under the 
reaction conditions. Oxidant OMe(Ox) represented the electron-rich oxidant, and oxidant 
Br(Ox) represented the electron-deficient oxidant. The temporal concentration plot of both 






















Figure 22: Intramolecular direct arylation reaction of C9 under the conditions shown in 
Scheme 32, with 0.1 M starting material. Data points were obtained by 1H NMR 
spectroscopy every 60 seconds, with CH2Br2 as an internal standard. 
From the graph in Figure 22, the consumption of both oxidants together follows the profile for 
starting material consumption, in agreement that the nature of the oxidant plays no role in the 
overall rate of reaction. The initial drop in concentration of total oxidant is as a result of 
activation of the precatalyst, where five equivalents of oxidant are consumed.43 There is also 
a smaller drop in the concentration of the starting material observed. This is due to a known 
bromodesilylation side reaction, where two of the bromides on the gold precatalyst are 
oxidised to bromonium, which can then react with the silane in the starting material.50 
Focusing on the consumption of the individual oxidants, OMe(Ox) and Br(Ox), it was found 
that the more electron-rich oxidant OMe(Ox) is consumed faster in the presence of the 
electron-deficient oxidant Br(Ox), which is contradictory to the results from both the 
electrochemical and equilibration study discussed in Chapter 2. The measured and calculated 
potentials indicate that the electron-deficient oxidants have a higher reduction potential and 
are therefore more oxidising. However, initial results from the competition reactions have 
shown that the more oxidising oxidant does not react preferentially, indicating that the 
oxidation of gold(I) under these reaction conditions is under kinetic, rather than 





From these observations, two preliminary hypotheses were proposed. Figure 23a illustrates 
the formation of an initial π-complexation between the gold(I) complex and the aromatic ring 
of the oxidant, prior to the reoxidation step,88 where an oxidant with an electron-rich aromatic 
ring would be favoured. The second proposal (Figure 23b)89,90 shows the dissociation of a 
ligand from the iodine centre, to form a more electrophilic iodonium species, which would 
then be the active species responsible for the oxidation of gold(I). 
 
Figure 23: Two possible intermediates for the oxidation of gold(I). (a): Formation of a 
π-complex and (b): Dissociation of an X ligand from the iodine(III) centre. 
3.3.3. Relative rates 
In order to differentiate between the two hypotheses shown in Figure 23, a Hammett 
correlation was investigated. Correlation of the logarithm of relative rate to σ is expected to 
support the formation of a π-complex, whereas correlation to σ+, where resonance from a para 
substituent to the I+ centre is considered, would support initial ligand dissociation from the 
iodine(III) centre. 
To quantify relative rates of oxidation, it was anticipated that Eq. 3 utilised by Singleton and 
Thomas91 could be applied. In the equation, the ratio of the competing reactants (r) is 
dependent on the initial ratio of reactants (r0), the fractional conversion of total competing 
reactants, F (between 0 and 1, where 1 represents the total consumption of both competing 
reactants), and the relative rate of reaction (krel). The equation can then be fitted to a plot of 
ratio versus conversion by varying krel.  






It should be noted that the equation has been derived to be used for the calculation of natural 
abundance KIE; where the concentration of one competing component is significantly less 
than the other competing component. Thus, an approximation is used in Eq. 3, and this is 




To test the validity of utilising Eq. 3 to calculate relative rates for the competition reactions, a 
plot of calculated ratio versus conversion of both components at very different rates was 
created and displayed in Figure 24.  











Figure 24: Graphs showing calculated ratios (r) versus conversion (F). Blue line indicates 
maximum ratio change calculated for a completely selective process (krel = ∞), and the red 
line indicates calculated ratios obtained using Eq. 3, when r0 = 1, and krel = 0.1. 
The resulting red curve is shown in comparison with a theoretical maximum ratio change 
shown in blue. This line was obtained as a result of a totally selective system (illustrated in 
Table 5), where one competing component (A) is consumed completely before the other 
competing component (B). It was observed that the ratio change shown by the red curve 
decreases too quickly at conversions below 0.5. 
Table 5: Calculation of ratios where the competition is completely selective for the 
consumption of compound A.  
 
A : B  r  F 
       
0.5 : 0.5  1.0  0.0 
0.3 : 0.5  0.6  0.2 
0.0 : 0.5  0.0  0.5 
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Wolfsburg and Beigeleisen 
Using an equation derived by Wolfsburg and Beigeleisen92 from two first order reactions in A 
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Eq. 7 was developed by Wolfsburg and Beigeleisen and relates the ratio between A and B to 





When the abundance of one of the competing components is much lower compared to the 




be assumed to equal to 1, and Eq. 7 simplifies to Eq. 8 and rearranges to give Eq. 3’, a 
rearranged form of Eq. 3.  
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Eq. 7 was rearranged so that F is the subject of the equation and is shown in Eq. 9. 



































The same test as used with Eq. 3 can used in this scenario to test the validity of Eq. 9. Using 
the same initial ratio and relative rates, the analogous plot to Figure 24 was constructed and 
displayed in Figure 25. In this case, the red curve occurs above the line representing the 
maximum ratio change and shows a feasible situation. 











Figure 25: Graphs showing calculated ratios (r) vs conversion (F). Blue line indicates 
maximum ratio change calculated for a completely selective process (krel = ∞), and the red 





Ratio versus conversion 
The relative rate of oxidation of OMe(Ox) versus Br(Ox) can be obtained by fitting Eq. 9 to 
experimentally obtained ratios and conversion. This was carried out by calculating F and 
adjusting the relative rate (krel) until a good fit is achieved. The resulting plot is shown in Figure 
26. 













Figure 26: Ratio versus conversion plot for the competition of OMe(Ox) and C4 in an 
intramolecular direct arylation reaction. Blue datapoints represent experimental ratios. Red 
line represents data calculated using Eq. 9. krel = kOMe/kBr = 1.88, r = [OMe(Ox)]/[Br(Ox)]. 
The best fit of the equation to experimental data was obtained when krel = 1.88, showing that 
the relative rate of consumption of OMe(Ox) was nearly twice as fast as the relative rate of 
consumption of the p-Br substituted oxidant, Br(Ox). The initial portion of the graph, where 
consumption of total oxidant is low, deviates from the fitted curve and has a flatter profile. 
This could be due to the oxidants undergoing equilibration (discussed in Chapter 2) in the 
initial portion of the reaction, where bromide or bromonium from the precatalyst is still present 
in the reaction mixture and have not yet been removed by the starting silane to give the 
bromodesilylated product, as described in Section 2. An alternative reason could be that the 
activation of the catalyst involves the consumption of these oxidants, and their relative rates 
are unknown.  
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To ensure that the equilibration process is not occurring throughout the reaction, 
p-MeArI(OAc)2 (Me(Ox)) and p-ClArI(OAc)2 (Cl(Ox)) were competed in the presence of 
2-bromothiophene, which has been previously shown to stop the equilibration between the 
oxidants by reacting with bromonium generated from the precatalyst.43 The results are 
displayed in Table 6, entry 3.  
Table 6: Comparison of relative rates obtained under different conditions to observe the 
effect of oxidant equilibration. krel = kX/kMe. 
No. Oxidant Catalyst krel 




   
2 (tht)Au(Cl) 0.86 
   
3 
(tht)Au(Br)3  







   
5 (tht)Au(Cl) 0.62 
 
Competition reactions between Me(Ox) and Cl(Ox) as well as Me(Ox) and p-CF3ArI(OAc)2 
(CF3(Ox)) with (tht)Au(Cl) as a catalyst were carried out. (tht)Au(Cl) was previously tested 
in Chapter 2 and was shown to not catalyse the equilibration between these iodine(III) 
oxidants.  
The relative rates obtained under both of the modified conditions (entries 2, 3, and 5) gave 
similar relative rates of reaction to the original conditions (entries 1 and 4). However, it was 
unexpected that the reaction with (tht)Au(Cl) (entries 2 and 5) gave a higher krel compared to 
the reaction with (tht)Au(Br)3 (entries 1 and 4) which is known to undergo equilibration. If 
equilibration is occurring throughout the reaction where the oxidants are competing, the krel 
value was expected to be closer to one, as the equilibration favours formation of the more 
electron-poor oxidant.  
However, the reactions for entries 2, 3, and 5 were not monitored to completion, and it is only 
towards full conversion where the fitting is most sensitive to changes in krel and will therefore 
provide a more accurate value for the relative rate of reaction. 
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Figure 27: Graph indicating the accuracy of the krel values obtained, where the red line shows 
the best fit obtained (krel = 0.97) based on the experimental data (black circles). The blue line 
shows the resulting curve when krel = 0.98, and the black line shows the situation where 
krel = 0.96. 
Hammett correlation 
With a method of quantifying relative rates of reaction for competition reactions in hand, a 
Hammett plot was constructed by competing a range of para-substituted ArI(OAc)2 oxidants 
against p-BrArI(OAc)2. It was found that log (krel) correlated best with σ+ values (Figure 28), 
indicating that the proposal where a ligand dissociates from the iodine centre to form an 






















y = - 0.413x + 0.087
R2 = 0.823


















y = - 0.260x + 0.045
R2 = 0.972  
 
Figure 28: Comparison of Hammett plots using σ and σ+ values. Top: log krel versus σ, 
bottom: log krel versus σ+. 
Furthermore, Swain-Lupton parameters74 were utilised, where the value on the x-axis (𝜎𝑆𝐿) is 
derived from a mix of induction (F) and resonance (R) parameters, as shown in Equation 10, 
where x is between 0 and 1. The best fit was obtained when x = 0.36, and the value is weighted 
towards the resonance component. 
𝜎𝑆𝐿 = 𝑥𝐹 + (1 − 𝑥)𝑅 Equation 10 
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y = - 0.780x + 0.033
R2 = 0.946
 
Figure 29: log krel versus σSL obtained for the competition of substituted aryl oxidants.  
𝜎𝑆𝐿 = 𝑥𝐹 + (1 − 𝑥)𝑅, where 𝑥 = 0.36. 
3.4. Competition of alkyl oxidants 
To completely rule out the possibility of needing π-complexation prior to oxidation of the 
gold(I) intermediate, as shown in Figure 23, the reactivity of an alkyl oxidant was analysed. 
Since these oxidants have no aromatic rings, if the alkyl oxidant is active under the reaction 
conditions, this would further illustrate that the oxidation occurs initially via the dissociation 
of a ligand attached to the iodine centre to form an iodonium species, as drawn in Figure 23. 
 
Figure 30: Hypervalent iodine(III) oxidant with an alkyl group in the equatorial position. 
3.4.1. Synthesis 
Alkyl hypervalent iodine(III) oxidants shown in Figure 30 can be synthesised from the 
oxidation of trifluoroethyliodide (C11) with trifluoroperacetic acid.93,94 From the generated 
bistrifluoroacetate compound C12, the sulfonate analogues, such as tosylate C13 or mesylate 
C14 can be synthesised by reacting with the corresponding sulfonic acids, as illustrated in 
Scheme 34. These compounds were found to be stable and could be stored in the refrigerator 




Scheme 34: Synthetic route towards the synthesis of a hypervalent iodine(III) oxidant with 
an alkyl group in the equatorial position.93 
However, the use of trifluoroperacetic acid is undesirable, as it is potentially explosive.95 Other 
methods have been developed, where trifluoroperacetic acid is generated in-situ from 
trifluoroacetic anhydride and hydrogen peroxide,96 but the avoidance of forming any 
trifluoroperacetic acid was favourable.  
An initial attempt at utilising sodium perborate in acetic acid97 did not give any hypervalent 
iodine(III) product when analysed by 1H NMR spectroscopy. It was then thought that we could 
take advantage of the equilibration reaction (discussed in Chapter 2) and use an aryl oxidant 
to oxidise the alkyl iodide within the coupling reaction. Since it was seen in Figure 26 that 
equilibration does occur at the very beginning when using (tht)Au(Br)3 as a catalyst, a small 
amount of the alkyl oxidant could be generated, and subsequently competed against the initial 
aryl oxidant added when equilibration was halted. 
3.4.2. Equilibration and competition  
When the reaction shown in Scheme 35 was carried out, it was found that an insignificant 
amount of alkyl oxidant (less than 1%) was generated during the reaction.  
 
Scheme 35: Intramolecular cyclisation of C9 catalysed by gold(III), with Br(Ox) and alkyl 
iodide in an attempt to generate some alkyl iodine(III) oxidant. 
Since relying on the equilibration reaction within the coupling reaction was unsuccessful, the 
equilibration was carried out in a separate vial. The equilibration reaction was then halted by 
the addition of an electron-rich aromatic compound (m-OMeArI), which removes bromonium, 
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the species assumed to catalyse the equilibration reaction. Aryl silane C9 and the gold(III) 
catalyst were then added to this mixture, and the consumption of both the alkyl oxidant and 
the aryl oxidant were monitored. Figure 31 summarises the experiment carried out. 
 
 



















Figure 31: Intramolecular cyclisation of compound C9, with 2 mol% (tht)Au(Br)3 as the 
catalyst. Br(Ox) (1 equiv.) and CF3CH2I (1 equiv.) were equilibrated with Bu4NBr (1 mol%) 
in CDCl3/CD3OD, and the equilibration was halted with m-OMeArI. Silane C9 and 
(tht)Au(Br)3 were added to the mixture. All concentrations were obtained relative to CH2Cl2 
as a standard. Circle datapoints were directly obtained based on the integrations of the 





The integrations of Alkyl(Ox) at the start of the reaction was not directly possible due to an 
overlapping peak, originating from camphorsulfonic acid. This peak shifts to a higher 
frequency as the reaction progresses when more of the acid is liberated as the iodine oxidant 
is consumed. As a result, Alkyl(Ox) can be monitored from the latter half of the reaction 
onwards. However, the initial profile for Alkyl(Ox) can be estimated by back calculating from 
the alkyl iodide (C11) peak. 
The graph in Figure 31 shows that although Alkyl(Ox) reacts at a significantly slower rate 
when compared to Br(Ox), it is still active in reoxidising gold(I) under the reaction conditions. 
Its activity is highlighted towards the end of the reaction, (between 2500 s and 3000 s) and as 
the concentration of Br(Ox) drops, the rate of consumption of Alkyl(Ox) increases to maintain 
a constant turnover rate for the catalyst.  
Plotting the ratio versus conversion for the competition of Alkyl(Ox) and Br(Ox), it was found 
that the relative rate of reaction of Alkyl(Ox) versus Br(Ox) is 0.49 (Figure 32). 
















Figure 32: Graph showing the ratio versus conversion from the data in Figure 31. 
Experimental values illustrated by the circles, and calculated fit using Eq.97 shown with the 




3.4.3. Validation of method 
In an attempt to validate this method for competing oxidants, the same procedure as illustrated 
in Figure 31 was carried out, where Cl(Ox) and Me(Ox) were competed. Unfortunately, only 
the oxidant integrations during the first half of the reaction was obtainable, due to the 
camphorsulfonic acid peak, which shifts towards the oxidant peaks as the reaction proceeds, 
resulting in a less accurate value of krel obtained. 
These oxidants were also competed, where equilibration was carried out whilst the direct 
arylation reaction was occurring. The results are summarised in Table 7. 
Table 7: Comparison of krel values obtained with the competition of Me(Ox) and Cl(Ox) 
under different conditions: Me(Ox) and Cl(Ox) added as oxidants, Me(Ox) and ClArI 
equilibrated prior to the reaction (as described in Figure 31) and Me(Ox) and ClArI 
equilibrated as the intramolecular cyclisation was carried out, as attempted in Scheme 35. 
No. Conditions   krel 
    
1 Me(Ox) and Cl(Ox)  0.83 
    
2 Me(Ox) and ClArI, preequilibrated  0.84 
    
3 Me(Ox) and ClArI, equilibrate in situ  0.83 
 
3.5. Proposed mechanism 
Based on the results of this chapter, a tentative mechanism has been proposed (Scheme 36) for 
the oxidation of the gold(I) complex formed under the reaction conditions shown in Scheme 
32. Initial dissociation of an X ligand on the iodine(III) oxidant is proposed to occur, and this 
is supported by electron-rich oxidants having a higher krel. Furthermore, log krel correlates best 
with σ+ compared to σ, as well as resonance-weighted Swain-Lupton parameters, indicating 
that resonance towards a positive charge is important.  
From this, the X ligand could coordinate to the gold(I) centre to give an anionic complex, 
which is then oxidised by the iodonium compound generated to give a reduced iodoarene and 




Scheme 36: Proposed mechanism of gold(I) oxidation with hypervalent iodine(III) oxidants 
under the gold(III) catalysed direct arylation conditions. Initial dissociation of the X ligand 
from the oxidant is thought to occur prior to oxidation of the gold(I) complex. 
3.6. Conclusions 
Competition experiments between different oxidants within a gold(III) catalysed direct 
arylation reaction have shown that electron-rich hypervalent iodine(III) oxidants have a higher 
relative rate of reaction, when compared to electron-poor oxidants. This is contrary to the 
results obtained in Chapter 2, where electron-deficient oxidants were found to be stronger 
oxidants, with higher reduction potentials. Therefore, it is suggested that the oxidation of 
gold(I) within the reaction conditions studied is under kinetic control, rather than 
thermodynamic control.  
Quantitative relative rate data was obtained using a modified version of an equation derived 
by Wolfsburg and Beigeleisen.92 Fitting of this equation to experimentally obtained data 
allowed for krel to be obtained, and log krel was found to correlate better to σ+ when compared 
to σ values for substituents on the aromatic ring of the oxidant. This led to the proposal that 
dissociation of an X ligand from the iodine(III) centre was occurring prior to oxidation of 
gold(I).  
To investigate the necessity of π-complexation of the oxidant to the gold centre for oxidation, 
an alkyl iodine(III) oxidant was synthesised via an equilibration reaction with Br(Ox) 
(described in Chapter 2), and the two oxidants were subsequently competed in a direct 
arylation reaction. It was found that the alkyl oxidant was active in turning over the catalyst, 
which disfavours the proposal that π-complexation of the oxidant to gold(I) was required prior 










Absolute rates of oxidation 
 





In the previous chapter, it was highlighted that the rate of oxidation within a gold(III) catalysed 
intramolecular reaction of arylsilanes could not directly be monitored, as the turnover-limiting 
step of the catalytic cycle does not involve the oxidation of gold(I).50 Instead, competition 
studies were carried out where two hypervalent iodine(III) oxidants were co-reacted and the 
relative rates of one oxidant over the other could be analysed. It was found that electron-rich 
oxidants had higher relative rates over electron-deficient oxidants, even though the studies in 
Chapter 2 indicated that the more electron-deficient oxidants have a higher redox potential, 
and are therefore are the stronger oxidants, thermodynamically. It was proposed that 
dissociation of an X ligand from the iodine(III) centre occurred prior to oxidation of the gold(I) 
complex.  
However, there are several issues associated with the competition studies. Firstly, interactions 
between the hypervalent iodine(III) species cannot be ruled out, and this may have affected 
the results obtained. Furthermore, as described in Chapter 2, hypervalent aryliodine(III) 
oxidants and aryl iodides can equilibrate to form a mixture of hypervalent aryliodine(III) 
species under the reaction conditions studied for the intramolecular arylation reaction.  
Therefore, different approaches of obtaining absolute rate of reactions were considered and 
will be discussed in this chapter.  
4.2.  Preliminary results 
4.2.1. Monitoring resting state 
Previous studies 
Prior to exploring the reoxidation of gold(I) generated from the intramolecular cyclisation 
reaction of arylsilanes such as D1 in Scheme 37 to give D2, the resting state of the catalyst in 
the catalytic cycle was examined. Previous work50 indicated that the turnover limiting step was 




Scheme 37: Summary of previous studies carried out on the reaction of a gold(III) catalysed 
intramolecular arylation reaction of substrate D1 to give D2. Complex D3 is proposed to be 
the resting state of the catalyst.50 
Current studies 
The resting state was previously observed by 1H NMR spectroscopy, where a peak at 
approximately 4 ppm was observed, with an integration equating to the concentration of 
catalyst added.50 Similar analysis was carried out on the reaction of compound D4 to give D5 
(Figure 33, top) and the reaction was monitored by 19F NMR spectroscopy. The observed peak 
corresponding to the resting state (Au-int) was found to be at approximately −116 ppm, as 




Figure 33: Top – Reaction monitored by 19F NMR spectroscopy. Bottom – 19F NMR spectra 
obtained at 159 s into the reaction illustrated at the top, with 0.2 M D4, 5 mol% (tht)Au(Br)3, 
0.75 equiv. p-FArI(OAc)2 and 0.8 equiv. CSA in 0.5 mL CDCl3/CD3OD (50:1). 
Approximately 10% conversion was observed from the spectra above. 
Addition of a standard (2-BrArF) to the gold pre-catalyst stock solution in a 1:1 ratio allowed 
for a more accurate insight into the amount of gold added to the reaction mixture prior to 
initiation of the reaction. The volume of the gold stock solution added was varied and the 
results are shown in Figure 34. All three datasets have the same profile and start with an 
increase in the concentration of the resting state, as the catalyst is activated. The flat profile in 
the middle shows the steady-state concentration of this intermediate, and it was found that its 
integration equated to the same concentration as the integration of the standard. This is 
consistent when the volume of the stock solution was changed, and thus the amount of 
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Figure 34: Temporal concentration plot showing the intermediate thought to be the resting 
state of the catalyst and the standard (2-BrArF) added. Three different concentrations of 
catalyst were used, and the time scale for the red and the purple data was adjusted. Reaction 
carried out is illustrated at the top of Figure 33 with 0.2 M D4, 0.75 equiv. p-FArI(OAc)2, 
0.8 equiv. CSA in 0.5 mL CDCl3/CD3OD (50:1). Red data corresponds to 3 mol% 
(tht)Au(Br)3, blue data corresponds to 5 mol% (tht)Au(Br)3, and purple data corresponds to 
7 mol% (tht)Au(Br)3 used. 
Decay of resting state 
The graph shown in Figure 34 shows the temporal concentration profiles of the resting state 
of the catalysts and the standard added. The time scale of the runs for 0.006 M and 0.014 M 
of [Au] were adjusted so that the decay profile of the formed intermediate overlapped, 





















Figure 35: First order fit to the decay observed in Figure 34, [Au] = 0.010 M. 
Nature of resting state 
It was previously proposed that the turnover-limiting step of the reaction was a reductive 
elimination process from a biaryl gold(III) complex, where the resting state of the catalyst is 
bound by both rings of the starting material shown below in Figure 36.50 
 
Figure 36: Proposed intermediate for the resting state of gold in the intramolecular 
cyclisation reaction of D4, catalysed by (tht)Au(Br)3. The X and L ligands attached to the 
gold are unknown. 
To further probe the nature of the resting state, two different arylsilanes were compared as 
starting materials, as shown in Scheme 38. Both these starting materials contain a fluorine 
label on them, but on the different aryl rings. These starting materials would converge on the 




Scheme 38: Comparison of the cyclisation reaction of D4 and D7 via intermediate D6.  
The 19F NMR spectra for both reactions, obtained after the reactions indicated in Scheme 38 
were initiated, are illustrated in Figure 37. The peaks relating to both starting materials are 
shown on the spectra. It should be noted that the product peak is identical in both reactions, as 
expected. Furthermore, the peak for the resting state of the catalyst previously identified in 
Figure 33 occur with identical chemical shifts in both reactions. This shows that they either 
converge on the same intermediate, or that both intermediates have the fluorine label at very 
similar chemical environments.  
Considering the chemical shifts in the first reaction with compound D4 as the starting material, 
the fluorine in the bromodesilylation side product has a chemical shift of −113.4 ppm, where 
the silane itself has its fluorine chemical shift at −113.6 ppm. This shows that even a change 
in the silane ring has a visible impact on the chemical shift of the fluorine on the arene ring. 




Figure 37: 19F NMR spectra obtained for the reaction of D4 (top) and D7 (bottom) under the 
reaction conditions described in Figure 33, obtained after 159 s and 390 s respectively. 
4.2.2.  Reoxidation of Gold(I) 
It was previously suspected that the resulting gold(I) species formed after reductive 
elimination had a very short lifetime, with the reaction mixture forming significant amounts 
of colloidal gold (“gold black”) when there is insufficient oxidant present.43  
To probe the lifetime of the gold(I) species generated under the reaction conditions described 
in Scheme 39, experiments were carried out where sub-stoichiometric amounts of oxidant 
were added, and the consumption of oxidant was monitored by 1H NMR spectroscopy. When 
all the oxidant had been consumed, additional portions of oxidant were then added to the 
reaction mixture at different time intervals. The reaction mixture was then monitored further 








Scheme 39: Intramolecular cyclisation of substrate D4, with multiple addition of sub-
stoichiometric amounts of oxidant. 
The graph in Figure 38 shows the consumption of oxidant versus time, where the lines indicate 
when more oxidant was added to the reaction mixture. With subsequent additions of oxidant, 
the rate of reaction decreases. This is consistent with the suggestion that the catalyst, in absence 
of the oxidant is metastable. Therefore, each time more oxidant is added, a smaller amount of 
catalyst is reactivated. 















Figure 38: Temporal concentration plot of the oxidant in the reaction illustrated in Scheme 
39. The black data points represent the oxidant monitored, and the vertical dotted lines show 
the times when more oxidant was added. Conditions used: 0.1 M D4 in 1.0 mL 





The relative rates of reaction after each addition were plotted against the cumulative length of 
time the reaction mixture was left without oxidant, and the data from Figure 38 is shown as 
Run 1. The experiment was repeated with increasing and decreasing delay times, and the 
relative rates of the reactions are shown in Figure 39. In general, a longer delay results in a 
lower amount of reactivated catalyst. 




















Figure 39: Graph showing the relative rate of reaction versus total time the reaction shown in 
Scheme 39 was left without oxidant.  
By comparing the relative rates of reaction after the first addition of oxidant across the three 
runs, the amount of reactivated catalyst is lower for the longer delays (Run 2). However, there 
seems to be a shallower drop in reaction rate when comparing the first data point of Run 3 and 
Run 2. Approximately 20% of the catalyst was lost in 5 seconds of Run 3 and approximately 
double that amount, 40% of the catalyst, was lost in 120 seconds in Run 2. This indicates that 
a larger amount of catalyst is deactivating as soon as the reaction runs out of oxidant, and the 




Interestingly, the amount of time the reaction mixture was left without oxidant does not 
directly correlate with the amount of catalyst reactivated, and instead, this was affected also 
by the number of times it was reactivated. For example, in Run 3, there was 60% of the active 
catalyst remaining in the reaction by the third reoxidation, and the total amount of time the 
reaction mixture has been left in the absence of oxidant is approximately 50 seconds. However, 
in Run 2, the first reoxidation, which occurs after approximately 120 seconds also results in 
60% of the active catalyst remaining. This could be a result of the addition process, where 
impurities, such as water could introduced alongside the oxidant, which may aid the 
decomposition of the catalyst.98 
4.3. Aims of the chapter 
These sets of experiments have indicated that the resulting gold(I) species is stable for long 
enough under the reaction conditions to be reoxidised, and therefore, the oxidation of gold(I) 
can be studied. Scheme 40 summarises the approach in monitoring this oxidation, based on 
the known mechanism of this reaction. 43,50  
 
Scheme 40: Summary of the method used in monitoring the oxidation of gold(I) under the 
intramolecular direct arylation reaction catalysed by (tht)Au(Br)3. 
In this proposed approach, the gold(III) catalytic cycle is initiated where with an excess of 
starting material (ArSiMe3) over the oxidant (Ox). Once the oxidant has been fully consumed, 
the catalytic cycle stops at the gold(I) complex following reductive elimination to release the 
product. A second oxidant can then be added to the mixture, and the subsequent reaction can 




4.4. Monitoring fast reactions 
Previous studies50 have indicated that the rate of gold(I) oxidation is too rapidi to be observed 
by NMR spectroscopy via the method illustrated in Scheme 39 and Figure 38, where the time 
between addition of oxidant and the first acquired spectra was approximately 80 seconds.  
Furthermore, the results in Figure 38 indicate that all of the catalyst that can be reactivated has 
already been oxidised by the time the first spectra was obtained. This was seen in the 
concentration versus time profile of the starting material shown in Figure 40. Since the rate of 
reaction follows zero-order kinetics, the consumption of starting material will show a 
straight-line profile. If more gold is reactivated after the first spectra has been taken, the rate 
of reaction for the latter sections of the reaction will be faster. However, the spectra were 
collected with a 30 second interval between data points, and small changes in the rate may not 
be observable at this resolution. 
















Figure 40: Temporal concentration plot of starting material, D4 in the reaction shown in 
Scheme 39 under the reaction conditions described in Figure 38. 
 
i Fastest reaction carried out achieved 95% conversion to product in 10 minutes using 1 mol% catalyst. 
This gave 1 turnover every 6.5 seconds. 
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4.4.1. UV-vis spectrometry 
Since the reaction between the generated gold(I) complex and hypervalent iodine(III) oxidants 
is thought to be rapid, it was proposed that the oxidation reaction could be monitored by 
UV-spectroscopy, as data can be acquired on the millisecond timescale.99 Furthermore, it was 
found that reagents can be easily added to cuvettes via an adder-mixer,100–102 which consists of 
a rod with a square or rectangular attachment at one end. A small amount of reagent 
(approximately 100 μL)102 can be placed on the attachment at the end of the rod, and the 
solutions are mixed by vertical movements of the rod, achieving dead times of a few 
seconds.100 
The plots shown in Figure 41 shows an overlay of the UV spectrum obtain for the gold(III) 
precatalyst, the arylsilane B4, and PhI(OAc)2 with CSA. From this, it was proposed that the 
growth of the gold(III) complex (product from oxidation of gold(I)) could be monitored, as 
the peak at approximately 400 nm occurs in the absence of any other absorbance peaks.  





















 Oxidant + CSA
 
Figure 41: Overlay of UV-vis absorbance spectra of (tht)Au(Br)3 (0.033 mM), D4 (0.5 mM), 





However, further testing on the reaction conditions showed that the absorbance of catalytic 
amounts of gold resulted in an almost negligible peak at around 400 nm. Increasing the amount 
of gold used in the reaction would result in increasing the amount of oxidant used, and the 
saturation limit of the UV-vis detector would be reached. The graph shown in Figure 42 
illustrates the t0 time-point of the reaction, where only starting material B4 and (tht)Au(Br)3 
are present, and the t1 time-point of the reaction, where the oxidant has been added to the 
mixture to start the reaction.  






















 ArSiMe3 + (tht)Au(Br)3
 ArSiMe3 + (tht)Au(Br)3 + oxidant
 
Figure 42: Overlay of UV-vis absorbance spectra of the reaction shown Figure 33 
(0.3 mM D4 and 10 mol% (tht)Au(Br)3). Red line shows the t0 spectra and the black line 
shows the t1 spectra obtained following initiation by addition of oxidant (0.45 mM oxidant). 
4.4.2. Rapid injection 
Setup 1.0 
Having had little success in utilising UV-vis spectroscopy in monitoring the oxidation of 
gold(I), it was proposed that NMR spectroscopy could be utilised, and reagents could be added 
whilst the reaction was inside the magnet of the NMR spectrometer to reduce the dead time 




Figure 43: Summary of design utilised to add and mix reagents inside the NMR magnet. 
Three pieces of tubing were inserted through a standard plastic NMR cap. Oxidant was 
added via the tubing shown in red, air was bubbled through the light blue tubing to mix the 
reagents. The grey tubing was used as a vent. Reaction mixture illustrated as pale blue at the 
bottom of the tube. 
Three pieces of tubing were inserted into the lid of the NMR tube, with two of them going to 
the bottom of the tube. The oxidant was delivered through the reagent tubing (red in Figure 
43) and the second tube was used to deliver air bubbles to the reaction mixture. This was to 
allow for mixing to take place when the new oxidant was added within the magnet of the NMR 










At the other end of the reagent tubing, a three-way valve was attached to allow for a reservoir 
syringe and a loading syringe to be connected. The movement of reagent is shown in Figure 
44. The reservoir syringe was used fill the loading syringe (red arrow) and subsequently used 
to prime the reagent tubing (blue arrow). This helps prevent the formation of air bubbles within 
the reagent tube. 
 
Figure 44: Syringe setup that was connected to the end of the reagent tube (red in Figure 43). 
The 2.5 mL syringe was used as the reservoir syringe, and the 50 μL syringe was used as the 
loading syringe which injected the reagent into the NMR tube. Movement of reagent 
followed the red arrow first, then the blue.  
Using this setup, the mixing efficiency was tested using a blue solution in chloroform injected 
into chloroform. Figure 45 shows the results taken after the bubbling has stopped, which 
occurs at approximately 4 seconds after the bubbler was turned off. The blue solution was 




Figure 45: Injection of a blue solution into chloroform. Image was taken approximately 
4 seconds after the addition of the blue solution, and after bubbling has stopped.  
Reaction monitoring using setup 1.0 
From Figure 45, it appears that the solution is fully mixed by the time the bubbling stops. The 
setup shown in Figure 43 and Figure 44 was then used to study the reoxidation of gold(I) by 
addition of a new oxidant to the reaction mixture, as discussed in Scheme 40. 
 
Scheme 41: Intramolecular cyclisation of substrate D4 with substoichiometric amounts of 
oxidant. A second oxidant was added after the reaction ran out of initial oxidant. 
The reaction shown in Scheme 41 was carried out to obtain preliminary results. In the first part 
of the reaction, intramolecular cyclisation of D4 was carried out with sub-stoichiometric 
amounts of oxidant. Once the oxidant was used up, a fluorine-labelled oxidant (p-FArI(OAc)2) 



































Figure 46: Graph showing the temporal concentration of the product from the intramolecular 
cyclisation reaction, D5 (Scheme 41), the product from the added oxidant, p-FArI, the 
proposed resting state of the catalyst (D6) and the internal standard (2-BrArF) added in a 1:1 
ratio with p-FArI(OAc)2. Data obtained every 20 seconds before addition of oxidant, and 
every 2.5 seconds after addition of oxidant. All integrals were obtained by 19F NMR 
spectroscopy relative to 1,3-difluorobenzene. 
The graph in Figure 46 shows the temporal concentration plot of the reaction in Scheme 41. 
The first portion of the graph (up to 400 s) shows the growth of the product, and the 
concentration of the resting state of the catalyst. As discussed previously, the profile of the 
resting state matches that shown in Figure 34. When the formation of product D5 stops, the 
bubbler was turned on, and more oxidant was added. The next timepoint obtained was when 
the bubbling had halted, and this can be seen by monitoring the concentration of the standard 
(1,3-C6H4F2) added at the very beginning of the reaction. During the bubbling, the 
concentration of this standard drops, as air is introduced into the sample, and the solution is 
displaced from the active volume in the NMR probe head. This is shown in Figure 47 where 
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Figure 47: Absolute integration of 1,3-difluorobenzene obtained by 19F NMR spectroscopy 
as the bubbling was started. 
From the graph shown in Figure 46, after addition of the oxidant, the formation of reduced 
oxidant (p-FArI) was monitored, along with the concentration of the gold resting state (D6) 
and the standard added together with the oxidant (1,2-BrArF). It was observed that the growth 
of p-FArI was linear, which was unexpected as this indicates that the concentration of oxidant, 
at this point in the reaction described in Scheme 42, plays no role in the rate of gold(I) 
oxidation. It was then thought that the added oxidant was not mixed well when added to the 
reaction in the NMR tube, and that the production of p-FArI was controlled by mixing. 
However, the concentration of the standard added together with the oxidant indicates that the 
mixture within the receiver coils have a constant concentration over the monitored time.  
 
Scheme 42: Summary of expected reaction between the gold(I) complex formed and the 
added oxidant. 
Setup 1.1 
A drawback from the design shown in Figure 44 was that the time of oxidant addition was not 
known. Furthermore, the point when more oxidant was added was not observable by NMR 
spectroscopy as the signals obtained during bubbling was too weak. A modification of this 
design was carried out, where a trigger was accommodated into the setup so that the addition 
of oxidant resulted in the start of NMR acquisition. This is illustrated in Figure 48. 





Figure 48: Syringe setup with a trigger to start spectra acquisition on the NMR spectrometer. 
Three-way valves are shown as V in a circle. 
The design shown in  Figure 48 has three syringes, with one of the syringes as the waste syringe 
(1 mL). The 250 μL syringe (reagent syringe) directly connects to the reagent line to deliver 
oxidant inside the NMR tube, and the 2.5 mL syringe (trigger syringe) was filled with water 
and connects directly to the waste syringe. The trigger syringe pushes out the plunger of the 
waste syringe so that the trigger is pushed. A three-way valve was used to load and unload the 
syringes and to prime the reagent line, similar to that shown in Figure 44. 
Both the reagent syringe and the trigger syringe are connected to the same push plate and is 
driven by a compressed air (CA) drive. This allows for a faster flow of reagent to the reaction 
inside an NMR tube, which would assist in the mixing.  
The waste syringe was positioned at a distance which required 400 μL of solution from the 
trigger syringe to completely extend the syringe plunger so that it meets the trigger. Using the 
syringe sizes as shown in Figure 48, this equates to 40 μL of reagent added to the NMR tube.  
 
Figure 49: Setup of spaces on the plunger of the waste syringe. Larger spaces result in less 
volume required to push the trigger. 
Spacers were made to reduce the distance between the plunger of the waste syringe and the 
trigger as shown in Figure 49. This reduces the amount of water required from the trigger 
syringe, and thus allows for a variable amount of reagent added. The spacers were designed 
so that 5 μL – 40 μL of reagent can be added, with 5 μL increments. 







Figure 50: 1H NMR spectra obtained from the injection of AcOH in CDCl3 (20 μL) into a 
0.5 mL solution of p-fluoroaniline in CDCl3. 
The mixing of the setup shown in Figure 48 with bubbling was tested using an acid-base 
reaction between p-fluoroaniline and acetic acid (AcOH) in CDCl3. The 1H NMR spectra 
obtained are shown as a stack in Figure 50, where the first spectrum was obtained before 
addition of acetic acid, the second spectrum was obtained as soon as the trigger started 
acquisition and subsequent spectra (3-7) were obtained at intervals of 3 seconds. The bubbler 
was turned off approximately 2 seconds after acetic acid was added. 
Figure 50 shows that the sample inside the NMR tube was fully mixed by spectrum 4, at which 





Reaction monitoring using setup 1.1 
The reaction shown in Scheme 41 was repeated with the current setup and varying the amount 
of oxidant added. Unfortunately, problems were encountered with the wire connecting the 
trigger and the NMR spectrometer, which meant that the exact time point the new oxidant was 
added could not be recovered. However, using the information gained from Figure 50, the 
point of oxidant addition could be estimated to be within a 3 second interval. An example of 
this is shown below in Figure 51. Acquisition was started before bubbling and addition of the 
new oxidant. The point at which bubbling began can be seen in the broadening of the peaks 
(spectrum 9, Figure 51) and ceases by spectrum 17.  Oxidant can be seen appearing in 
spectrum 16, so spectrum 15 was taken as t = 0. The peaks for oxidant and the 1,2-BrArF 
standard seen prior to oxidant addition was attributed to the reagents within the tubing setup 
in the NMR tube. 
 
Figure 51: 19F NMR spectra obtained from the reaction in Scheme 41 (0.2 M D4). Spectra 
1-8 were obtained prior to bubbling and addition of new oxidant. The spectra shown in red 
were obtained when bubbling occured. Spectra 18-21 were obtained following the addition 
of p-FArI(OAc)2 (0.005 mmol). From left to right, the peaks correspond to: oxidant in 
solution (−104.2 ppm), oxidant in tube (−104.5 ppm), 1,2-BrArF (−107.3 ppm), 1,3-
difluorobenzene (−110.0 ppm), D4 (−113.7 ppm), p-FArI (−114.4 ppm), D5 (−115.9 ppm) 
and Au-int (−116.2 ppm). 
87 
 
The amount of oxidant added was modified by injection of different volumes of the same stock 
solution from the reagent syringe (Figure 48). This was achieved by using the spacers 
described in Figure 49 to adjust the starting point of the plunger from the waste syringe. The 
product from the oxidant added was monitored, and the results are illustrated in Figure 52. 








0.014  0.0075 mmol (0.015 M)
 0.0050 mmol (0.010 M)










Figure 52: Top – summary of reaction monitored by 19F NMR spectroscopy with 0.2 M D4. 
Bottom – temporal concentration plot of p-FArI, product from the oxidation of gold(I).  
The growth in p-FArI follows a linear profile with similar gradients across the three different 
amounts of oxidant added. This was similar to the results obtained in Figure 46, where a linear 
increase in p-FArI was also observed. However, in Figure 52, the growth of product has more 
of a curvature towards the end. This is highlighted when a high-order polynomial fit was 
applied, and with the data from the addition of 0.0025 mmol of oxidant.  
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The final amounts of product obtained for addition of 0.005 mmol and 0.0075 mmol of oxidant 
was found to be lower than the amount added. This was possibly as a result from a small leak 
between the syringe and the three-way valve which played a bigger role when a larger force 
(compressed air drive) was used to push the reagents out. However, the concentration of 
p-FArI obtained at the end was found to be the same as the amount of standard added (in a 1:1 
ratio) together with the oxidant. 












 p-FArI (0.010 M)
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Figure 53: Graph showing the concentration of p-FArI and 2-BrArF as the internal standard 
versus time of the reaction shown in Figure 52, top, after the addition of 0.10 M 
p-FArI(OAc)2. 
With the exception from the addition of 0.0050 mmol of oxidant (red), results from both the 
addition of 0.0075 mmol (blue) and 0.0025 mmol (black) of oxidant appear to have an initial 
jump in the concentration of p-FArI generated. This may have resulted from an initial region 
of high concentration of oxidant before the sparging of air mixes the solution. The mixing of 
a blue solution into chloroform shown in Figure 54 was obtained approximately one second 
after addition, and a clear gradient can be seen between the bottom and top of the solution in 
the NMR tube. However, it is still important to note that the exact time of oxidant addition is 




Figure 54: Injection of 20 uL of blue solution into chloroform. Approximately one second 
after injection and turning off the bubbler. A concentration gradient can be seen where the 
colour is deeper at the bottom of the NMR tube. 
 Furthermore, when the temporal concentration plot of the oxidant and aryl iodide were 
overlaid (Figure 55), the initial concentration of oxidant was seen to be a lot higher than the 
concentration of its product obtained at the end of the reaction.  
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Figure 55: Graph showing the concentration change of added oxidant and p-FArI over time 




Although the exact timepoint that oxidant was added cannot be accurately determined, the 
resulting concentration gradient within the NMR tube may still have affected the results shown 
in Figure 52. Alternative design setups were explored, firstly to achieve a thoroughly mixed 
solution in less than 1 s, and to enable the start of the reaction to be monitored. Since the latter 
issue was as a result of recovery from bubbling, rapid injection methods using the setup shown 
in Figure 48 with a compressed air drive was considered, where the injection of the new 
reagent would be the method for mixing.  
Setup 2.0 
In 2003, a rapid sample-mixing technique was developed in order to monitor real-time protein 
folding inside an NMR spectrometer.103 A few years later, the technique was developed 
further,104 and Figure 56 below summarises the insert used inside the NMR tube. 
 




A glass capillary or a coaxial tube insert was used to hold and deliver reagents inside the NMR 
tube, with a glass micropipette attached to the end to allow for a collimated jet of liquid to be 
injected. The tip of the micropipette was positioned just above the radiofrequency coil in the 
magnet, and just below the surface of the solution in the tube. A Shigemi tube was used, which 
allowed a smaller sample volume to be used without affecting the lineshape of the spectra 
obtained. Furthermore, it was proposed that the flat bottom of the tube produced greater 
turbulence when compared to a round bottom.103 The whole insert was held in place within the 
tube with PTFE collars, and was supported by the NMR cap at the top. 
A Y-connector was attached to the top of the tubing (or glass capillary) and a PTFE transfer 
line was attached to carry reagents to the inside of the NMR tube. The transfer line was then 
connected to a glass syringe, which was mounted onto a pneumatic injector. 
The mixing efficiency of the device was tested using injection of a fluorescent dye into water, 
with pH jump experiments, and with the injection of H2O into D2O. It was found that complete 
mixing was achieved within 100 ms, when 50 μL of solution was injected into 280 μL inside 
the NMR tube.103 
In comparison, the system we developed used a larger volume of solution in the tube (500 μL) 
and injected 10-30 μL of reagent. As highlighted in Figure 54, mixing along the length of the 
NMR tube proved problematic. Using the information from the rapid-injection device 
developed,103,104 we adjusted our design so that efficient mixing could be achieved without 
bubbling air through the solution. The insert is illustrated in Figure 57. 
 




Similar to the rapid-injection design discussed previously,103,104 the insert consists of a piece 
of Tefzel® tubing connected to a micropipette at one end, and a narrower piece of tubing on 
the other, which leads to the syringe setup shown in Figure 48. The two pieces of tubing were 
connected via HPLC fittings, joined together by a threaded union. This allowed for the inset 
to be swapped over for different designs during the testing phase, without having to waste long 
pieces of tubing. The NMR cap was used to hold the insert in place at a set height from the 
bottom of the tube, and the micropipette was used to direct the jet flow of reagent into the 
NMR tube. 
The insert shown in  Figure 57 was placed inside a Shigemi tube matched to CDCl3, so that a 
smaller amount of reaction mixture could be used. Swapping the reagent syringe from the 
250 μL to a 500 μL syringe meant that 10 μL – 80 μL of reagents could be added with the 
current syringe setup.  
 
Figure 58: Injection of a blue solution into chloroform. All images were obtained 
approximately 3 seconds after injection. Pressure values refer to the driven pressure from the 
compressed air drive. Medium tip has a length of 0.7 cm, and the long tip has a length of 
2.5 cm. From left to right: A: 300 μL chloroform, 60 μL blue solution, 5 bar, medium tip in 
solution. B: 250 μL chloroform, 60 μL blue solution, 5 bar, medium tip in solution. C: 
300 μL chloroform, 60 μL blue solution, 8 bar, long tip in solution. D: 300 μL chloroform, 
50 μL blue solution, 8 bar, long tip in solution. E + F: 250 μL chloroform, 60 μL blue 
solution, 9 bar, medium tip above solution. G + H: 250 μL chloroform, 60 μL blue solution, 
5 bar, medium tip above solution. 
The mixing efficiency was studied by injecting a solution of blue dye in chloroform and 
monitoring the spread of the colour in chloroform inside the NMR tube (Figure 58). The first 
test (A) carried out was injection of 60 μL of dye into 300 μL of solvent. This gave poor 
mixing, with areas of low dye concentration at the bottom and near the top of the solution. 
93 
 
Decreasing the volume of solvent used from 300 μL to 250 μL improved the mixing at the 
bottom of the tube, but the top of the solution remained poorly mixed. This was because 
solution inside the NMR tube was rising around the Tefzel® tubing, and it was thought that 
this tubing was hindering mixing at the top. A longer micropipette tip was tested (C and D) 
but there were still issues with the mixing at the top of the solution. The micropipette tip was 
removed from the solution and placed just above the top of the solvent. This was shown to 
have the best mixing efficiency, even with lower pressures on the compressed air drive 
(G and H). However, since the jet injected was hitting the surface of the solution, a significant 
amount of bubbles were formed during injection.  
This setup (Figure 58, G and H) was further tested inside the magnet of the NMR spectrometer, 
where AcOH was injected into a solution of p-fluoroaniline in CDCl3. The results are shown 
in Figure 59, where the reaction was monitored by 1H NMR spectroscopy. 
 
Figure 59: Stacked 1H NMR spectra showing the injection of 60 μL of AcOH (0.5 M 
solution in CDCl3) into a 250 μL solution of p-fluoroaniline in CDCl3 (0.16 M) using setup 
G (and H) shown in Figure 58. Addition occurred between 0 – 2 seconds.  
It was seen that mixing was achieved within 2 seconds from injection, with a slight overshoot 
by 0.1 ppm when compared to the spectra obtained at 120 seconds. This overshoot is small 
when considering the initial change in chemical shift, which was 1.8 ppm obtained when 








Reaction monitoring using setup 2.0 
The reoxidation of gold(I) was then monitored, where the reaction shown at the top of Figure 
52 was observed by 19F NMR spectroscopy. When the formation of product D5 stopped, more 
oxidant (p-FArI(OAc)2) was added whilst the reaction was still in the magnet of the NMR 
spectrometer using the series of tubing illustrated in Figure 56 and Figure 57, and following 
setup G (and H) shown in Figure 58. The resulting temporal concentration plot of p-FArI is 
shown in Figure 60. 




















Figure 60: Graph showing the formation of p-FArI over time following the reaction shown at 
the top of Figure 52, after the addition of 0.0025 mmol p-FArI(OAc)2. 
Figure 60 shows the growth in p-FArI, the product from oxidation of gold(I) over two identical 
runs. It can be seen that there was an issue with the volume of oxidant stock solution added. 
The target amount to be added was 0.0025 mmol (0.008 M) of oxidant in 60 μL of solution, 
but from Figure 60, in both cases, the amount of oxidant added was higher than expected. 
From the final amount of p-FArI obtained in Run 1 (0.0035 mmol), the volume of oxidant 
stock added to the NMR tube worked out to be 88 μL, which is nearly 50% more than expected.  
Both Run 1 and Run 2 indicate that the amounts of oxidant added does not affect the rate of 
p-FArI production. This is similar to the results obtained in Figure 52. 
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Focusing on the profile obtained of p-FArI in Run 1, there appears to be two separate regions 
of growth. This is highlighted in Figure 61, where two linear fits were applied to the different 
regions of data.  
















1000y = 0.441x + 0.0163
R2 = 0.995
1000y = 0.242x + 1.66
R2 = 0.995
 
Figure 61: Graph showing the temporal concentration of the oxidation product, p-FArI and 
the resting state of the catalyst, Au-int from the reaction shown at the top of Figure 52 
following the addition of p-FArI(OAc)2 (0.0025 mmol). 
A higher rate of p-FArI production was seen at the start of the graph shown in Figure 61, 
compared to the rate observed after 10 seconds. Assuming a straight-line fit could be applied 
to the growth of aryl iodide, the rate after 10 seconds was nearly half of that observed before 
10 seconds. The concentration of the resting state (Au-int) versus time was also plotted in 
Figure 61. It appears that the initial growth of Au-int overlays with the growth of p-FArI, 
which also coincides with the fast region described earlier. This implies that the rate of 
oxidation (Scheme 43, equation 1) is slower or comparable with the rate of C-Si auration of 




Scheme 43: 1) Reaction of a gold(I) complex with oxidant to give the corresponding aryl 
iodide product and a gold(III) complex. 2) Reaction of a gold(III) complex with the 
arylsilane starting material (D4) to give the resting state of the catalyst. 
The decrease in rate of p-FArI formation seen could be a result of a decreased concentration 
of the initial gold(I) complex in solution. This is accompanied by a decrease in the rate of 
Au-int formation, although this decrease is much greater. However, it should be noted that the 
oxidant will also be consumed when Au-int reacts to release D5 and more gold(I), which will 
then be oxidised, to produce more p-FArI.  
              
Scheme 44: Simplified catalytic cycle for the gold(III) catalysed intramolecular cyclisation 
of arylsilanes. Input values for the model are shown on the right. 
A simple catalytic cycle was simulated (Scheme 44) and the resulting graph in Figure 62 shows 
the expected profile for p-FArI and Au-int. The starting point used for the model is the gold(I) 
complex (AuI) and oxidant (Ox). These react to give a gold(III) species (AuIII) which reacts 
with arylsilane (ArSiMe3) to give the resting state of the catalytic cycle, Au-int. The release 
of product from Au-int was set to have a small rate constant and is the turnover-limiting step. 
Once product is released, the AuI is regenerated to react with more oxidant. 
Input values: 
k1 = 10 mol-1 dm3 s-1 
k2 = 0.01 s-1 
k3 = 10 mol-1 dm3 s-1 
[Ox] = 0.0030 M 
[AuI] = 0.0025 M 
[ArSiMe3] = 0.20 M 
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Figure 62: Graph showing the temporal concentration of p-FArI and Au-int obtained from 
modelling the catalytic cycle shown in Scheme 44. 
Under the conditions described in Scheme 44, the initial portion of the curves in Figure 62 
match the profile obtained in Figure 61. However, the rate of oxidation compared to the rate 
of turnover is too slow, showing significant curvature towards the end. This is contrary to 
studies carried out previously on the reaction shown in Scheme 37, where pseudo-zero order 
kinetics were observed for the production of aryl iodide.50 
However, increasing the rate of oxidation used in the model so that a pseudo-zero order profile 
is obtained for p-FArI results in an initial jump in [p-FArI]. This is shown in Figure 63. The 
graph shows the temporal concentration profile of p-FArI and Au-int, and the insert shows the 




Figure 63: Graph showing the change in concentration versus time profile of p-FArI and 
Au-int as a result of increasing k1 and k3 to 1000 mol-1 dm3 s-1. The concentration of Ox used 
in the model was increased to 0.005 M for clarity. 
A second model was developed, where the AuI intermediate is proposed to be in equilibrium 
with an off-cycle species, AuX (Scheme 45). Using this model, the rate of p-FArI formation 
would be controlled by the rate of AuI production. 
 
 Scheme 45: Modified catalytic cycle used in Dynochem® to include the possibility of an 
off-cycle species which releases AuI, which can then react with the oxidant. 
The model shown in Scheme 44 and Scheme 45 were fitted to experimental data, and the 
results of these fits are illustrated in Figure 64.  
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Figure 64: Top: Fitting of the model shown in Scheme 45 to experimental data. Lower limit 
of the fitting obtained from k3 are shown by the blue dotted lines When k3 is less than k1, the 
fitting of the intermediate starts to deviate, and a lower peak concentration of Au-int 
obtained. The purple dashed line illustrates a more extreme version of this decrease to 
emphasise the flattening of the Au-int profile. Bottom: Fitting of the model shown in 
Scheme 44 to experimental data. Fitted values obtained are shown at the side of each graph. 
  
Fitted values: 
k1 = 2490 mol-1 dm3 s-1 
k2 = 0.0247 s-1 
k3 = 9710 mol-1 dm3 s-1 
k4 = 0.0589 s-1 
k-4 = 0.0339 s-1 
[Ox] = 0.0011 M 
[AuX] = 0.0081 M 
[ArSiMe3] = 0.065 M 
Fitted values: 
k1 = 7 mol-1 dm3 s-1 
k2 = 0.0252 s-1 
k3 = 7 mol-1 dm3 s-1 
 [Ox] = 0.0011 M 
[AuI] = 0.0081 M 
[ArSiMe3] = 0.065 M 
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The graph at the top of Figure 64 illustrates the fit obtained to experimental data using the 
model shown in Scheme 45. The first 40 seconds of the plot shows a reasonable fit for both 
p-FArI and Au-int and the rate constants obtained are displayed to the right of the plot. Both 
the oxidation step and the C-Si auration reaction have very large rate constants, especially 
when compared to the turnover-limiting step. In this model however, the rate of p-FArI 
production is now controlled by the release of AuI from its inactive form, AuX. (k4 and k-4). 
Therefore, the initial jump in concentration of both p-FArI and Au-int as described in Figure 
63 does not occur. 
In contrast, the graph displayed at the bottom of Figure 64 shows a poor fit between the 
modelled data and the experimental data. Rate constants obtained from the fit showed large 
differences (in comparison to the results at the top) in the rate for the oxidation step and the 
C-Si auration step. Furthermore, the shape of the graph obtained for the concentration of both 
species, as described previously, is different when compared to the shape of the experimental 
data. 
The temporal concentration of the added oxidant and standard (2-BrArF) was plotted alongside 
the concentration of p-FArI and displayed in Figure 65. 














Figure 65: Graph showing the change in concentration of the added oxidant, p-FArI and 





Similar to the results obtained from setup 1.1 shown in Figure 55, the concentration of the 
oxidant at the start of the addition is higher than the final concentration of p-FArI added. In 
addition, the concentration of the standard added follows the same pattern for the first 
datapoint. Although no visible concentration gradient was observed for this setup when tests 
with injection of a blue solution was carried out (Figure 58, G and H), the addition of AcOH 
to p-fluoroaniline displayed a small increase in acid concentration in the first few seconds after 
addition when compared to the end spectra obtained after 2 minutes (Figure 59). Therefore, 
regions of high concentration of oxidant within the reaction mixture inside the NMR tube may 
have been responsible for the higher rate of p-FArI production at the start. 
4.. Conclusion 
The study of the oxidation step in a gold(III)-catalysed direct arylation reaction (Scheme 37) 
was carried out, where direct observation of the rate of oxidation was the objective. In order 
to achieve this, the stability of the resulting gold(I) complex was probed, and it was found that 
when insufficient amounts of oxidant was added, the arylation reaction could be partially 
reactivated by addition of more hypervalent iodine(III) oxidant. Interestingly, most of the 
deactivation of the catalyst occurred as soon as the reaction ran out of oxidant, and it was 
calculated that 80% of the catalyst could be reactivated after the reaction mixture was left for 
5 seconds without oxidant. In contrast, leaving the reaction without oxidant for 120 seconds 
resulted in only 40% of the catalyst deactivating.  
Methods into monitoring the oxidation step were then explored. It was initially proposed that 
this could be monitored using UV-vis spectroscopy. However, it was found that the UV spectra 
for the gold(III) catalyst was too weak under catalytic conditions. Increasing the amounts of 
catalyst used meant that an increasing amount of oxidant was required to activate the catalyst, 
and this posed a problem as the saturation limit on the UV-vis detector was reached. 
Rapid-injection methods of reagents into an NMR tube inside the NMR magnet were then 
considered. Using the design shown in Figure 43, the oxidant was added via a piece of tubing, 
and air was bubbled through a separate piece of tubing to mix the reagents together. However, 
this design had two main disadvantages: the reaction could not be monitored while bubbling 
occurred as the concentration within the coils of the NMR spectrometer was too low and 
mixing of the added reagent was too slow.  
Using a design developed by Hore et. al.103,104 a similar design was created to achieve rapid 
mixing without bubbling. This also involved reducing the amount of solvent in the NMR tube, 
increasing the amount of reagent injected, and using a flat-bottomed Shigemi tube to improve 
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mixing efficiency. Different positions of the new tubing were tested along with different 
volumes of solvent and reagents to achieve good mixing. It was found that injection of 60 μL 
of reagent into 250 μL with the tip of the reagent tubing just above the solvent line gave the 
best mixing when tested with the injection of a blue solution into a clear solution.  
Further testing of this setup was carried out with the injection of AcOH into p-fluoroaniline, 
and the mixing efficiency was monitored by 1H NMR spectroscopy. It was found that the 
solution was mostly mixed within 2 seconds from injection, where a slightly higher acid 
concentration was seen when compared to a spectrum obtained after 120 seconds. 
This setup was used to monitor the oxidation of gold(I) within the intramolecular direct 
arylation reaction of D4. Focusing on the product from the oxidant, p-FArI, it appeared that 
the rate of its formation was higher in the first 10 seconds after addition of oxidant. Two 
models of the catalytic cycle were generated (Scheme 44 and Scheme 45). The first was a 
simple model with three steps: C-Si auration of the starting material to the gold(III) catalyst, 
release of product from the resting state of the catalyst, and the oxidation of gold(I).  
The first model had a poor fit to the experimental data, where the profile of p-FArI generation 
modelled was too curved. Increasing the rate of oxidation in this model gave an initial jump 
in p-FArI seen, which is inconsistent with the experimental data. The second model had an 
additional equilibrium between the gold(I) complex and an off-cycle, inactive species, labelled 
AuX. The second model accounted for the slow growth in p-FArI seen, where the rate of 
oxidation was controlled by the release of gold(I) from AuX, where X is unknown, and could 








Oxidation of phosphine-gold(I) chloride 
 





5.1.1. Oxidation of (Ph3P)Au(OTs) 
Previous discussion and studies on the gold-catalysed oxidative coupling reaction between 
aryl silanes and arenes have been focused on the catalytic cycle involving the activated form 
of the precatalyst, (tht)Au(Br)3.43,50 Prior to using (tht)Au(Br)3 as the catalyst, a 
phosphine-ligated gold(I) complex, (Ph3P)Au(OTs) (E1)42 was used as the precatalyst for the 
coupling reaction. It was found that a significant induction period of approximately 
45 minutes43 resulted from the use of E1.  
The reaction of E1 with excess oxidant (E2-F) and CSA was studied in the absence of the 
coupling substrates (arylsilane and arene), as shown in Scheme 46.  
 
Scheme 46: Oxidation of E1 with hypervalent iodine(III) oxidant under catalytic gold 
conditions. 
Monitoring the reaction by 1H NMR spectroscopy and 31P{1H} NMR spectroscopy showed 
that two equivalents (relative to E1) of oxidant were consumed (Figure 66). This was 
accompanied by the production of one equivalent of triphenylphosphine oxide, and it was 
suggested that the oxidation of both the gold(I) and the phosphine ligand was responsible for 





Figure 66: Graph showing the formation of Ph3PO and aryl iodide relative to the amount of 
gold complex E1 added over time.43 
Three different pathways for the activation of E1 were proposed.43 The length of induction 
period obtained when using electron-rich and electron-poor phosphines coordinated to the gold 
tosylate complex ((p-RC6H4)3Au(OTs)) was analysed. It was found that the use of an 
electron-rich phosphine (R = Me) resulted in a shorter induction period when compared to 
using an electron-poor phosphine (R = CF3). This suggested that an initial oxidation of E1 
occurs to give the corresponding gold(III) complex, rather than an initial dissociation of 
phosphine from the gold.  
From this gold(III) complex, two pathways were considered: the dissociation of phosphine to 
produce phosphine oxide and the active catalyst; and the reductive elimination of a 
phosphonium(V) salt to give a gold(I) complex, which can then be oxidised to the active 
catalyst. Increasing the steric bulk on the phosphine ligand (from p-tolyl to o-tolyl) resulted in 
an increase in the length of the induction period. This supports the proposal that reductive 
elimination of a phosphonium salt is occurring (Scheme 47). 
 
Scheme 47: Proposed pathway for the oxidation of E1 with a hypervalent iodine(III) 
oxidant.43 
5.1.2. Oxidation of (C6F5)Au(PPh3) 
The oxidation of phosphine-gold(I) complexes has been studied previously,78,82 and the 




Scheme 48: Oxidation reaction of E3 and PhI(OAc)2 to give complex E4.82 
The oxidation of complex E3 was carried out in the presence of one equivalent of PhI(OAc)2 
as the oxidant, in 1,2-dichloroethane as the solvent. The reaction was carried out at 93 °C, as 
no reactivity was seen at room temperature. Previous discussion on the reactivity of gold(I) 
complexes with hypervalent iodine(III) oxidants in Chapter 3 indicated that the expected 
product from the reaction shown in Scheme 48 would be a gold(III) complex with two 
additional ligands from the iodine oxidant coordinated, (C6F5)Au(PPh3)(OAc)2, where both 
OAc ligands have originated from the iodine(III). However, the product observed was complex 
E4, with no acetate ligands attached. Changing the solvent used in the reaction from 
1,2-dichlorethane to benzene produced the expected gold(III) complex, 
(C6F5)Au(PPh3)(OAc)2.45 
To probe the formation of complex E4, the reaction in Scheme 48 was monitored by 
31P{1H} NMR spectroscopy which revealed the presence of several intermediates, including 
[Au(PPh3)2]+ at 46 ppm, as well as Ph3PO and/or AuCl(PPh3)2 at 29 ppm. The former was 
found to increase in concentration at the start of the reaction, and decay as the reaction 
proceeded towards full consumption of the starting material.  
The effect of the anionic ligand on the reaction shown in Scheme 48 was probed by addition 
of one equivalent of (Ph3P)Au(Cl) (E5). It was found that the formation of product E4 was 
accelerated, as well as the consumption of both the starting material, E2 and the intermediate 
[Au(PPh3)2]+.  
From these results, two pathways for the formation of E4 were proposed. The first pathway 
shown in Scheme 49 involves ligand dissociation of the anionic ligand to give the intermediate 
[Au(PPh3)2]+, which was then oxidised by PhI(OAc)2 in solution to give [AuX4]−, where 
X = OAc or Cl (from solvent activation). It was also stated that the redox potential of 
[Au(PPh3)2]+ was more negative when compared to neutral gold(I) complexes. From complex 
[AuX4]−, it was suggested that either transmetallation or ligand exchange with the starting 




Scheme 49: Proposed pathway for the oxidation of E3, with an initial ligand dissociation 
step. X = OAc or Cl. 
The second pathway suggested that the oxidation occurred directly from complex E3 to give 
(PPh3)AuIII(C6F5)(X)2, which can also undergo transmetallation or ligand exchange with E3. 
The studies described above have shown that the oxidation of gold(I) complexes are not 
necessarily as simple and straightforward as described in Chapter 3. Multiple steps have been 
shown to occur with the observation of intermediates such as [Au(PPh3P)2]+, moreover the 
ligands coordinated to the gold centre are not always clear.  
5.2. Aims of the chapter 
This chapter focuses on studying the mechanism of the reaction shown in Scheme 50. The 
reaction was monitored by 1H NMR spectroscopy to follow the consumption of the oxidant 
and formation of iodobenzene, as well as by 31P{1H} NMR spectroscopy to monitor the 
formation of triphenylphosphine oxide. 
 
Scheme 50: Reaction studied to probe the oxidation of phosphine-gold(I) complex E5 with 





Similar to the oxidation reaction carried out with (Ph3P)Au(OTs) (E1), the oxidation of 
complex E5 consumed two equivalents of oxidant for each gold(I) complex to give one 
equivalent of triphenylphosphine oxide and two equivalents of aryl iodide. However, in 
contrast to the oxidation of complex E1, the reaction with complex E5 was significantly faster, 
with the formation of two equivalents of iodobenzene complete in 60 minutes in comparison 
to 120 minutes obtained with complex E1. The graph showing the growth of aryl iodide 
relative to the amount of gold complex added for the reaction from both complexes is shown 
in Figure 67. 















Time / min  
Figure 67: Graph showing the comparison on the rate of growth of PhI relative to amount of 
gold(I) complex added for E1 and E5. The reaction was carried out as summarised in 
Scheme 50 with 0.005 mmol gold complex, 0.10 mmol PhI(OAc)2 and 0.12 mmol CSA in 
0.715 mL CDCl3/CD3OD (50:1). 
5.3.1. Changing the nature of oxidant 
The role of the oxidant was probed using a hypervalent iodine(III) oxidant with a p-CF3 group 
on the aromatic ring, and comparing the results when the reaction was carried out with the 
unsubstituted hypervalent iodine(III) oxidant. This is summarised in Figure 68 (top). The rates 
of aryl iodide formation as well as production of triphenylphosphine oxide were identical for 
both oxidants, even though the electronics on the oxidants were very different. This suggests 
that the oxidant is not involved in the rate-determining step of the reaction, or that the 
electronic nature of the oxidants do not affect its reactivity. As examined in Chapter 2, the 
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oxidant with a p-CF3 group has a higher reduction potential and is thermodynamically more 
oxidising than the unsubstituted oxidant. However, under these conditions, a large excess of 
oxidant was used when compared to complex E5.  
 





 ArI (R = CF3)
 ArI (R = H)
 Ph3PO (R = CF3)







Figure 68: Top: Scheme of reaction carried out. Bottom: Concentration versus time graph 
showing the growth of aryl iodide and triphenylphosphine oxide, comparing the effects of 
using E2-H and E2-CF3 as oxidants. The reaction was carried out with 0.002 mmol E5, 0.10 
mmol oxidant and 0.12 mmol CSA in 0.715 mL CDCl3/CD3OD (50:1). 
5.3.2. Stoichiometric amount of oxidant 
The oxidation reactions of gold complexes E1 and E5 were carried out with an excess of 
oxidant. To study the effect of the amount of oxidant added, a reaction with 1:2 ratio of gold(I) 
complex to oxidant was carried out. In this case, the growth of aryl iodide and 
triphenylphosphine oxide showed a significant induction period.  
110 
 














Time / min  
Figure 69: Graph showing the concentration change over time of complex E5, aryl iodide, 
and triphenylphosphine oxide. The horizontal lines indicate concentrations that are equal to 
one and two equivalents of the starting complex E5 added. The reaction was carried out with 
0.005 mmol E5, 0.010 mmol E2-H, and 0.012 mmol CSA in 0.715 mL CDCl3/CD3OD 
(50:1). 
Figure 69 shows how the concentration of complex E5, Ph3PO, and ArI changes over time. As 
expected, the final concentrations of ArI reaches two equivalents relative to the amount of E5 
added, and one equivalent of Ph3PO is formed. Interestingly, in the first 5 minutes of the 
reaction, there is very little formation of product or consumption of the starting complex E5. 
After this induction period, the rate of reaction increases, and most of the reaction is complete 
in the next 5 minutes. The gold complex E5 was fully consumed in this time although not all 
the phosphine oxide or aryl iodide has been formed. Following this burst in product formation, 







Effect of product addition 
The initial two regions (10 minutes) of the profile obtained for the growth of aryl iodide could 
indicate that the reaction is autocatalytic, where small amounts of product formation could 
catalyse its formation and thus lead to a rapid increase in the rate of reaction. Another 
explanation could be that there is an inhibitor present, and that the inhibitor has to react before 
complex E5 reacts. To test the former hypothesis, both products, triphenylphosphine oxide 
(1 equiv.) and aryl iodide (1 equiv.) were tested as catalysts by adding these compounds to the 
start of the reaction.  



















Figure 70: Overlay of the growth of ArI over time from three different reactions to test the 
effect of ArI and Ph3PO in the reaction. Reaction conditions used were 0.005 mmol of E5, 
0.010 mmol PhI(OAc)2, and 0.012 mmol CSA in 0.715 mL CDCl3/CD3OD (50:1). 0.005 
mmol Ph3PO or 0.010 mmol p-FArI were added in the appropriate runs. All concentrations 




The addition of an aryl iodide (p-FArI) to the reaction shown in Scheme 50 gave a very similar 
plot as the reaction without added aryl iodide. Similarly, addition of triphenylphosphine oxide 
to the start of the reaction resulted in a similar growth of aryl iodide, even though a slightly 
longer induction period was seen. This could be a result of experimental error, where a 
different stock solution of complex E5 was used for this run. These results indicate that both 
the aryl iodide product (PhI) and triphenylphosphine oxide do not function as a catalyst for the 
reaction of complex E5.  
To further probe the induction period observed in the reaction of complex E5 and hypervalent 
iodine(III) oxidant, the reaction in Scheme 51 was carried out, where more of complex E5 was 
added.  
Addition of more starting complex, E5 
 
 
Scheme 51: Summary of reaction carried out with addition of more starting material E5 
when the production of ArI stops. 
Figure 71 shows the temporal concentration of aryl iodide in three separate reactions. Run 1 
was carried out as described in Scheme 51, where the reaction between (Ph3P)Au(Cl) (E5) and 
oxidant was carried out. When the formation of aryl iodide stops, more of complex E5 was 
added, at the timepoint indicated by the vertical dotted line. Run 2 shows the profile for the 
concentration of aryl iodide without the addition of complex E5 and Run 3 shows the reaction 
profile for the formation of aryl iodide when the reaction was carried out under the same 
conditions as the second half of Run 1. The change in conditions for Run 3 included increasing 
the volume of solvent used, which was due to addition of complex E5 as a stock solution. The 
amount of oxidant in the second half of Run 1 and consequently the start of Run 3 was reduced, 
as two equivalents (0.010 mmol) of oxidant were consumed. It should be noted that the graph 
for Run 3 has been adjusted so that t0 occurs at the point of complex E5 addition, and that the 
concentration has been elevated so that it overlays with the graph from Run 1. 
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Figure 71: Run 1: Reaction carried out as illustrated in Scheme 51 in 0.715 mL 
CDCl3/CD3OD (50:1) with the addition of more E5 (0.005 mmol, 100 μL in CDCl3) , 
represented by the vertical dotted line. Run 2: 0.005 mmol E5, 0.050 mmol PhI(OAc)2, and 
0.060 mmol CSA in 0.715 mL CDCl3/CD3OD (50:1). Run 3: 0.005 mmol E5, 0.040 mmol 
PhI(OAc)2, and 0.060 mmol CSA in 0.8 mL CDCl3 and 15 μL CD3OD. 
Focusing on the graph of Run 1 in Figure 71, the growth of aryl iodide proceeds as expected, 
with a short induction period at the beginning. However, upon addition of more E5, this 
induction period is no longer present, and most of the aryl iodide has formed by the time the 
next spectrum was taken. Comparison of this section of the graph to Run 3 highlights the loss 
of induction period. This indicates that the reaction forms a compound that is capable of 
increasing the rate of its reaction, or that the inhibitor present is not in the stock solution of 
complex E5.  
The reaction carried out with ten equivalents of oxidant (Scheme 51) was compared to the 
reaction carried out with two equivalents of oxidant (Figure 70). This is shown in Figure 72. 
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Figure 72: Graph comparing the growth in ArI formation with excess and stoichiometric 
amount of oxidant (PhI(OAc)2). Conditions used: 0.005 mmol E5, 0.050 mmol (10 equiv.) or 
0.010 mmol (2 equiv.) PhI(OAc)2, and 0.060 mmol (24 equiv.) or 0.012 mmol (2.4 equiv.) 
CSA in 0.715 mL CDCl3/CD3OD (50:1). 
The graph in Figure 72 shows that increasing the amount of oxidant added decreases the 
induction period observed. However, under these conditions, the amount of CSA added was 
relative to the amount of oxidant added (1.2 equiv. amount of oxidant). CSA reacts with 
hypervalent iodine(III) diacetates to give the hydroxycamphorsulfunate oxidants,105 where the 
two acetate ligands on the iodine centre have been replaced (Chapter 2). A slight excess of 
CSA was used to ensure that all the hypervalent iodine(III) diacetate exists as the 
hydroxycamphorsulfunate oxidant. Therefore, the amount of free CSA in solution changes 
with changing amounts of oxidant added, which led to the study on the effects of CSA on the 
reaction.   
5.3.3. Effect of CSA 
Changing CSA concentration 
Scheme 52 summarises the reaction carried out to probe the role of CSA in the reaction of 
complex E5 with hypervalent iodine(III) oxidant. The amount of oxidant used was kept 
constant, and the amount of CSA added was varied. This gives a situation where the amount 




Scheme 52: Reaction conditions used to probe the role of CSA. 
The graph in Figure 73 shows the change in aryl iodide concentration over time for reactions 
with different amounts of CSA added. Increasing the amount of CSA added while keeping the 
oxidant concentration constant reduces the induction period observed in the growth of aryl 
iodide. However, it is unlikely that CSA was playing a direct role in the sudden increase in 
rate, and this is highlighted when comparing the profiles where 0.030 mmol and 0.012 mmol 
of CSA was added. 



















Figure 73: Graph showing the growth of ArI over four separate runs with different amounts 
of CSA, as illustrated in Scheme 52. Conditions used: 0.005 mmol E5, 0.010 mmol 




Looking at the approximate values, the point where the rate increases with 0.012 mmol of CSA 
occurs around the moment when 0.001 M of aryl iodide has been generated. This equates to 
about 0.001 mmol of CSA released from the oxidant, which gives a total of 0.003 mmol of 
free CSA in solution. Focusing back on the plot with 0.030 mmol of CSA added, at the start 
of this reaction, approximately 0.02 mmol of free CSA exists in solution. This value is greater 
than five times the amount of CSA in solution when the profile for the black datapoints 
(0.012 mmol) increases in rate. In spite of the large excess of free CSA in the solution, a 
significant induction period was still observed (Figure 73, red datapoints). 
However, in this analysis, the possible equilibrium shown in Scheme 53 was not considered. 
This was because there was an insignificant amount of PhI(OAc)2 detected by 1H NMR 
spectroscopy, indicating that the equilibrium lies heavily to the left of the equilibrium. 
Therefore, it is unlikely that the formation of CSA via this equilibrium would influence the 
discussion relating to Figure 73. 
 
Scheme 53: Equilibrium between hydroxycamphorsulfonate and diacetate hypervalent 
iodine(III) oxidants. 
Use of E7 as oxidant 
Further testing on the importance of free CSA was carried out by the use of compound E7 as 
the oxidant. In this case, all the oxidant exists as compound E7, and no free CSA was present 
in the solution.  
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Figure 74: Comparison of the growth of ArI when using the preformed oxidant E7 and when 
using PhI(OAc)2 and CSA to form E7 in-situ. Reaction conditions: 0.005 mmol E5, 0.010 
mmol PhI(OAc)2 with 0.012 mmol CSA or 0.010 mmol E7 in 0.715 mL CDCl3/CD3OD 
(50:1). Insert: Time adjusted profile for the red line so that the growth section showing the 
burst in reactivity is overlaid. 
The graph in Figure 74 shows the temporal concentration of aryl iodide with and without added 
CSA. The red datapoints display the results from the addition of compound E7 without any 
excess CSA present. The induction period obtained as a result was significantly longer when 
compared to the results obtained in Figure 73 (the black datapoint correlates to the addition of 
0.012 mmol of CSA as indicated in Figure 73). Despite the long induction period, the rest of 
the profile obtained under both the conditions described are identical (Figure 74, insert).  
This could indicate that CSA is involved in an initiation or activation of complex E5, or that 
CSA was involved in removing the inhibitor in the reaction, and the rate this occurs is 
dependent on the concentration of CSA in solution.  
Premixing CSA and E5 
To test whether CSA reacts or removes an inhibitor, the reaction mixture without oxidant was 
left standing for 20 minutes, then PhI(OAc)2 was added, and the formation of aryl iodide was 
monitored. This reaction was carried out for two different concentrations of CSA (with 
1.2 equiv. of oxidant that was subsequently added). This is summarised in Scheme 54. 













Scheme 54: Summary of the reaction carried out where CSA and E5 were premixed before 
the addition of PhI(OAc)2 to initiate the reaction. 
Premixing the gold complex E5 with CSA before addition of oxidant produced almost 
identical results to that obtained when CSA and oxidant were added at the same time. This is 
shown in Figure 75, where the cross datapoints and the line of the same colour indicates 
identical concentrations of all components added.  




















Figure 75: Graph comparing the growth of ArI where PhI(OAc)2 and CSA were added at the 
same time (crosses) with the reaction where E5 and CSA were premixed before the addition 
of PhI(OAc)2 (line). Run 1 and Run 1’: 0.005 mmol E5, 0.010 mmol PhI(OAc)2, and 0.012 
mmol CSA. Run 2 and Run 2’: 0.005 mmol E5, 0.05 mmol PhI(OAc)2, and 0.06 mmol CSA. 
All reactions were carried out in 0.715 mL CDCl3/CD3OD (50:1). 
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5.3.4. Addition of HCl 
 
Scheme 55: Summary of reaction carried out with HCl added. 
The effect of adding acid to the reaction profile obtained was tested, since CSA also behaves 
as a Brönsted acid (Scheme 55). This was carried out by substituting CD3OD with a solution 
of hydrochloric acid in methanol (1.25 M).  















 HCl run 1
 HCl run 2
 Standard conditions
 
Figure 76: Graph showing the change in ArI concentration over time for two identical runs 
with HCl added and comparing this to the same reaction without HCl. Reaction conditions: 
0.005 M E5, 0.010 M PhI(OAc)2, and 0.012 M CSA in 0.7 mL CDCl3 with 15 μL HCl in 





The growth of aryl iodide over time is shown in Figure 76.  The test with HCl was carried out 
twice to check for reproducibility, and the reaction carried out without any HCl was overlaid 
for comparison. The concentration changes over time showed a very different profile to that 
observed previously. The induction period seen under the standard conditions is not present in 
the reaction profile when HCl was added, and the burst in rate of aryl iodide formation does 
not occur. Furthermore, the decrease in rate towards the end of the reaction does not occur.  
Instead, the profile shows four different regions: an initial slow growth of aryl iodide 
(< 5 min), a slight increase in rate (5 – 10 min), another slower period of aryl iodide production 
(10 – 13 min), and finally, a larger jump in rate of reaction towards the end. Both HCl runs 
follow the same profile and overlay fairly well, with the exception of the final rate increase. 
Run 2 has a smaller rate jump at the end when compared to Run 1.  
Monitoring by 31P{1H} NMR spectroscopy 
When the reaction with HCl was monitored by 31P{1H} NMR spectroscopy, three additional 
peaks were observed (Figure 77) in addition to the starting material (complex E5) and product 
(Ph3PO). 
 
 Figure 77: Stacked temporal 31P{1H} NMR spectra of the reaction shown in Scheme 55, 
obtained under the conditions described in Figure 76. Each spectrum was obtained after a 2.5 
min delay, with the first spectrum obtained before initiation of the reaction (t0). δ = 64.8 
ppm, 56.8 ppm, 43.7 ppm, 35.0 ppm (Ph3PO), 33.1 ppm (E5). The peak at 0 ppm is from an 




Both the peaks at 64.8 ppm and 56.8 ppm in the 31P{1H} NMR spectra shown in Figure 77 
appear together with the product from the reaction, triphenylphosphine oxide, whereas the 
peak at 43.7 ppm forms after initiation and disappears by the time the product signal starts to 
appear. This suggests that the compound at 43.7 ppm may be an intermediate in the reaction 
and is sufficiently stable under the conditions described in Scheme 55.  



















Figure 78: Graph describing the temporal concentration change of ArI, Ph3PO, E5, and the 
intermediate (int) detected at 43.7 ppm for the reaction shown in Scheme 55 and the stacked 
31P{1H} NMR spectra shown in Figure 77. 
The temporal concentration of complex E5, triphenylphosphine oxide and the intermediate are 
shown in Figure 78, with the graph for aryl iodide growth overlaid in the background. In the 
first 7 minutes of the reaction, the intermediate grows together with the decay of the starting 
complex E5, and no triphenylphosphine oxide is observed. This is accompanied by the 
formation of aryl iodide. As the intermediate starts decaying, triphenylphosphine oxide is 
produced, together with more aryl iodide. Interestingly, the rate of aryl iodide formation 





5.3.5. Addition of chloride 
It was thought that chloride in the solution43 was responsible for the intermediate seen at 
43.7 ppm (Figure 77). Therefore, the effect of adding Bu4NCl was explored (Scheme 56). 
 
Scheme 56: Reaction carried out where the addition of chloride as Bu4NCl was tested. 
The stacked temporal 31P{1H} NMR spectra are shown in Figure 79. As with Figure 77, the 
peak at 43.7 ppm corresponding to an intermediate was found to be present. However, the 
other two side products (Figure 77, 64.8 ppm and 56.8 ppm) were not detected. Furthermore, 
unlike the spectra seen in Figure 77, Ph3PO starts to form before all the intermediate is 
consumed.  
 
Figure 79: Stacked temporal 31P{1H} NMR spectra obtained for the reaction described in 
Scheme 56. Each spectrum was obtained after 2.5 min, with the first spectra taken at t0, and 
the second spectra obtained at 3.5 min after initiation of the reaction. δ = 43.7 ppm (int), 33.1 
ppm (E5), and 30.6 ppm (Ph3PO). The peak at 0 ppm is from an external capillary standard 
containing (OH)3PO. 
The signals seen in Figure 79 were plotted as concentration against time, and the resulting 
graph is shown in Figure 80.  
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Figure 80: Graph showing the temporal concentration of the 31P{1H} NMR peaks observed 
in the spectra shown in Figure 79 based on the reaction summarised in Scheme 56, where 
0.005 mmol of E5, 0.010 mmol PhI(OAc)2, 0.012 mmol CSA, and 0.005 mmol of Bu4NCl 
were dissolved in 0.715 mL CDC3/CD3OD (50:1). 
Similar to the plots obtained in Figure 69, the reaction follows a similar pattern. An initial 
induction period was seen in the first 100 minutes, followed by a burst in reactivity to give 
Ph3PO and consume both the starting gold complex E5 and the intermediate. Finally, the 
reaction rate drops towards the end of the reaction (> 125 min) to give a curved profile at the 
end.  
However, unlike the plots shown previously, the induction period obtained was a lot longer 
(100 min versus 5 min) and in this time, there was a small but significant formation of Ph3PO. 
Furthermore, during the induction period, the intermediate discussed previously was formed 




Nature of intermediate formed 
Since the intermediate was only observed in the presence of chloride in solution (with the 
addition of HCl and Bu4NCl), it was postulated that the identity of the intermediate was a 
gold(III) complex with three Cl− ligands and a triphenylphosphine ligand (Figure 81). 
Comparison with literature data showed that complex E8 has a 31P{1H} NMR signal at 
44.3 ppm106 in CDCl3 whereas the intermediate formed has a peak at 43.7 ppm. This suggests 
that the intermediate formed is feasibly complex E8, based on its chemical shift and the 
reaction conditions where the intermediate was observed. 
 
Figure 81: Proposed identity of the intermediate observed with the addition of chloride into 
the reaction. 
5.3.6. Proposed pathway in the presence of free chloride 
It was proposed that under the reaction conditions where free chloride is present in solution 
(either by the addition of Bu4NCl or HCl), the reaction takes a separate pathway via E8, which 
forms from the reaction of complex E5 (Scheme 57). E8 then reacts to give triphenylphosphine 
oxide as a product. As with the plot obtained in Figure 69, after the induction period, 
triphenylphosphine oxide is then formed at a significantly faster rate, which could be as a result 
of a switch in the pathways, so that the same pathway as observed without additional chloride 





Scheme 57: Proposed pathway for the reaction of E5 with hypervalent iodine(III) oxidants in 
the presence of free chloride. X = OCSA, OH, or Cl. 
Reaction of E8 
To probe the pathway proposed in Scheme 57, complex E8 was synthesised and tested in a 
reaction with PhI(OAc)2 and CSA. The reaction was monitored by both 31P{1H} and 1H NMR 
spectroscopy and the results are illustrated in Figure 82. 
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Figure 82: Graph showing the consumption of the oxidant and the formation of the aryl 
iodide during the reaction of complex E8 (0.005 mmol) with PhI(OAc)2 (0.010 mmol) and 
CSA (0.012 mmol) in 0.715 mL CDCl3/CD3OD (50:1). The line in the background shows 
the growth of ArI obtained from the reaction described in Figure 69. 
The graph shown in Figure 82 illustrates the change in concentration seen for the oxidant as 
well as the products, aryl iodide and triphenylphosphine oxide. The intermediate E8 was not 
detected in the 31P{1H} NMR spectra as the reaction occurred, indicating that the reaction from 
E8 is rapid. Overall, only one equivalent of oxidant relative to gold complex added was 
consumed, and one equivalent of triphenylphosphine oxide was formed. In comparison to the 
reaction carried out under the same conditions but with (Ph3P)Au(Cl) (E5) as the starting gold 
complex, the induction period observed for (Ph3P)Au(Cl)3 E8 was a lot shorter, agreeing with 
the previous statement that the reaction from E8 was observed to be faster than the oxidation 
of E5 to give E8. However, the origin of the induction period for the reaction of E8 is unclear. 
Effect of E8 
Further test of the proposed pathway was carried out by spiking complex E8 into the reaction 
shown in Scheme 56. This was to confirm that the intermediate observed was assigned 




Figure 83: Stacked 31P{1H}NMR spectra of the reaction described in Scheme 56 with the 
addition of complex E8 prior to the acquisition of spectra 6. Spectra 1 corresponds to the 
spectra obtained at t0, and spectra 2 was obtained with a delay of 3 minutes. The time gap 
between each spectra is 2.5 minutes, with the exception of the gap between spectra 6 and 
spectra 7, which had a delay of 6 minutes. The black arrow indicates addition of 
(Ph3P)Au(Cl)3 (E8).  
The three signals observed in the stacked 31P{1H} NMR spectra shown in Figure 83 were 
plotted against time, and the resulting graph is displayed in Figure 84.  
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 Ph3PO - without E8
 
Figure 84: Graph showing the change in concentration of complex E5, E8, and 
triphenylphosphine oxide for the reaction shown in Scheme 56, with one equivalent of 
complex E8 added in at 16 min. The reaction was carried out with 0.005 mmol E5, 0.010 
mmol PhI(OAc)2, 0.012 mmol CSA in 0.715 mL CDCl3/CD3OD (50:1). The line in the 
background represents the growth of triphenylphosphine oxide without the addition of E8, as 
observed in Figure 80. 
The graph in Figure 84 shows the temporal concentration plot of E5, E8, and 
triphenylphosphine oxide. The dotted line indicates the point where one equivalent of E8 was 
added to the reaction mixture, and the plot in the background illustrates how the reaction would 
behave without spiking in E8. It can be seen that the introduction of E8 decreases the induction 
period dramatically from 100 min which agrees with the previous observation that the reaction 
from E8 occurs faster than the reaction from E5 to form E8. Assuming that both E8 and E5 
results in the formation of the same products, and that the reaction from E5 goes via E8, this 
observation suggests that the reaction from E8 produces the component responsible for 





The oxidation of phosphine-gold(I) chloride complexes with hypervalent iodine(III) oxidant 
was studied. Similar to the phosphine-gold(I) tosylate complex, the reaction consumed two 
equivalents of oxidant to produce two equivalents of aryl iodide and one equivalent of 
phosphine oxide. However, the chloride complex reacted at a much faster rate when compared 
to the tosylate complex. (Figure 67) 
Using two equivalents of oxidant to gold(I) complex and 2.4 equivalents of CSA (Figure 69), 
an induction period was observed, followed by a burst in aryl iodide production. As the amount 
of aryl iodide formed reached two equivalents, the reaction slowed down significantly, and 
curved towards the end. 
Keeping the concentration of oxidant the same but increasing the amount of CSA added, the 
role of free CSA was explored. It was found that higher concentrations of free CSA within the 
solution reduced the length of the induction period (Figure 73). The use of the preformed 
oxidant, E7, which meant that no free CSA was present in solution resulted in a very long 
induction period. However, beyond the induction period, the profile obtained for the growth 
of aryl iodide overlaid well with previous reactions where free CSA was present (Figure 74).  
The dramatic increase in reaction rate suggested that either the reaction was autocatalytic, or 
there was a background reaction where an inhibitor had to be consumed before the reaction 
could proceed. The former was tested by addition of known products (iodobenzene and 
triphenylphosphine oxide, Figure 70) to the start of the reaction and the latter was tested by 
premixing CSA with the gold(I) complex before the reaction was initiated (Figure 75). These 
experiments revealed identical rates of aryl iodide growth. 
HCl was added to assess the effect of a Brönsted acid on the reaction rate. A new intermediate 
was detected by 31P{1H} NMR spectroscopy at 43.7 ppm, and the reaction was further probed 
by addition of a chloride salt, Bu4NCl. The formation of this intermediate was observed under 
these conditions, and the length of the induction period was dramatically increased. The 
intermediate was assigned to a gold(III) complex with three Cl− and one triphenylphosphine 
ligand bound (E8). This complex was synthesised separately and tested in a reaction with an 
hypervalent iodine(III) oxidant. Only one equivalent of oxidant was consumed, which resulted 
in the formation of one equivalent of aryl iodide (Figure 82).  
Addition of E8 to an initiated reaction with Bu4NCl decreased the length of the induction 
period, suggesting that reaction from E8 also produced a product that could increase the rate 
of phosphine-gold(I) chloride oxidation. 
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5.4.1. Proposed reaction 
 
Scheme 58: Proposed reaction pathway for the oxidation of E5. PPh3 has been abbreviated to 
P for clarity, X = OH, OR, Cl. 
Based on the experiments carried out in this chapter, a tentative pathway for the reaction of 
(Ph3P)Au(Cl) (E5) with hypervalent iodine(III) oxidants has been proposed (Scheme 58). 
Focusing first on the Cl route, E5 reacts with either “Cl+” or Cl2 to give complex E8, which 
has been synthesised independently and tested under the reaction conditions explored. 
Complex E8 could then reductive eliminate, as proposed previously with the oxidation of 
(Ph3P)Au(OTs) (E1)43 to give PCl2, which can hydrolyse to give phosphine oxide and two 
equivalents of chloride as well as AuCl. This can then react with ArI(X)2 to give a gold(III) 
complex and another equivalent of ArI. Since the phosphine ligand is no longer on the final 
gold complex formed here, the nature of this complex is unclear, and could have reacted with 
free chloride in solution to give AuCl4−, which is a known and stable anion.107,108 The first step 
of this pathway was considered to be the slower step when compared to the reductive 
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elimination step, as the reaction from complex E8 was a lot quicker, and addition of E8 
midway through the reaction shown in Scheme 56 resulted in a shorter induction period. 
Following the reaction via the CSA route, an initial equilibrium between E5 and CSA was 
proposed, to give complex E9. From this, the Cl− ligand formerly on the gold could be oxidised 
to give a species that could react with gold more quickly, or the resulting complex E9 could 
react with hypervalent iodine(III) oxidants at a greater rate when compared to complex E5. 
These suggestions could explain the role of CSA in reducing the induction period. Although 
CSA was not suggested to be directly catalysing the reaction, if new pathways involving CSA 
were provided where the formation of products as well as the species responsible for increasing 
the rate of reaction of E5 were accelerated, the shorter induction period seen for higher free 
CSA concentration could be reasoned. 
In Scheme 58, following the CSA pathway, multiple gold(III) products8 were proposed based 
on the reaction of E5 and/or E9 with hypervalent iodine(III) oxidants. This is consistent with 
the fact that the peak for E5 observed in 31P{1H} NMR spectroscopy shrinks before the peak 
for triphenylphosphine oxide is seen (Figure 69), suggesting that multiple, low concentration 
species are formed, and it is possible that these species are in equilibrium with each other.  
The species highlighted in red indicates the formation of free CSA, which could be a factor in 
the accelerating rate of reaction. Finally, the removal of free chloride in solution to give AuCl4− 
could explain the switch from the Cl pathway to the CSA pathway, which appears to be 
observed in Figure 80. Furthermore, removal of chloride will reduce the formation of 











Conclusion and future work 
 
6. Conclusion and future work  
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The work carried out in this thesis have focused on the role of hypervalent aryliodine(III) 
oxidants and its reactivity with gold(I) complexes. Chapters 2 and 3 have shown that the 
oxidant with a higher redox potential, and thus the stronger oxidant thermodynamically reacted 
slower in a gold(III)-catalysed direct arylation reaction, when competed with the oxidants that 
had lower redox potentials. Together with the construction of a Hammett plot against σ+ 
values, it was proposed that ligand dissociation from the iodine(III) centre was occurring prior 
to the oxidation of gold(I). This is illustrated in Scheme 59. 
 
Scheme 59: Summary of proposed mechanism for the oxidation of gold(I) with hypervalent 
iodine(III) oxidants. 
Due to several issues associated with the nature of competition studies, approaches towards 
obtaining absolute rates of oxidation were considered, and discussed in Chapter 4. A rapid 
injection system was developed to deliver oxidant to an NMR tube inside the NMR 
spectrometer. This reduces the dead-time observed previously, allowing for the observation of 
gold(I) oxidation. The results obtained indicated a possible equilibrium between the gold(I) 
species and an off-cycle species, AuX. This step was probed with the aid of a chemical 
modelling software, Dynochem®, and the simplified catalytic cycle shown in Scheme 60 was 
modelled.  
 
Scheme 60: Summary of model fitted to the experimental observation for the growth of ArI. 
The best fit was obtained when an equilibrium with an off-cycle species, AuX, where X is 




Further development into the rapid injection system would prove beneficial for this study. For 
example, the resolving the issue surrounding the trigger button would allow for a more 
accurate t1 determination. This will provide more accurate analysis of the reaction, including 
a better fit of the reaction model to the experimental data. In addition to this, the issue regarding 
the volume of reagent added during the reaction has to be determined and repaired. This will 
ensure full control over the reaction conditions tested, as well as to ensure a broader 
applicability of the rapid-mixing device.  
Additional insight into the mixing distribution of the rapid injection device would provide 
better understanding and allow identification of areas for improving mixing efficiency. The 
testing carried out in Chapter 4 showed that mixing with the final setup was complete after 
approximately 3 seconds. However, the spatial distribution of the injected component over 
time has not been identified. Hore et. al.103 utilised NMR imaging techniques to observe the 
radial and axial mixing of their device. This was carried out by injecting a small amount of 
H2O into D2O and observing the flow of injected liquid along the x-axis and z-axis of the tube. 
From these experiments, they concluded that the injected liquid flows down the middle and up 
the sides of the tube for efficient mixing, and the solution was completely mixed between 40 
and 50 ms. 
  
Figure 85: Stacked 1H NMR spectra showing the one-dimensional NMR images, where the 
spectra were recorded at 10 ms interval. Left: real-time NMR images obtained along the 
z-axis (right-hand side shows the top of the NMR sample), right: images obtained along the 






Furthermore, the identification of the unknown gold-complex, AuX, will assist in 
understanding the proposed equilibrium, as shown in Scheme 60. The oxidation of Au(I) can 
be more accurately studied if the kinetic parameters of the equilibration can be obtained. 
Currently, it is thought that X could originate from water within the reaction mixture. This is 
a complicated issue, as the active oxidant produces water as it is consumed. Studying the 
independent reactivity of the active oxidant will allow quantification of water produced, and 
thus the effect of water can be probed, both experimentally as well as using Dynochem®. In 
addition, the identity of X can be dictated by utilising potential trapping ligands to stabilise 
the gold(I) complex.  
 
Scheme 61: Proposed method of observing the oxidation of gold(I) complex formed under 
the direct arylation reaction conditions. 
Another main issue surrounding the study into the mechanism of gold(I) oxidation within the 
direct arylation reaction is that the identity of the gold(I) species is unknown. Throughout the 
direct arylation reaction, the ligands around the gold complex are proposed to change.43 
However, it has been found that the use of ortho-substituted silanes are able to trap the gold 
complex before it undergoes reductive elimination.109 Obtaining crystal structures of these 
complex will aid in the identification of potential ligands around the gold complex. 
 
Scheme 62: Crystal structure of a trapped gold(III) complex obtained by addition of DMAP 
to the reaction mixture. 
In contrast to catalytic conditions in the direct arylation reaction, the oxidation of 
phosphine-gold(I) chloride with stoichiometric amounts of oxidant was probed, where the 
starting reagents could be monitored by 1H NMR and 31P NMR spectroscopy. Two equivalents 
of oxidant relative to gold(I) were consumed to give two equivalents of aryl iodide and one 




It was found that the length of induction period observed was dependent on the amount of free 
CSA as well as free chloride in solution. The latter resulted in the observation of a new 
intermediate, proposed to be (Ph3P)Au(Cl)3. This was confirmed with the independent 
synthesis of the complex as well as spiking the complex into an already initiated reaction 
mixture. 
A complex reaction pathway was proposed with two distinct routes suggested: a chloride 
pathway which is dominant in the presence of additional chloride, and a CSA pathway which 
the complex takes in absence of additional chloride. This is summarised in Scheme 58, 
Chapter 5). The proposed reaction could be systematically probed by synthesis of the 
intermediates (or similar complexes) and observing their behaviour under the reaction 
conditions.  
The reaction of (Ph3P)Au(OTs) with PhI(OAc)2 and CSA was found to give PhI and Ph3PO at 
a much slower rate when compared to the oxidation of (Ph3P)Au(Cl). This suggests that the 
pathway from the proposed complex E9 ((Ar3P)Au(OCSA) with HCIB as the oxidant is slower 
compared to oxidation with PhI(Cl)2109 or PhI(OH)(Cl). The rate of reaction between complex 
E9 and PhI(Cl)282 will allow for the proposed CSA route to be studied further.  
In addition, similar studies could be carried out on different analogues of phosphine-gold(I) 
complexes, where a variety of phosphines with different electronic and steric properties can 
be explored. Similarly, the reactivity of phosphine-gold(I) complexes with different anionic 
ligands can be probed. This study was previously carried out under catalytic, direct arylation 
conditions.43 Stoichiometric studies of these reactions could provide further insight into the 











7. Experimental   
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7.1. General experimental details 
7.1.1. Techniques 
Analytical thin-layer chromatography was performed on precoated aluminum-backed plates 
(Silica Gel 60 F254; Merck), and visualised using a combination of UV light (254 nm). 
Column chromatography was performed using Davisil® 60A silica gel (35-70 μm; 
Fisher Scientific) or Geduran® Silica Gel 60 (40-63 μm; Merck). 
7.1.2. Reagents and solvents 
All commercial reagents were obtained from Sigma-Aldrich, Fluorochem, Fisher Scientific, 
Acros Organics or Alfa Aeser. (Ph3P)Au(Cl) and AuBr3 were purchased from Sigma Aldrich. 
HAuCl4 was purchased from Fisher Scientific. (IPr)Au(Cl) was generously donated by 
Umicore AG & Co. KG. The following gold complexes were synthesised according to 
literature procedures: (tht)Au(Br)3,111 (Ph3P)Au(OTs),112 (tht)Au(Cl)113, (IPr)Au(Br)114. All 
arylsilane compounds50 and hypervalent aryliodine(diacetate) compounds97 were synthesised 
according to literature procedure.  
Deuterated solvents were purchased from Sigma-Aldrich and Cambridge Isotopes Limited. 
Anhydrous organic solvents were obtained from a solvent purification system 
(MBraun SPS 800) situated in the School of Chemistry, University of Edinburgh. Commercial 
grade solvents were used for extractions, TLC analysis and flash column chromatography. 





NMR spectra were recorded at 27 °C unless stated otherwise; 1H, 13C{1H}, and 19F NMR 
spectra were recorded at 600/500/400 MHz, 125/100 MHz and 470/376/282 MHz, 
respectively, using Bruker Avance I 600, Bruker Avance I 400, Bruker Avance III 500 and 
Bruker Avance III+ 400 spectrometers. 1H and 13C{1H} NMR spectra were referenced to 
residual solvent peaks (CHCl3, δH 7.26 ppm; CDCl3, δC 77.16 ppm); chemical shifts are 
reported in ppm relative to tetramethylsilane standard. 19F NMR spectra are reported in ppm 
relative to a BF3·OEt2 external standard. 31P{1H} NMR spectra are reported in ppm relative to 
a 85% aqueous H3PO4 external standard. Coupling constants, J, were calculated using 
Mestrenova versions 10, and are reported to the nearest 0.1 Hz. Coupling constants that did 
not match as a result of digitization are reported as rounded averages. The following 
abbreviations (and their combinations) are used to label the multiplicities: s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet) and br (broad). 
IR spectroscopy 
Infrared spectra of neat compounds were recorded over the range 4000-600 cm-1 using a 
Perkin-Elmer Spectrum 1000 Series FTIR spectrophotometer with an ATR diamond cell. 
Melting point analysis 
Melting points were measured using Stuart SMP3 melting point apparatus in open capillaries 
and are uncorrected. 
Electrochemistry 
Electrochemical measurements were made using 1 mM of the analyte in 12 mL of degassed 
acetonitrile or DCM, using 0.1 M [n Bu4N][PF6] as the supporting electrolyte, under a flow of 
dry N2 gas. An Autolab ECO Chemie PGSTAT potentiostat was used, with a glassy-carbon 
disk (d = 3 mm) working electrode, Pt-gauze counter electrode, Ag-wire quasi-reference 
electrode, and ferrocenium/ferrocene standard (Fc+ /Fc = 0 V). Data were processed using 
GPES Manager 4.9. Cyclic voltammograms were recorded for quiescent solution at variable 
scan rates between 100 – 500 mV s –1. Square-wave voltammograms were recorded using a 
frequency of 25 Hz, a step potential of 5 mV and an amplitude of 20 mV, giving a scan rate of 




All UV spectroscopy experiments were carried out in an ultraviolet–visible cuvette (pathlength 
10 mm) with 3 mL of solvents, with concentrations ranging from 0.03 mM to 0.5 mM. Spectra 
were collected using Ocean Optics USB4000 detector and the data processed in Kinetic Studio, 
TgK Scientific. 
Videos of rapid injection 
Filmed in slow motion (240 frames per second) on an iPhone SE.  
7.2. Synthetic procedures 
(Ph3P)Au(Cl)3 
(Ph3P)Au(Cl) (46.6 mg, 0.1 mmol) was dissolved in DCM (1 mL) and stirred under nitrogen 
in a round-bottom flask wrapped with foil. NaBO3.4H2O (30.8 mg, 0.2 mmol) and HCl(aq) (20 
μL, 30.5% concentration) were added to the flask, and more DCM (1 mL) was used to wash 
down the sides of the flask. The reaction was left to stir for 2 hours, and ice-cold water (5 mL) 
and DCM (5 mL) was added. The organic layer was separated and washed with more water 
(5 mL), then dried with MgSO4 and filtered. The filtrate was concentrated by blowing a stream 
of nitrogen over the solution. The resulting solid was dissolved in the minimum amount of 
DCM and pentane was added. The flask was left to cool in the freezer. The resulting solid was 
filtered off and washed with pentane, then dried under vacuum to give (Ph3P)Au(Cl)3 as a 
yellow solid (30 mg, 53% yield). The compound was stored in a vial wrapped with foil in the 
freezer. 
1H NMR (400 MHz, Chloroform-d) δ 7.77 – 7.63 (m, 9H), 7.61 – 7.51 (m, 6H). 13C NMR (101 
MHz, Chloroform-d) δ 135.25 (d, J = 10.3 Hz), 133.91 (d, J = 3.3 Hz), 129.36 (d, J = 12.9 
Hz), 123.42 (d, J = 69.5 Hz). 31P NMR (162 MHz, Chloroform-d) δ 43.59 (s).106 
7.3. Procedures and data relevant to Chapter 2 
7.3.1. Control reactions 
General Procedure 
MeArI(OAc)2 (10.5 mg, 0.0312 mmol) was dissolved in CDCl3 (1 mL) and PhI (3.50 µL, 
0.0312 mmol), CD3OD (200 µL), CSA (9.46 mg, 0.0406 mmol, 1.3 equiv) and (tht)Au(Br)3 
(31 µL from a 0.01 M solution in CDCl3, 2 mol%) were added depending on the experiment.  
143 
 
7.3.2. Reaction monitoring 
A: MeArI(OAc)2 (52.4 mg, 0.155 mmol), PhI (17.5 µL, 0.155 mmol) and CH2Br2 (5.50 µL, 
0.078 mmol) were combined. The mixture was made up to 5 mL with a 50:1 solution of 
CDCl3/CD3OD. 
1.0 mL of stock solution A was added to camphorsulfonic acid (9.46 mg, 0.041 mmol, 1.3 
equiv) in an NMR tube. The 1H NMR spectrum at t0 was obtained at this point. (tht)Au(Br)3 
(62.4 µL of a 0.005 M solution in CDCl3, 1 mol%) and CDCl3 (37.6 µL) were added to the 
tube, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where 
t1 is the time between mixing all the components and the midpoint of the time it takes to acquire 
the first spectrum. A 1H NMR spectrum is then obtained every 2 minutes. 
1.0 mL of stock solution A was added to camphorsulfonic acid (9.46 mg, 0.041 mmol, 1.3 
equiv) in an NMR tube. The 1H NMR spectrum at t0 was obtained at this point. (tht)Au(Br)3 
(31.2 µL of a 0.005 M solution in CDCl3, 0.5 mol%) and CDCl3 (68.8 µL) were added to the 
tube, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where 
t1 is the time between mixing all the components and the midpoint of the time it takes to acquire 
the first spectrum. A 1H NMR spectrum is then obtained every 2 minutes. 
1.0 mL of stock solution A was added to camphorsulfonic acid (9.46 mg, 0.041 mmol, 1.3 
equiv) in an NMR tube. The 1H NMR spectrum at t0 was obtained at this point. (tht)Au(Br)3 
(18.7 µL of a 0.005 M solution in CDCl3, 0.3 mol%) and CDCl3 (81.3 µL) were added to the 
tube, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where 
t1 is the time between mixing all the components and the midpoint of the time it takes to acquire 
the first spectrum. A 1H NMR spectrum is then obtained every 2 minutes. 
1.0 mL of stock solution A was added to camphorsulfonic acid (9.46 mg, 0.041 mmol, 1.3 
equiv) in an NMR tube. The 1H NMR spectrum at t0 was obtained at this point. (tht)Au(Br)3 
(12.5 µL of a 0.005 M solution in CDCl3, 0.2 mol%) and CDCl3 (87.5 µL) were added to the 
tube, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where 
t1 is the time between mixing all the components and the midpoint of the time it takes to acquire 






Figure 86: Graph showing the change in ratio between H(Ox) and Me(Ox) over time with 
different catalyst loadings. 
7.3.2. Catalyst screen 
MeArI(OAc)2 (10.5 mg, 0.0312 mmol), CSA (9.46 mg, 0.0406 mmol, 1.3 equiv) and PhI (3.50 
µL, 0.0312 mmol was dissolved in CDCl3/CD3OD (50:1, 1 mL). Catalyst (2 mol%) was added. 
7.3.3. Reaction of PhI(OAc)2 with m-OMeArI (Scheme 25) 
m-OMeArI (59.5 μL, 0.50 mmol), PhI(OAc)2 (177 mg, 0.55 mmol, 1.1 equiv) and 
camphorsulfonic acid (151.65 mg, 0.65 mmol, 1.3 equiv) were dissolved in CHCl3/MeOH 
(50:1 mixture, 1 mL). Bu4NBr (177 mg, 0.55 mmol, 1.1 equiv) was added, and the mixture 
was left for 90 minutes. The solvent was removed, and the crude mixture analysed by 1H NMR 



























Figure 87: 1H NMR spectra of the crude reaction mixture for the reaction shown in Scheme 
25. 
7.3.4. Oxidant potentials 
General procedures for each run are shown below. A summary of the calculated equilibrium 
constant (K) and the calculated potentials are shown in Table 8. 
Run 1 and run 2: 
PhI(OAc)2 (101 mg, 0.310 mmol), camphorsulfonic acid (94.6 mg, 0.40 mmol, 1.3 equiv) and 
CH2Br2 (11 µL, 0.15 mmol, 0.5 equiv) were combined. The mixture was made up to 5 mL 
with a 50:1 solution of CDCl3/CD3OD. 
0.5 mL of the stock solution above was added to the appropriate ArI (0.0312 mmol, 1 equiv) 
and (tht)Au(Br)3 (62 µL of a 0.005 M solution in CDCl3, 1 mol%). The mixture was left 
overnight, then analysed by 1H NMR. All peaks were integrated relative to the CH2Br2 
standard. 
Run 3: 
PhI(OAc)2 (100 mg, 0.310 mmol), camphorsulfonic acid (94.6 mg, 0.40 mmol, 1.3 equiv) and 
CH2Br2 (11.0 µL, 0.156 mmol, 0.5 equiv) were combined. The mixture was made up to 5 mL 
with a 50:1 solution of MeCN-d3/CD3OD. 
0.5 mL of the stock solution above was added to the appropriate ArI (0.1 mmol, 1 equiv) and 
Bu4NBr (62 µL of a 0.010 M solution in MeCN, 2 mol%). The mixture was left overnight, 






Ortho bromo to I 




PhI(OAc)2 (322 mg, 1.0 mmol) and CH2Br2 (35.3 µL, 0.50 mmol, 0.5 equiv) were combined. 
The mixture was made up to 5 mL with CDCl3. 
0.5 mL of the stock solution above was added to the appropriate ArI (0.1 mmol, 1 equiv) and 
(tht)Au(Br)3 (200 µL of a 0.005 M solution in CDCl3, 1 mol%). The mixture was left for two 
days, then analysed by 1H NMR. All peaks were integrated relative to the CH2Br2 standard. 
Table 8: Calculated potentials obtained relative to PhI(X)2 of various substituted hypervalent 
aryliodine(III) oxidants 
 No. R  σ  K E / v 
        
Run 1 1 p-CF3  0.54  11.12 0.0311 
 2 p-NO2  0.78  40.35 0.0478 
 3 p-tBu  -0.20  0.30 -0.0155 
 4 p-Me  -0.17  0.41 -0.0115 
 5 p-Cl  0.23  2.75 0.0131 
 6 p-Br  0.23  2.92 0.0139 
 7 p-OMe  -0.27  0.24 -0.0186 
 8 p-F  0.06  1.54 0.0056 
 9 m-NO2  0.71  29.29 0.0437 
        
Run 2 1 p-F  0.06  1.38 0.0042 
 2 p-CF3  0.54  10.04 0.0298 
 3 p-NO2  0.78  27.98 0.0431 
 4 p-tBu  -0.20  0.40 -0.0117 
 5 p-OMe  -0.27  0.20 -0.0210 
 6 p-Br  0.23  2.76 0.0131 
        
Run 3 1 p-CF3  0.54  9.46 0.0289 
 2 p-NO2  0.78  23.84 0.0407 
 3 m-NO2  0.71  12.45 0.0324 
 4 p-tBu  -0.20  0.41 -0.0113 
 5 p-Me  -0.17  0.43 -0.0107 
 6 p-Br  0.23  2.71 0.0128 
        
Run 4 1 p-F  0.06  1.36 0.0040 
 2 p-CF3  0.54  8.10 0.0270 
 3 p-NO2  0.78  30.61 0.0442 
 4 p-tBu  -0.20  0.43 -0.0108 
 5 p-Br  0.23  2.41 0.0114 




7.3.5. Electrochemistry procedures 
The reduction potential for hypervalent aryliodine(III) diacetates were obtained as described 
in the general experimental for electrochemistry experiments in DCM. 
The cyclic voltammogram and square-wave voltammograms of these oxidants are shown 
below. 
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Figure 88: Left: Cyclic voltammogram of PhI(OAc)2. Right: Square-wave voltammogram of 
PhI(OAc)2. 






























Figure 89: Left: Square-wave voltammogram of p-ClArI(OAc)2. Right: Square-wave 
voltammogram of p-MeArI(OAc)2. 
148 
 













Figure 90: Left: Square-wave voltammogram of p-FArI(OAc)2. Right: Square-wave 
voltammogram of p-CF3ArI(OAc)2. 
7.4. Procedures and data relevant to Chapter 3 
7.4.1. General procedure for competition reactions 
 
A: C9 (344 mg, 1.25 mmol) and CD3OD (245 μL) were mixed, and the solution made up to 
10 mL with CDCl3. 
B: (tht)Au(Br)3 (26.2 mg, 0.05 mmol) was dissolved and made up to 5 mL with CDCl3. 
 
Stock solution A (0.80 mL) and stock solution B (0.20 mL) were combined in an NMR tube. 
The 1H NMR spectrum at t0 was obtained at this point, and the spectrometer was tuned and 
shimmed. The solution was emptied into a vial containing oxidant 1 (0.5 mmol), oxidant 2 
(0.5 mmol), and CSA (27.9 mg, 0.12 mmol) and the mixture was shaken, then pipetted back 
into the NMR tube. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between 
mixing all the components and the midpoint of the time it takes to acquire the first spectrum. 
A 1H NMR spectrum was then obtained every 60 seconds, with 1 scan. 















7.4.2. Procedures relating to the data in Table 6 
Reaction 1 
As described in the general procedure 
Reaction 2 
A: C9 (344 mg, 1.25 mmol) and CD3OD (245 μL) were mixed, and the solution made up to 
10 mL with CDCl3. 
 
Stock solution A and (tht)Au(Cl) (0.64 mg, 2 mol%) were combined in an NMR tube. The 1H 
NMR spectrum at t0 was obtained at this point, and the spectrometer was tuned and shimmed. 
The solution was emptied into a vial containing p-MeArI(OAc)2 (18.5 mg, 0.55 mmol), 
p-ClArI(OAc)2 (19.6 mg, 0.55 mmol), and CSA (27.9 mg, 0.12 mmol) and the mixture was 
shaken, then pipetted back into the NMR tube. A 1H NMR spectrum at t1 was then obtained, 
where t1 is the time between mixing all the components and the midpoint of the time it takes 
to acquire the first spectrum. A 1H NMR spectrum was then obtained every 120 seconds, with 
8 scans. 
Reaction 3 
A: C9 (344 mg, 1.25 mmol) and CD3OD (245 μL) were mixed, and the solution made up to 
10 mL with CDCl3. 
B: (tht)Au(Br)3 (26.2 mg, 0.05 mmol) was dissolved and made up to 5 mL with CDCl3. 
 
Stock solution A (0.80 mL), stock solution B (0.20 mL), and 2-bromothiophene (0.69 μL, 
7 mol%) were combined in an NMR tube. The 1H NMR spectrum at t0 was obtained at this 
point, and the spectrometer was tuned and shimmed. The solution was emptied into a vial 
containing p-MeArI(OAc)2 (16.8 mg, 0.50 mmol), p-ClArI(OAc)2 (17.8 mg, 0.50 mmol), and 
CSA (27.9 mg, 0.12 mmol) and the mixture was shaken, then pipetted back into the NMR 
tube. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between mixing all the 
components and the midpoint of the time it takes to acquire the first spectrum. A 1H NMR 





As described in the general procedure 
Reaction 5 
A: C9 (344 mg, 1.25 mmol) and CD3OD (245 μL) were mixed, and the solution made up to 
10 mL with CDCl3. 
 
Stock solution A and (tht)Au(Cl) (0.64 mg, 2 mol%) were combined in an NMR tube. The 1H 
NMR spectrum at t0 was obtained at this point, and the spectrometer was tuned and shimmed. 
The solution was emptied into a vial containing p-MeArI(OAc)2 (16.8 mg, 0.50 mmol), 
p-CF3ArI(OAc)2 (19.5 mg, 0.50 mmol), and CSA (27.9 mg, 0.12 mmol) and the mixture was 
shaken, then pipetted back into the NMR tube. A 1H NMR spectrum at t1 was then obtained, 
where t1 is the time between mixing all the components and the midpoint of the time it takes 
to acquire the first spectrum. A 1H NMR spectrum was then obtained every 120 seconds, with 
8 scans. 
7.4.3. Procedure relating to Figure 31 
A: C9 (344 mg, 1.25 mmol) and CD3OD (245 μL) were mixed, and the solution made up to 
10 mL with CDCl3. 
B: (tht)Au(Br)3 (26.2 mg, 0.05 mmol) was dissolved and made up to 5 mL with CDCl3. 
C: Bu4NBr (6.44 mg, 0.02 mmol) was dissolved and made up to 2 mL with CDCl3. 
 
CF3CH2I (9.8 μL, 0.1 mmol), p-BrArI(OAc)2 (40.1 mg, 0.1 mmol), and CSA (28.4 mg, 0.12 
mmol) were dissolved in CDCl3 (0.5 mL) in a small vial. Stock solution C (100 μL) was added 
and the vial was shaken vigorously, then left to stand for 15 minutes. A small amount of 
m-OMeArI was added to the solution, and the vial was shaken. The cap of the vial was left off 
to allow for the solvent to evaporate. 
 
Stock solution A (0.8 mL) and stock solution B (0.2 mL) were combined in an NMR tube. The 
1H NMR spectrum at t0 was obtained at this point, and the spectrometer was tuned and 
shimmed. The solution was emptied into the vial holding the oxidants and CSA described 
above, and the mixture was shaken, then pipetted back into the NMR tube. A 1H NMR 
spectrum at t1 was then obtained, where t1 is the time between mixing all the components and 
the midpoint of the time it takes to acquire the first spectrum. A 1H NMR spectrum was then 
obtained every 60 seconds, with 1 scan. 
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7.5. Procedures and data relevant to Chapter 4 
7.5.1. Monitoring the resting state 
 
A: D4 (129 mg, 0.5 mmol), CD3OD (49 μL), and 1,3-C6H4F2 (12 μL) were combined and made 
up to 1 mL with CDCl3.  
B: (tht)Au(Br)3 (26.2 mg, 0.05 mmol) and 1,2-BrArF were combined and made up to 2 mL 
with CDCl3. 
0.010 M [Au] 
Stock solution A (200 μL), stock solution B (100 μL), and CDCl3 (200 μL) were mixed 
together in an NMR tube. The 19F NMR spectrum at t0 was obtained at this point, and the 
spectrometer was tuned and shimmed. CSA (19.2 mg, 0.083 mmol) and p-FArI(OAc)2 (25.5 
mg, 0.075 mmol) were added to the tube, and the tube was shaken vigorously. A 19F NMR 
spectrum at t1 was then obtained, where t1 is the time between mixing all the components and 
the midpoint of the time it takes to acquire the first spectrum. Subsequent spectra were taken 
every 5 seconds, with 1 scan. 
0.006 M [Au] 
Stock solution A (200 μL), stock solution B (60 μL), and CDCl3 (240 μL) were mixed together 
in an NMR tube. The 19F NMR spectrum at t0 was obtained at this point, and the spectrometer 
was tuned and shimmed. CSA (19.2 mg, 0.083 mmol) and p-FArI(OAc)2 (25.5 mg, 0.075 
mmol) were added to the tube, and the tube was shaken vigorously. A 19F NMR spectrum at t1 
was then obtained, where t1 is the time between mixing all the components and the midpoint 
of the time it takes to acquire the first spectrum. Subsequent spectra were taken every 5 




0.014 M [Au] 
Stock solution A (200 μL), stock solution B (140 μL), and CDCl3 (60 μL) were mixed together 
in an NMR tube. The 19F NMR spectrum at t0 was obtained at this point, and the spectrometer 
was tuned and shimmed. CSA (19.2 mg, 0.083 mmol) and p-FArI(OAc)2 (25.5 mg, 0.075 
mmol) were added to the tube, and the tube was shaken vigorously. A 19F NMR spectrum at t1 
was then obtained, where t1 is the time between mixing all the components and the midpoint 
of the time it takes to acquire the first spectrum. Subsequent spectra were taken every 5 
seconds, with 1 scan. 
7.5.2. Reaction shown in Figure 37 
A: CD3OD (39 μL) and 1,3-C6H4F2 (10 μL) were combined and made up to 2 mL with CDCl3. 
D7 (25.8 mg, 0.1 mmol) and (tht)Au(Br)3 (2.64 mg, 0.005 mmol, 5 mol%) were dissolved in 
A (0.5 mL). The 19F NMR spectrum at t0 was obtained at this point, and the spectrometer was 
tuned and shimmed. CSA (18.5 mg, 0.080 mmol) and p-FArI(OAc)2 (25.5 mg, 0.075 mmol) 
were added to the tube, and the tube was shaken vigorously. A 19F NMR spectrum at t1 was 
then obtained, where t1 is the time between mixing all the components and the midpoint of the 
time it takes to acquire the first spectrum. Subsequent spectra were taken every 10 seconds, 
with 1 scan. 
7.5.3. Reoxidation of gold 
 
A: D4 (323 mg, 1.25 mmol), CD3OD (245 μL), and CH2Br2 (50 μL) were combined and made 
up to 10 mL with CDCl3. 
B: (tht)Au(Br)3 (26.3 mg, 0.05 mmol) was made up to 5 mL with CDCl3. 
Stock solution A (0.8 mL) and stock solution B (0.2 mL) were combined in an NMR tube. The 
1H NMR spectrum at t0 was obtained at this point, and the spectrometer was tuned and 
shimmed. CSA (27.9 mg, 0.12 mmol) and PhI(OAc)2 (8.05 mg, 0.025 mmol) were added to 
the tube, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, 
where t1 is the time between mixing all the components and the midpoint of the time it takes 
to acquire the first spectrum. Subsequent spectra were taken every 30 seconds, with 1 scan. 
153 
 
When the oxidant was completely consumed, the sample was ejected and more PhI(OAc)2 
(8.05 mg, 0.025 mmol) was added after approximately 30 seconds. The tube was returned to 
the spectrometer and monitored further by 1H NMR spectroscopy. This was repeated three 
times, until D4 was completely consumed. 
The experiment was repeated with varying delay times before more oxidant was added. 
7.5.4. Setup 1.0 
 
NMR tube insert 
PEEK tubing (1.59 mm OD, 1.0 mm ID) was used to deliver air into the tube. The tubing was 
connected using HPLC fittings to a 50 mL disposable syringe. Air was bubbled into the system 
using a syringe pump. The same tubing was used for the vent. Tefzel® tubing (0.80 mm OD, 
0.25 mm ID) was used to deliver reagents into the tube. This tubing was connected using 
HPLC fittings to a three-way valve, with a 50 μL syringe attached on one end, and a 2.5 mL 






The NMR tube used was a standard 7-inch tube with a plastic cap. The plastic cap was pierced 
with three holes so that the NMR tube insert described above can be fitted in.  The insert was 
placed so that the end of the tubing reached the bottom of the NMR tube.  
Mixing test with a blue solution 
Blue solution was obtained by stirring chloroform (15 mL) with the nib of a permanent pen 
(edding® 142 M blue) suspended in solution for 20 minutes. 
Chloroform (0.5 mL) was added to an NMR tube. The bubbler was switched on, and when a 
constant stream of bubbles was produced, blue solution (20 μL) was injected, and the bubbler 
was immediately switched off. 
Reaction monitoring 
 
A: D4 (103 mg, 0.40 mmol), (tht)Au(Br)3 (10.6 mg, 0.020 mmol), 1,3-C6H4F2 (9.8 μL, 0.1 
mmol), and CD3OD (39 μL) were mixed and made up to 2 mL with CDCl3. 
B: p-FArI(OAc)2 (170 mg, 0.5 mmol), CSA (139 mg, 0.6 mmol), CD3OD (39 μL), and 1,2-
BrArF (55 μL, 0.5 mmol) were combined and made up to 2 mL with CDCl3. 
The reagent tubing in the NMR tube insert was primed with solution B. 
Stock solution A (0.5 mL) was added into an NMR tube with the NMR tube insert, and the 19F 
NMR spectrum at t0 was obtained after tuning and shimming the spectrometer. The insert was 
removed and PhI(OAc)2 (18.9 mg, 0.059 mmol) and CSA (18.2 mg, 0.078 mmol) were added 
to the tube. The tube was capped and shaken vigorously to dissolve all the reagents. The insert 
was placed back into the tube, and a 19F NMR spectra were acquired using a pseudo-2D pulse 
program, with a single scan per spectrum and a 20 second delay between spectra. When the 
oxidant was completely consumed, the acquisition of spectra was stopped, and restarted with 
identical parameters with the exception of a delay time of 2.5 seconds between spectra.  
155 
 
The bubbler was switched on, and the lock display was observed for a constant lock signal, 
indicating a constant stream of bubbles was being produced. Solution B (20 μL) in the NMR 
tube insert was injected and the bubbler was immediately switched off. The resulting reaction 
was monitored by 19F NMR spectroscopy as set up previously. 
7.5.5. Setup 1.1 
Acid/base mixing test 
A: p-fluoroaniline (95 μL, 1.0 mmol) was made up to 5 mL with CDCl3. 
B: AcOH (286 μL, 5 mmol) was made up to 5 mL with CDCl3. 
The reagent tubing in the NMR tube insert was primed with solution B. 
Stock solution A (0.5 mL) was added into an NMR tube with the NMR tube insert. A 1H NMR 
spectrum at t0 was obtained after tuning and shimming the spectrometer. The bubbler was 
switched on, and the lock display was observed for a constant lock signal, indicating a constant 
stream of bubbles was being produced. Solution B (20 μL) in the NMR tube insert was injected 
and the bubbler was immediately switched off. The trigger from the injection initiated the 
pseudo-2D pulse program and started acquisition of 1H NMR spectra with 1 scan and a delay 
time of 3 seconds between spectra. 
Reaction monitoring 
 
A: D4 (103 mg, 0.40 mmol), (tht)Au(Br)3 (10.6 mg, 0.020 mmol), 1,3-C6H4F2 (9.8 μL, 0.1 
mmol), and CD3OD (39 μL) were mixed and made up to 2 mL with CDCl3. 
B: p-FArI(OAc)2 (425 mg, 1.25 mmol), CSA (319 mg, 1.38 mmol), CD3OD (98 μL), and 1,2-
BrArF (137 μL, 1.25 mmol) were combined and made up to 5 mL with CDCl3. 
The reagent tubing in the NMR tube insert was primed with solution B. 
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Stock solution A (0.5 mL) was added into an NMR tube with the NMR tube insert, and the 19F 
NMR spectrum at t0 was obtained after tuning and shimming the spectrometer. The insert was 
removed and PhI(OAc)2 (18.9 mg, 0.059 mmol) and CSA (18.2 mg, 0.078 mmol) were added 
to the tube. The tube was capped and shaken vigorously to dissolve all the reagents. The insert 
was placed back into the tube, and a 19F NMR spectra were acquired using a pseudo-2D pulse 
program, with a single scan per spectrum and a 20 second delay between spectra. When the 
oxidant was completely consumed, the acquisition of spectra was stopped, and restarted with 
identical parameters with the exception of a delay time of 2.5 seconds between spectra.  
The bubbler was switched on, and the lock display was observed for a constant lock signal, 
indicating a constant stream of bubbles was being produced. Solution B (10 μL, 20 μL, or 
30 μL) in the NMR tube insert was injected and the bubbler was immediately switched off. 
The resulting reaction was monitored by 19F NMR spectroscopy as set up previously. 
7.5.6. Setup 2.0 
 
NMR tube insert 
A glass micropipette was glued into the Tefzel® tubing using LOCTITE® EA 9497. To the 
other end of the Tefzel® tubing, another piece of Tefzel® tubing with a larger internal 
diameter was attached using HPLC fittings. The end of the Tefzel® tubing was connected to 
the syringe setup described in Figure 48. 
An NMR cap was pierced, and the tubing was inserted through it. The position of the cap 




Mixing test with a blue solution 
Blue solution was obtained by stirring chloroform (15 mL) with the nib of a permanent pen 
(edding® 142 M blue) suspended in solution for 20 minutes. 
General procedure: 
Chloroform was added to a Shigemi tube. The NMR tube insert was primed with the blue 
solution and placed inside the tube. The blue solution was injected with a driven pressure 
from a compressed air drive against the syringe setup shown in Figure 48. The different 
conditions tested are summarised in Table 9. 
 
Table 9:  Testing mixing efficiency under different conditions. 
 Run CHCl3 / μL Micropipette tip / mm Blue solution / μL Pressure / bar 
     
A 300 0.7 60 5 
B 250 0.7 60 5 
C 300 2.5 60 8 
D 300 2.5 50 8 
E 250 0.7 60 9 
F 250 0.7 60 9 
G 250 0.7 60 5 





Acid/base mixing test 
Using condition G (and H) from Table 9. 
A: p-fluoroaniline (60 μL, 0.633 mmol) was made up to 4 mL with CDCl3. 
B: AcOH (286 μL, 5 mmol) was made up to 10 mL with CDCl3. 
The reagent tubing in the NMR tube insert was primed with solution B. Tuning and shimming 
of the NMR spectrometer was carried out on a dummy sample with the NMR tube insert placed 
inside the Shigemi tube. 
Stock solution A (0.25 mL) was added into a Shigemi tube with the NMR tube insert. 1H NMR 
specta were obtained using a pseudo-2D pulse program with a single scan and a delay time of 
2 seconds between each spectrum. Solution B (60 μL) in the NMR tube insert was injected, 
and the resulting reaction was monitored. 
Reaction monitoring 
 
Using conditions G (and H) from Table 9 
A: D4 (206 mg, 0.80 mmol), (tht)Au(Br)3 (21.15 mg, 0.040 mmol), 1,3-C6H4F2 (19.6 μL, 0.2 
mmol), and CD3OD (78 μL) were mixed and made up to 4 mL with CDCl3. 
B: p-FArI(OAc)2 (142 mg, 0.418 mmol), CSA (106 mg, 0.457 mmol), CD3OD (196 μL), and 
1,2-BrArF (45 μL, 0.418 mmol) were combined and made up to 10 mL with CDCl3. 
The reagent tubing in the NMR tube insert was primed with solution B. Tuning and shimming 
of the NMR spectrometer was carried out on a dummy sample with the NMR tube insert placed 




Stock solution A (0.25 mL) was added into an NMR tube with the NMR tube insert, and the 
19F NMR spectrum at t0 was obtained. The insert was removed and PhI(OAc)2 (24.2 mg, 
0.0751 mmol) and CSA (18.6 mg, 0.0801 mmol) were added to the tube. The tube was capped 
and shaken vigorously to dissolve all the reagents. The insert was placed back into the tube, 
and a 19F NMR spectra were acquired using a pseudo-2D pulse program, with a single scan 
per spectrum and a 15 second delay between spectra. When the oxidant was completely 
consumed, the acquisition of spectra was stopped, and restarted with identical parameters with 
the exception of a delay time of 2 seconds between spectra. Solution B (60 μL) in the NMR 
tube insert was injected. The resulting reaction was monitored by 19F NMR spectroscopy as 
set up previously. 
7.6. Procedures and data relevant to Chapter 5  
7.6.1. General considerations 
1H NMR spectroscopy and 31P{1H} NMR spectroscopy were carried out with a 90° pulse 
angle. Integrations from 31P{1H} NMR spectroscopy were obtained relative to pre-calibrated 
H3PO4 standards in glass capillaries. 
7.6.2. Oxidation of (Ph3P)Au(X) 
Oxidation of (Ph3P)Au(Cl) 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
PhI(OAc)2 (32.2 mg, 0.100 mmol) and CSA (28.4 mg, 0.120 mmol) were dissolved in an NMR 
tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 1H NMR spectrum at t0 was 
obtained at this point. 0.100 mL of stock solution A was added to the tube, and the tube was 
shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between 
mixing all the components and the midpoint of the time it takes to acquire the first spectrum. 
A 1H NMR spectrum was then obtained every 3.5 minutes, with 8 scans where d1 = 20 s. The 
NMR spectrometer was tuned and shimmed on a dummy sample prior to starting the 
experiment. 
Oxidation of (Ph3P)Au(OTs) 
(Ph3P)Au(OTs) (3.15 mg, 0.005 mmol) was dissolved in an NMR tube with CDCl3 (0.700 mL) 
and CD3OD (0.015 mL). The NMR spectrometer was tuned and shimmed, and the 1H NMR 
spectrum at t0 was obtained at this point. PhI(OAc)2 (32.2 mg, 0.100 mmol) and CSA (28.4 
mg, 0.120 mmol) were added to the tube, and the tube was shaken vigorously. A 1H NMR 
spectrum at t1 was then obtained, where t1 is the time between mixing all the components and 
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the midpoint of the time it takes to acquire the first spectrum. A 1H NMR spectrum was then 
obtained every 90 s, with 2 scans where d1 = 20 s.  
7.6.2. Oxidation of (Ph3P)Au(Cl) with ArI(OAc)2 
(Ph3P)Au(Cl) (1.02 mg, 0.002 mmol) was dissolved in CDCl3 (0.600 mL) and CD3OD (0.015 
mL) in an NMR tube. The NMR spectrometer was tuned and shimmed, and the 1H NMR 
spectrum at t0 was obtained at this point. Oxidant (0.100 mmol) and CSA (28.4 mg, 0.120 
mmol) was added to the tube and the tube was shaken vigorously. A 1H NMR spectrum at t1 
was then obtained, where t1 is the time between mixing all the components and the midpoint 
of the time it takes to acquire the first spectrum. A 1H NMR spectrum was then obtained every 
3 minutes, with 6 scans where d1 = 20 s.  
The same experiment was repeated, but monitored by 31P{1H} NMR spectroscopy, where 
spectra were obtained every 5 minutes, with 6 scans and d1 = 45 s. 
7.6.3. Stoichiometric amounts of oxidant 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
PhI(OAc)2 (3.22 mg, 0.010 mmol) and CSA (2.84 mg, 0.012 mmol) were dissolved in an NMR 
tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 1H NMR spectrum at t0 was 
obtained at this point. 0.100 mL of stock solution A was added to the tube, and the tube was 
shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between 
mixing all the components and the midpoint of the time it takes to acquire the first spectrum. 
A 1H NMR spectrum was then obtained every 60 seconds, with 2 scans where d1 = 20 s. The 
NMR spectrometer was tuned and shimmed on a dummy sample prior to starting the 
experiment. 
The same experiment was repeated, but monitored by 31P{1H} NMR spectroscopy, where 




7.6.4. Effect of product addition 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
Addition of triphenylphosphine oxide 
PhI(OAc)2 (3.22 mg, 0.010 mmol), CSA (2.84 mg, 0.012 mmol) and Ph3PO (1.38 mg, 0.005 
mmol) were dissolved in an NMR tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 
1H NMR spectrum at t0 was obtained at this point. 0.100 mL of stock solution A was added to 
the tube, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, 
where t1 is the time between mixing all the components and the midpoint of the time it takes 
to acquire the first spectrum. A 1H NMR spectrum was then obtained every 60 seconds, with 
2 scans where d1 = 20 s. The NMR spectrometer was tuned and shimmed on a dummy sample 
prior to starting the experiment. 
Addition of para-fluoroaryliodine 
PhI(OAc)2 (3.22 mg, 0.010 mmol), CSA (2.84 mg, 0.012 mmol) and p-FArI (1.15 μL, 0.010 
mmol) were mixed in an NMR tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 1H 
NMR spectrum at t0 was obtained at this point. 0.100 mL of stock solution A was added to the 
tube, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where 
t1 is the time between mixing all the components and the midpoint of the time it takes to acquire 
the first spectrum. A 1H NMR spectrum was then obtained every 60 seconds, with 2 scans 
where d1 = 20 s. The NMR spectrometer was tuned and shimmed on a dummy sample prior 
to starting the experiment. 
7.6.4. Addition of more starting complex (Figure 71) 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
Run 1 
PhI(OAc)2 (16.1 mg, 0.050 mmol) and CSA (14.2 mg, 0.060 mmol) dissolved in an NMR tube 
with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 1H NMR spectrum at t0 was obtained at 
this point. 0.100 mL of stock solution A was added to the tube, and the tube was shaken 
vigorously. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between mixing 
all the components and the midpoint of the time it takes to acquire the first spectrum. A 1H 
NMR spectrum was then obtained every 2 minutes, with 4 scans where d1 = 20 s. The NMR 
spectrometer was tuned and shimmed on a dummy sample prior to starting the experiment. 
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When no more product formed, the tube was ejected from the spectrometer and 0.100 mL of 
stock solution A was added, the tube was shaken vigorously and placed back inside the 
spectrometer. The reaction was then monitored as previously described. 
Run 2 
PhI(OAc)2 (16.1 mg, 0.050 mmol) and CSA (14.2 mg, 0.060 mmol) dissolved in an NMR tube 
with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 1H NMR spectrum at t0 was obtained at 
this point. 0.100 mL of stock solution A was added to the tube, and the tube was shaken 
vigorously. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between mixing 
all the components and the midpoint of the time it takes to acquire the first spectrum. A 1H 
NMR spectrum was then obtained every 3.5 minutes, with 8 scans where d1 = 20 s. The NMR 
spectrometer was tuned and shimmed on a dummy sample prior to starting the experiment. 
Run 3 
PhI(OAc)2 (12.8 mg, 0.040 mmol) and CSA (14.2 mg, 0.060 mmol) dissolved in an NMR tube 
with CDCl3 (0.700 mL) and CD3OD (0.015 mL). The 1H NMR spectrum at t0 was obtained at 
this point. 0.100 mL of stock solution A was added to the tube, and the tube was shaken 
vigorously. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between mixing 
all the components and the midpoint of the time it takes to acquire the first spectrum. A 1H 
NMR spectrum was then obtained every 3.5 minutes, with 8 scans where d1 = 20 s. The NMR 
spectrometer was tuned and shimmed on a dummy sample prior to starting the experiment. 
7.6.5. Changing [CSA] 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
PhI(OAc)2 (3.22 mg, 0.010 mmol) and CSA (0.012 mmol, 0.030 mmol, 0.060 mmol or 0.090 
mmol) were dissolved in an NMR tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 
1H NMR spectrum at t0 was obtained at this point. 0.100 mL of stock solution A was added to 
the tube, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, 
where t1 is the time between mixing all the components and the midpoint of the time it takes 
to acquire the first spectrum. A 1H NMR spectrum was then obtained every 60 seconds, with 
2 scans where d1 = 20 s. The NMR spectrometer was tuned and shimmed on a dummy sample 




7.6.6. Using HCIB as oxidant 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
HCIB (4.52 mg, 0.010 mmol) was dissolved in an NMR tube with CDCl3 (0.600 mL) and 
CD3OD (0.015 mL). The 1H NMR spectrum at t0 was obtained at this point. 0.100 mL of stock 
solution A was added to the tube, and the tube was shaken vigorously. A 1H NMR spectrum 
at t1 was then obtained, where t1 is the time between mixing all the components and the 
midpoint of the time it takes to acquire the first spectrum. A 1H NMR spectrum was then 
obtained every 60 seconds, with 2 scans where d1 = 20 s. The NMR spectrometer was tuned 
and shimmed on a dummy sample prior to starting the experiment. 
7.6.7. Premixing CSA and (Ph3P)Au(Cl) (Figure 75) 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
Run 1:  
CSA (14.2 mg, 0.060 mmol) was dissolved in an NMR tube with CDCl3 (0.600 mL) and 
CD3OD (0.015 mL). 0.100 mL of stock solution A was added to the tube, and the mixture was 
left for 20 minutes. The 1H NMR spectrum at t0 was obtained after this. PhI(OAc)2 (16.1 mg, 
0.050 mmol) was added, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was 
then obtained, where t1 is the time between mixing all the components and the midpoint of the 
time it takes to acquire the first spectrum. 
Run 1’: 
PhI(OAc)2 (16.1 mg, 0.050 mmol) and CSA (14.2 mg, 0.060 mmol) were dissolved in an NMR 
tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 1H NMR spectrum at t0 was 
obtained at this point. 0.100 mL of stock solution A was added to the tube, and the tube was 
shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between 
mixing all the components and the midpoint of the time it takes to acquire the first spectrum. 
A 1H NMR spectrum was then obtained every 60 seconds, with 2 scans where d1 = 20 s. The 





Run 2:  
CSA (2.83 mg, 0.012 mmol) was dissolved in an NMR tube with CDCl3 (0.600 mL) and 
CD3OD (0.015 mL). 0.100 mL of stock solution A was added to the tube, and the mixture was 
left for 20 minutes. The 1H NMR spectrum at t0 was obtained after this. PhI(OAc)2 (3.22 mg, 
0.010 mmol) was added, and the tube was shaken vigorously. A 1H NMR spectrum at t1 was 
then obtained, where t1 is the time between mixing all the components and the midpoint of the 
time it takes to acquire the first spectrum.  
Run 2’: 
PhI(OAc)2 (3.22 mg, 0.010 mmol) and CSA (2.84 mg, 0.012 mmol) were dissolved in an NMR 
tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 1H NMR spectrum at t0 was 
obtained at this point. 0.100 mL of stock solution A was added to the tube, and the tube was 
shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where t1 is the time between 
mixing all the components and the midpoint of the time it takes to acquire the first spectrum. 
A 1H NMR spectrum was then obtained every 60 seconds, with 2 scans where d1 = 20 s. The 
NMR spectrometer was tuned and shimmed on a dummy sample prior to starting the 
experiment. 
7.6.8. Addition of HCl 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
PhI(OAc)2 (3.22 mg, 0.010 mmol) and CSA (0.012 mmol, 0.030 mmol, 0.060 mmol or 0.090 
mmol) were dissolved in an NMR tube with CDCl3 (0.600 mL) and HCl in methanol (0.015 
mL, 1.25 M) was added to the mixture. The 1H NMR spectrum at t0 was obtained at this point. 
0.100 mL of stock solution A was added to the tube, and the tube was shaken vigorously. A 
1H NMR spectrum at t1 was then obtained, where t1 is the time between mixing all the 
components and the midpoint of the time it takes to acquire the first spectrum. A 1H NMR 
spectrum was then obtained every 60 seconds, with 2 scans where d1 = 20 s. The NMR 
spectrometer was tuned and shimmed on a dummy sample prior to starting the experiment. 
The same experiment as above was carried out, but monitored by 31P{1H} NMR spectroscopy, 




7.6.9. Addition of Bu4NCl 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
Bu4NCl (1.39 mg, 0.005 mmol), PhI(OAc)2 (3.22 mg, 0.010 mmol), and CSA (2.84 mg, 0.012 
mmol) were dissolved in an NMR tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 
31P{1H} NMR spectrum at t0 was obtained at this point. 0.100 mL of stock solution A was 
added to the tube, and the tube was shaken vigorously. A 31P{1H} NMR spectrum at t1 was 
then obtained, where t1 is the time between mixing all the components and the midpoint of the 
time it takes to acquire the first spectrum. A 31P{1H} NMR spectrum was then obtained every 
2.5 min, with 3 scans where d1 = 45 s. The NMR spectrometer was tuned and shimmed on a 
dummy sample prior to starting the experiment. 
7.6.10. Reaction of (Ph3P)Au(Cl)3 with PhI(X)2 
PhI(OAc)2 (3.22 mg, 0.010 mmol), and CSA (2.84 mg, 0.012 mmol) were dissolved in an 
NMR tube with CDCl3 (0.700 mL) and CD3OD (0.015 mL). The 1H NMR spectrum at t0 was 
obtained at this point. (Ph3P)Au(Cl)3 (2.78 mg, 0.005 mmol) was added to the tube, and the 
tube was shaken vigorously. A 1H NMR spectrum at t1 was then obtained, where t1 is the time 
between mixing all the components and the midpoint of the time it takes to acquire the first 
spectrum. A 1H NMR spectrum was then obtained 30 seconds, with 1 scan. The NMR 
spectrometer was tuned and shimmed on a dummy sample prior to starting the experiment. 
The same experiment was repeated, but monitored by 31P{1H} NMR spectroscopy, where 




7.6.11. Effect of (Ph3P)Au(Cl)3 addition 
A: (Ph3P)Au(Cl) (24.7 mg, 0.050 mmol) was made up to 1 mL with CDCl3. 
Bu4NCl (1.35 mg, 0.005 mmol), PhI(OAc)2 (3.22 mg, 0.010 mmol), and CSA (2.84 mg, 0.012 
mmol) were dissolved in an NMR tube with CDCl3 (0.600 mL) and CD3OD (0.015 mL). The 
31P{1H} NMR spectrum at t0 was obtained at this point. 0.100 mL of stock solution A was 
added to the tube, and the tube was shaken vigorously. A 31P{1H} NMR spectrum at t1 was 
then obtained, where t1 is the time between mixing all the components and the midpoint of the 
time it takes to acquire the first spectrum. A 31P{1H} NMR spectrum was then obtained every 
2.5 min, with 3 scans where d1 = 45 s. The NMR spectrometer was tuned and shimmed on a 
dummy sample prior to starting the experiment. 
After the 15th spectrum was obtained, (Ph3P)Au(Cl)3 (2.88 mg, 0.010 mmol) was added to the 
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